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ABSTRACT 
 
Severe lower limb injuries are potentially devastating and pose some of the most difficult 
decisions in trauma surgery. The goal is to ensure survival and reconstruct the most 
functional limb possible. Ideally this is achieved by salvaging the injured limb. However, 
in certain situations amputation is the safest and most effective method of achieving an 
optimal outcome. Errors in these decisions may have profound consequences, yet they are 
frequently based on incomplete information and uncertain risks. Furthermore, most 
surgeons have limited experience making these decisions, and existing decision-support 
tools are unhelpful. 
The aim of this thesis was to improve the understanding of decision-making following 
severe lower limb trauma, and develop accurate prognostic models that can help identify 
those patients whose limb can be safely and effectively salvaged, and also identify those 
for whom attempts at limb salvage would be dangerous or fail.  
The rationale for amputation decisions was analysed in a cohort of severe lower limb 
injuries (n = 579). Two prognostic models were designed to support difficult aspects of 
these decisions. Both models were developed using Bayesian networks that combine 
existing knowledge with individual patient data. The first provides early and accurate 
identification (AUROC = 0.927) of patients at risk of Trauma-Induced Coagulopathy, the 
principal indication for damage-control intervention. The model’s performance in new 
patients, and ability to handle missing predictor information, was prospectively validated. 
The second model accurately predicts the likely outcome, in terms of viability, of 
attempted limb salvage. This model outperformed the most widely used decision-support 
tool, the Mangled Extremity Severity Score (AUROC 0.932 versus 0.723; P < 0.0001). 
These Bayesian network tools accurately quantify critical risks that make rational 
judgement on the safety and effectiveness of interventions possible. This information 
enables individualised and evidence-based decisions, at a time when decision-making is 
most effective. 
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KEY DEFINITIONS 
 
I have used the generally accepted definitions of the following key terms that are used 
throughout this thesis: 
 
Severe lower limb trauma: 
A lower limb injury that poses a threat to the patient’s life or the limb’s viability, and 
requires either 1) emergency surgery for haemorrhage, ischaemia or compartment 
syndrome, 2) surgical reconstruction of the functional tissues (vessels, bone, soft tissue, 
nerve) or 3) amputation.  
 
Traumatic amputation: 
A traumatic amputation is the complete amputation of the extremity by the injuring force. 
 
Primary amputation: 
Primary amputation is the surgical amputation of an injured limb as the first operative 
procedure, either because it is decided that reconstruction is not technically possible or 
that reconstruction would be harmful. 
 
Secondary amputation: 
Secondary amputation is the surgical amputation of an injured limb as a secondary 
procedure following an initial attempt at limb salvage. Secondary amputation may be 
performed within hours of injury to many years after injury. Indications include non-
viable tissue, infection, chronic pain, and functional limitations. 
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CHAPTER ONE 
 
Introduction 
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1.1  The Significance of Severe Lower Limb Trauma 
 
1.1.1 The Health Impact of Injuries 
Injuries may be defined as any intentional or unintentional physical damage to the tissues 
of the body caused by an external force such as a road traffic collision, a fall, or violence 
(Smith et al., 2010). They are a global public health problem, with every member of 
society in every country of the world at risk. In 2010, injuries caused 11.2 percent of the 
world’s burden of disease, including 5.1 million deaths (Lozano et al., 2012)	 and 47.2 
million years lived with disability (Murray et al., 2012, Vos et al., 2012). To put this in 
context, injuries are responsible for more global disease burden than HIV/AIDS, TB and 
Malaria combined (8.6 percent); all neoplasms (7.8 percent); or ischaemic heart disease 
(5.2 percent), the leading individual cause of worldwide disease burden (Murray et al., 
2012). Furthermore, injuries are one of the few causes of disease with an increasing 
global burden and this trend is predicted to continue (WHO, 2014).  
Although all humans are at risk, injuries typically affect young, healthy, active members 
of society and males more than females. Ninety percent of the global injury burden 
occurs in low- and middle-income countries (WHO, 2014), however in high-income 
countries, injury remains the leading cause of death in the first four decades of life (CDC, 
2010). 
 
Substantially more injuries result in long-term disability than in death (Chandran et al., 
2010). Approximately 80 percent of survivors of major injuries, defined as an Injury 
Severity Score > 15, (Gabbe et al., 2012, Ringburg et al., 2011, Evans et al., 2003) and a 
similar proportion of injured patients hospitalised for more than 24 hours (Polinder et al., 
2007, Holbrook et al., 1999), continue to experience injury-related functional disabilities 
one year after injury. Few of these patients will experience any functional recovery 
beyond a year after injury (Holbrook et al., 1999, Gabbe et al., 2012, Polinder et al., 
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2007). Up to a quarter of these patients experience severe disabilities that make them 
dependent on assistance for normal daily activities (Gabbe et al., 2012).  
 
 
1.1.2 The Health Impact of Lower Limb Injuries 
Musculoskeletal injuries are the most common reason for surgery following major trauma 
(Balogh et al., 2012) and an important contributor to global disability (Mock and Cherian, 
2008). Although our understanding of injury-related causes of disability is poor compared 
to our understanding of injury-related causes of death, lower extremity injuries are 
consistently identified as major determinants of poor long-term functional outcome, and 
the resulting disability and dependence (Gabbe et al., 2012, Pape et al., 2010, Polinder et 
al., 2007, Holbrook et al., 1999, Holtslag et al., 2007, Ringburg et al., 2011). In low-
income counties, such as Ghana, lower extremity injuries are the predominant cause of 
long-term disability (Mock et al., 2003). In developed countries, traumatic brain injury 
(Rosenfeld et al., 2012) and lower extremity injury (Pape et al., 2010, Brohi et al., 2011) 
are responsible for the majority of long-term injury-related disability. 
A landmark group of studies, the Lower Extremity Assessment Project (LEAP), 
investigated outcomes of patients with major lower-extremity injuries (MacKenzie and 
Bosse, 2006). This large, multicentre, prospective observational study recruited adult 
patients at eight level-1 trauma centres in the United States and followed them up for 
seven years (MacKenzie et al., 2005). The results provide the best available evidence on 
which to base our understanding of the health impact of major lower limb trauma. Overall, 
it found that the disability resulting from these injuries is both profound and prolonged 
(Bosse et al., 2002, MacKenzie et al., 2005). 
 
Physical Health 
A 2002 LEAP publication in the New England Journal of Medicine (Bosse et al., 2002) 
reported the functional outcomes of patients two years after severe lower extremity 
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injuries. The primary outcome measure was the Sickness Impact Profile (SIP), a self-
reported measure of health status (Bergner et al., 1981). The SIP measures an injury’s 
impact on overall health and its impact in two major domains, physical and mental health. 
They found that patients with lower extremity injuries had substantially worse physical 
function than normal populations, with over 40 percent having severe physical disability. 
Although early functional improvements were observed, these had plateaued by two years, 
and beyond this significantly worsened with time (MacKenzie et al., 2005). By seven 
years after injury only one third of lower limb trauma patients had normal physical 
function with over half experiencing severe physical disability (MacKenzie et al., 2005). 
Population ageing and the development of secondary conditions, such as arthritis and 
chronic pain, may in part explain this physical deterioration.  
Although the LEAP study describes the outcomes achieved at leading US level-1 trauma 
centres, similar high levels of profound physical disability following lower limb trauma 
have been reported in other high-income countries (Pape et al., 2010, Mkandawire et al., 
2002), low-income countries (Mock et al., 2003) and the military (Doukas et al., 2013). 
 
Mental Health 
It is now recognised that survivors of major injuries are at increased risk of developing 
mental health disorders (Shih et al., 2010, Holbrook et al., 2005). Post-Traumatic Stress 
Disorder (PTSD), major depression, anxiety, and substance abuse are the most common 
and frequently co-exist (Shih et al., 2010, Hoge et al., 2004, Brown et al., 2000). 
Development of these disorders diminishes the patients’ ability to cope with their 
physical disabilities and is an important determinant of poor long-term health outcomes 
(Wegener et al., 2011). 
 
The LEAP study described the poor psychosocial outcomes of civilians with severe lower 
limb injuries. Seven years after injury, half of limb trauma patients had psychosocial 
outcomes worse than normal, with more than one third having severe psychosocial 
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disabilities. Furthermore, a significant deterioration in psychosocial functioning with time 
was observed (MacKenzie et al., 2005). In a more detailed assessment of psychological 
distress, the LEAP investigators revealed that almost half of the patients screened positive 
for a psychological disorder within two years of injury and reaffirmed that the disability 
did not improve with time (McCarthy et al., 2003). Although the LEAP studies did not 
screen for PTSD, one in five patients in their cohort developed severe phobic anxiety and 
a similar proportion of patients developed severe depression (McCarthy et al., 2003). 
 
A meta-analysis of the psychological responses to civilian trauma showed a similar 
pattern of disorders to those developed in soldiers following military traumatic stress 
(Brown et al., 2000). This suggests a common psychopathology to major trauma, 
independent of mechanism or setting. The Military Extremity Trauma Amputation/Limb 
Salvage (METALS) study examined psychological outcomes following severe lower 
extremity injury in the recent wars in Afghanistan and Iraq (Doukas et al., 2013). They 
report high levels of psychological distress, mirroring the LEAP study results. At a mean 
follow-up time of three years post-injury, nearly one in five soldiers (18 percent) screened 
positive for PTSD and 13 percent had developed severe depression. 
 
Chronic Pain 
Acute pain normally accompanies tissue injury and will usually ease with healing. The 
development of chronic pain following injury is pathological. Chronic pain is highly 
prevalent after major trauma and is a leading cause of disability, lost productivity, and 
human suffering (Rivara et al., 2008). Furthermore, the development of chronic pain 
and/or mental health disorders can markedly impede functional recovery following injury 
(Wegener et al., 2011).  
 
A number of observational studies have reported the prevalence of chronic pain in severe 
lower limb trauma populations (Table 1.1). The largest prospective study was performed 
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by the LEAP group (Castillo et al., 2006). They demonstrated significantly higher levels 
of chronic pain than in the general population. Seven years after injury only 23 percent of 
patients were pain free, while in 28 percent pain was severe enough to interfere with daily 
activities. These levels of chronic pain are comparable to other notable debilitating pain 
conditions such as backache and migraine headache (Castillo et al., 2006).  
 
Table 1.1: Observational studies reporting the prevalence of chronic pain in populations 
with severe lower limb injuries. 
 
 
1.1.3 Factors that Influence the Health Impact of Severe Lower Limb Injuries 
There is a wide variation in functional outcome after major lower-extremity trauma that 
cannot be explained by the injury or injury treatment alone (MacKenzie and Bosse, 2006, 
Mock and Cherian, 2008). Using regression analysis, a number of additional factors that 
influence outcome have been identified, and together, may explain the majority of 
outcome variance (Bosse et al., 2002, MacKenzie et al., 2004). Broadly these can be 
divided into pre-injury, injury and post-injury factors (Figure 1.1). 
Reference 
Study 
type 
Sample 
Size 
Follow-up 
(months) 
Setting 
Chronic pain Outcome 
Measurea Overall  Severe 
Soni et al. (2012) Retro 18 60 Civilian 72 % 11 % EQ-5D 
Mkandawire et al. (2002) Retro 25 60 Civilian 80 % 12 % Pain scale 
Gopal et al. (2004) Retro 33 46 Civilian 45 % 3 % EQ-5D 
Georgiadis et al. (1993) Retro 34 44 Civilian 74 % 9 % Pain scale 
Hertel et al. (1996) Retro 44 83 Civilian 68 % 7 % VAS 
Hoogendoorn (2001) Retro 56 n/a Civilian 55 % 13 % Pain scale 
Giannoudis et al. (2009b) Retro 67 37.4 Civilian 51 % 9 % EQ-5D 
Mock et al. (2000) Prosp 302 12 Civilian 66 % 17 % VAS 
Doukas et al. (2013) Retro 324 37.5 Military n/a 20 % CPG 
Castillo et al. (2006) Prosp 397 84 Civilian 77 % 28 % CPG 
Retro, Retrospective; Prosp, Prospective; n/a, not available. 
a EQ-5D (Rabin and Charro, 2001); VAS, Visual Analogue Scale (Scott and Huskisson, 1976); CPG, 
Chronic Pain Grade Scale (Von Korff et al., 1992); Pain scale, Authors’ own pain scale. 
	 27	
 
Figure 1.1: Factors influencing the long-term functional outcome of trauma survivors 
with severe lower limb injuries. 
 
Pre-injury factors 
Older age, female gender and presence of co-morbidities are well-described risk factors 
for poor functional outcomes after major trauma (Gabbe et al., 2012, Holbrook et al., 
1999, Holbrook and Hoyt, 2004, Holtslag et al., 2007, Polinder et al., 2007) and severe 
lower limb trauma (Doukas et al., 2013, MacKenzie et al., 2005, Mock and Cherian, 
2008). Smoking and low self-efficacy have also been identified as important predictors of 
poor outcome in patients with severe lower limb injuries (MacKenzie et al., 2005), and 
these factors may be more amenable to modification. The LEAP study highlighted the 
impact that social and economic factors have on determining eventual functional outcome. 
In civilian lower-extremity trauma populations, poverty, low level of education and poor 
social support are independently associated with worse outcomes (MacKenzie et al., 2005, 
Mock and Cherian, 2008), while military rank and poor social support are independently 
associated with worse outcomes in military lower-extremity trauma populations (Doukas 
et al., 2013). Possible reasons for these associations include poverty and level of 
education being markers of access to health and rehabilitation care (MacKenzie and 
Bosse, 2006), and lower military rank being a marker of more intense combat experience 
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with a higher risk of developing complications such as depression and PTSD (Doukas et 
al., 2013). 
 
Injury factors 
The location and degree of tissue destruction following severe lower limb trauma, 
together with the treatment of these injuries, are the primary determinants of functional 
outcome. However, pre- and post-injury factors also have an important influence on 
eventual outcome. 
 
Post-injury factors 
There is growing evidence that the level of trauma care is an important predictor of long-
term functional outcomes after injury. Treatment at a specialised trauma centre is 
associated with improved outcomes in both major trauma (Gabbe et al., 2012) and severe 
lower limb trauma populations (Mackenzie et al., 2008).  
Secondary conditions such as treatment complications (Harris et al., 2009), chronic pain 
(Castillo et al., 2006),  and psychological disorders (McCarthy et al., 2003), also 
influence outcome, and the development of these conditions is common following severe 
lower limb injuries. Although these secondary conditions have previously been 
recognised as independent predictors of poor functional outcome after trauma (Holbrook 
et al., 1999, Mock et al., 2000), only in recent years has the major impact on functional 
outcomes been appreciated (Wegener et al., 2011). 
The relationship between gender, chronic pain and psychological morbidity may in part 
explain the gender difference in functional outcomes after severe lower limb injuries. 
Females are at particular risk of developing secondary psychological disorders, with 
significantly higher rates of post-injury depression and PTSD than males (Holbrook et al., 
2002, Holbrook et al., 2001). Chronic pain is also more common in females and in 
patients that develop secondary psychological disorders (Castillo et al., 2006).  
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An additional risk factor for developing chronic pain after lower-extremity injury is the 
intensity of acute pain during recovery; while opiate analgesia, high self-efficacy, and a 
higher level of education seem to be protective (Castillo et al., 2006). 
Finally, involvement in compensation litigation is associated with worse functional 
outcomes in major trauma (Harris et al., 2008) and major lower-extremity trauma 
populations (MacKenzie et al., 2005, Mock et al., 2000). 
 
1.1.4 Military Lower Limb Injuries 
Advances in body armour and military medicine have resulted in improved survival and a 
change in wounding patterns of injured soldiers (Owens et al., 2008). As a result, severe 
extremity trauma has become the predominant injury in modern warfare (Owens et al., 
2007). Injured soldiers differ in important ways from injured civilian populations. Most 
importantly, the mechanism of injury in modern warfare is predominantly high-energy 
blasts. Other important differences include: 1) soldiers are on average younger, 2) in 
better pre-injury physical condition, 3) have unmatched access to excellent trauma care, 
rehabilitation and prosthetic services and 4) have robust support networks. For these 
reasons, outcomes following severe lower extremity trauma may be different in soldiers 
than in civilians (MacKenzie and Bosse, 2006). 
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1.2  Contemporary Management of Severe Lower Limb Trauma 
 
1.2.1 Advances in Trauma Care  
Recent decades have seen major advances in the management of injured patients. Many 
of these advances impact the outcome of patients with severe lower limb trauma. This 
progress spans resuscitation, reperfusion, reconstruction, and rehabilitation, and in many 
respects, has been driven by military innovation. Limb salvage is now potentially possible 
in patients that would historically have died or required an amputation. In parallel, radical 
advances in prosthetic technology and rehabilitative medicine have improved the 
outcome of amputees.  
 
Resuscitation 
The concepts of damage control, which focus on rapidly restoring normal physiology in 
exsanguinating patients, have redefined trauma resuscitation (Shapiro et al., 2000). Early 
haemorrhage control combined with the management of coagulopathy have been 
recognised as central to outcome, and Damage Control Resuscitation (DCR) aims to 
directly address these endeavours (Jansen et al., 2009, Holcomb et al., 2007a, Duchesne 
et al., 2010a). DCR involves early haemostatic resuscitation with blood products, rather 
than the traditional crystalloid fluids, and the tolerance of moderate hypotension until 
haemorrhage control is imminent. Damage Control Surgery (DCS) (Shapiro et al., 2000, 
Rotondo et al., 1993) involves abbreviated techniques to stop haemorrhage, minimise 
contamination, and restore limb perfusion (Rasmussen et al., 2006b); while Damage 
Control Orthopaedics (DCO) (Giannoudis et al., 2009a, Pape, 2008) involves abbreviated 
techniques to provide skeletal stabilization and optimize soft tissue perfusion. Both DCS 
and DCO are performed simultaneously with DCR and aim to support effective 
resuscitation while limiting further harm. 
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Major advances in pre-hospital care facilitate these damage control principles and include 
earlier access to effective resuscitation and haemorrhage control strategies, and 
expeditious evacuation to appropriate medical facilities. Notable with regard to severe 
limb trauma is the newly defined role of tourniquets in modern trauma care, for 
temporary extremity haemorrhage control (Kragh et al., 2009).  
 
Reconstructive surgery 
Surgical advances in 1) vascular repair and reconstruction, 2) fracture fixation and bone 
reconstruction, 3) microvascular free tissue transfer and, to a lesser degree, 4) nerve 
reconstruction, have allowed limb salvage to replace amputation as the primary treatment 
for severe lower limb trauma (Wagels et al., 2013). Together with the time-tested 
principles of debridement and antisepsis, these modern advances in surgery form the 
pillars of limb reconstruction. Recent advances in wound management, such as negative 
pressure wound therapy, may also have a considerable impact on the management of 
severe lower limb injuries (Couch and Stojadinovic, 2011, Nanchahal J, 2009). 
 
Rehabilitation and prosthesis technology 
Remarkable advances in prosthetic components and materials, including breakthrough 
innovations in shock absorption, prosthetic joints and osseo-integration, have created 
more comfortable, efficient and life-like artificial limbs. These advances have afforded 
amputees remarkable functional levels and improved the quality of their lives (Laferrier 
and Gailey, 2010, Marks and Michael, 2001). 
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1.2.2 Principles of Lower Limb Trauma Management 
 
1.2.2.1 Pre-operative interventions 
 
Control haemorrhage 
Exsanguination from an extremity injury is a leading cause of preventable military death 
(Holcomb et al., 2007b, Mabry et al., 2000, Kelly et al., 2008). Although less common, 
civilian deaths from extremity exsanguination do occur (Dorlac et al., 2005). 
Consequently, control of catastrophic haemorrhage is the first clinical priority when 
treating a patient with severe lower limb injuries, which can usually be achieved with 
direct pressure and limb elevation. If haemorrhage continues a tourniquet is indicated. In 
extreme situations, such as those involving mass casualties or where rescuer safety is at 
risk, a tourniquet may be the primary means of extremity haemorrhage control. When 
indicated, correct tourniquet application improves survival with minimal associated 
morbidity (Kragh et al., 2009) (Kragh et al., 2008). Furthermore, early application 
improves effectiveness, particularly if applied before clinical signs of shock develop 
(Kragh et al., 2009). 
Incorrect application and prolonged use may result in iatrogenic morbidity and possible 
mortality. Skeletal muscle is the most vulnerable limb tissue to ischaemia. Animal and 
human studies suggest muscle may tolerate warm ischaemia for up to three hours, 
following this progressive and severe myonecrosis occurs (Blaisdell, 2002, Glass et al., 
2009). The amount of ischaemic muscle damage not only affects limb viability, it is also 
a critical aspect of reperfusion injury (Percival and Rasmussen, 2012). To minimise risk, 
the continued need for an emergency tourniquet should be reviewed at the earliest 
possible opportunity, preferably within two hours of application. 
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Prevent pain  
Opiate or Ketamine analgesia should be administered as soon after injury as possible. Not 
only do these agents control acute pain, they may also reduce the risk of chronic pain 
(Huse et al., 2001, Nikolajsen et al., 1996). Painful symptoms before amputation are 
associated with an increased risk of phantom limb pain (Flor, 2002, Nikolajsen and 
Jensen, 2001) and pre-emptive analgesia may disrupt the development of pain memories 
that are central to chronic pain pathogenesis (Katz and Melzack, 1990). Several studies 
suggest that pre-emptive analgesia with epidural anaesthesia may also reduce the 
incidence of phantom limb pain (Bach et al., 1988, Jahangiri et al., 1994). However, a 
randomised, double-blinded study showed no benefit and highlighted the risks of epidural 
anaesthesia (Flor, 2002). An important limitation of this study is that the sample 
population required amputation for chronic pathology, so epidural analgesia was not truly 
pre-emptive, as central nervous system changes may have already been established. The 
role of pre-emptive epidural anaesthesia in the acute limb trauma population has therefore 
not yet been clearly defined. 
 
Minimise contamination 
Infections are a common complication and an important source of morbidity following 
severe lower limb injuries. The infection risk is directly related to injury severity, and 
wound infections occur in approximately one quarter of civilian (Pollak et al., 2010) and 
military (Brown et al., 2010) mangled extremities.  
The most important step in minimising infection risk is operative debridement. Pre-
operative management should simply aim to remove gross contamination, seal the wound, 
and administer antibiotic prophylaxis (Nanchahal J, 2009, Murray et al., 2008). Pre-
operative wound exploration, debridement and irrigation may drive infection deeper into 
tissues and should be avoided (Nanchahal J, 2009). Repeated wound inspections and 
dressing changes also promote infection. To minimise this, wounds should be 
photographed, covered with a sterile, saline soaked dressing and sealed with an adhesive 
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film to minimise evaporation (Nanchahal J, 2009). Dressings and wounds should not be 
soaked in povidone-iodine antiseptics. The antimicrobial activity after exposure to blood 
is disputable, and the resulting tissue staining makes the assessment of tissue viability at 
debridement difficult. Furthermore, absorption of iodine in large open wounds can result 
in local and systemic toxicity (Nanchahal J, 2009, Misra and Nanchahal, 2003). 
Early administration of prophylactic antibiotics is a standard of care and of proven value 
in reducing the risk of infection (Gosselin et al., 2004, Hoff et al., 2011). In military and 
civilian settings, antibiotics should be administered as soon as possible, preferably within 
3 hours of injury (Patzakis and Wilkins, 1989, Jackson, 1984, Hauser et al., 2006, 
Nanchahal J, 2009). Guidelines on the choice of antibiotic and duration of prophylaxis 
are summarized in Table 1.2. Routine wound cultures are not recommended and should 
only be obtained to guide treatment when infection is clinically suspected (Murray et al., 
2008). Tetanus status should be checked and prophylaxis administered if required.  
 
1.2.2.2 Emergency operative interventions 
 
The best outcomes are achieved when patients with severe limb injuries are managed in 
specialist trauma centres by experienced multidisciplinary teams that include combined 
orthopaedic and plastic surgical care (Mackenzie et al., 2008, Nayagam et al., 2011, 
Nanchahal J, 2009). Direct triage, or immediate referral, of patients with these injuries to 
such units is justified. Emergency limb surgery is indicated when uncontrolled 
haemorrhage, compromised perfusion, compartment syndrome, or gross contamination 
are present. All other limb surgery should only take place after resuscitation and 
normalisation of physiology (Nanchahal J, 2009). 
 
Wound debridement  
Meticulous excision of devitalised tissue followed by wound irrigation is the most 
important intervention in reducing infection risk. The timing is controversial, urgent 
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surgery within six hours of injury is a widely accepted standard, but not supported by 
evidence (Crowley et al., 2007a). Delays of up to 24 hours do not increase infection risk 
or worsen outcome (Webb et al., 2007, Pollak et al., 2010, Naique et al., 2006, Crowley 
et al., 2007a). The best outcomes are achieved when an experienced ortho-plastic team 
performs scheduled surgery within 24 hours of injury (Nanchahal J, 2009).  
All viable tissue must be preserved, flaps should not be fashioned and no part of the 
wound should be closed at initial operation (Clasper, 2007, Tintle et al., 2010b). Removal 
of viable tissue at his stage may compromise limb reconstruction and eventual outcome. 
Wounds may however, be extended along faciotomy lines to improve exposure and 
facilitate complete excision of devitalised tissue. As wounds are evolving, a second 
procedure should be undertaken in 24 to 48 hours; further staged procedures may be 
required. Accurate technique is important to avoid excessive procedures, which may 
worsen outcome (Park et al., 2002). 
Guillotine amputations must be avoided (Mannion and Chaloner, 2005, Coupland, 1989, 
Clasper, 2007, Tintle et al., 2010b, Fergason et al., 2010). The only exception is as a pre-
hospital emergency procedure to relieve entrapment in an immediately life-threatening 
situation (Porter, 2010). 
 
Wound irrigation 
Wound irrigation with sterile saline is performed after adequate debridement. Antibiotic 
and antiseptic additives should be avoided (Crowley et al., 2007b, Anglen, 2005). A low-
pressure (< 15psi) irrigation method using the traditional fluid volume of at least nine 
litres is recommended (Crowley et al., 2007b, Nanchahal J, 2009). High-pressure pulsed 
lavage, especially above 50 psi, should be avoided as it may result in tissue damage and 
may drive bacteria deeper into wounds (Crowley et al., 2007b). 
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Table 1.2: Guidelines for antibiotic prophylaxis in patients with severe open fractures of 
the lower limb. 
 
 
Temporary wound dressing 
The ideal temporary wound dressing would prevent bacterial ingress, avoid tissue damage 
and desiccation, and not require regular changing. Negative pressure wound therapy 
Reference Association Antibiotic Duration 
Additional 
comments 
Nanchahal J 
(2009) 
BOA and 
BAPRAS 
Co-amoxiclav 1.2 grams 8-hourly IV 
or Cefuroxime 1.5 grams 8-hourly IV. 
Single dose of Gentamicin (1.5mg/kg) 
on induction of anaesthesia 
(debridement and reconstruction). 
Single dose of Vancomycin 1gram or 
Teicoplanin 800mg on induction of 
anaesthesia (reconstruction). 
Until soft tissue 
closure or a 
maximum of 72 
hours, whichever is 
sooner 
Mild penicillin allergy 
use cephalosporin. 
Severe penicillin 
allergy use 
Clindamycin 600mg 
6-hourly IV. 
Hoff et al. 
(2011) 
EAST Systemic antibiotic with gram 
positive and gram negative cover 
72 hours or not 
more than 24 hours 
after soft tissue 
coverage achieved 
Add Penicillin in 
suspected faecal or 
clostridial 
contamination. 
 
Hauser et 
al. (2006) 
SIS 1st generation Cephalosporin 24 – 48 hours Insufficient evidence 
to support additional 
gram negative or 
clostridial cover, 
prolonged courses or 
repeat short courses.  
Dufour D 
(1998) 
ICRC Penicillin G 5MIU 6-hourly IV for 48 
hours followed by Penicillin V 500mg 
6-hourly orally. 
5 days or until 
delayed primary 
closure 
Add Metronidazole in 
land mine injuries and 
delays to treatment of 
> 72 hours. 
BOA: British Orthopaedic Association 
BAPRAS: British Association of Plastic, Reconstructive and Aesthetic Surgeons 
EAST: Eastern Association for the Surgery of Trauma 
SIS: Surgical Infection Society 
ICRC: International committee of the Red Cross 
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meets many of these criteria and has dramatically changed the way complex traumatic 
wounds are managed (Orgill and Bayer, 2011, Couch and Stojadinovic, 2011, Nanchahal 
J, 2009). Randomised control trials support the improved wound healing and reduced 
infection risk of this therapy (Moues et al., 2004, Stannard et al., 2009). The use of 
antibiotic bead pouches in complex wounds may also reduce infection rates compared to 
systemic antibiotics alone (Nanchahal J, 2009). 
 
1.2.2.3 Definitive operative intervention 
 
Limb reconstruction 
Over the past few decades there have been tremendous advances in the ability to 
reconstruct limb trauma. It has now become technically possible to reconstruct severe 
lower limb injuries that would previously have mandated amputation. This has not made 
decision-making simpler, on the contrary, decisions now not only need to consider 
whether limb salvage is possible, but also the more complex question of whether a 
salvaged limb would produce a better outcome than would be achieved by an amputation 
with prosthesis. Nonetheless, these advances in vascular, soft tissue, and orthopaedic 
reconstruction, have transformed the outcomes of patients who suffer severe lower limb 
trauma. 
 
Vascular reconstruction 
In 1912, a French surgeon, Alexis Carrel, was awarded the Nobel Prize for his pioneering 
work developing vascular suturing techniques. These techniques form the basis of 
modern day vascular reconstruction. However, despite this knowledge, reconstruction of 
vascular injuries was rarely performed for many decades following Carrel’s descriptions. 
Ligation was still the standard surgical treatment for arterial trauma in World War II 
(1939 – 1945) (DeBakey and Simeone, 1946). The results were poor, with amputation 
rates of 81 percent following ligation of the common femoral artery, 55 percent following 
	 38	
ligation of the superficial femoral artery, and 73 percent following ligation of the 
popliteal artery (DeBakey and Simeone, 1946). By the end of World War II (1945), as 
these dismal outcomes became clear, there was a shift towards arterial repair, with 
improved limb salvage rates (Barr et al., 2015). Advances in the repair of vascular 
injuries continued during the Korean War (1950 – 1953) (Hughes, 1958). And by the 
Vietnam War (1955 – 1975), vascular reconstruction had become the standard of care for 
arterial trauma (Rich et al., 1970). The results of limb salvage had substantially improved, 
with amputation rates reduced to thirteen percent following reconstruction of extremity 
vascular trauma (Rich et al., 1970). 
Many of the principles fundamental to reconstruction of vascular injuries were developed 
during these 20th century wars. Vascular reconstruction should be performed under 
general anaesthesia with sufficient blood products available for transfusion if required. 
The injury should be adequately exposed with proximal and distal control of involved 
vessels. High-energy injuries may cause extensive intimal damage; therefore the injured 
vessel should be carefully debrided until normal intima is seen. Next, proximal and distal 
arterial thrombus is removed using an embolectomy catheter followed by irrigation with 
heparin/saline solution. Definitive vascular reconstruction is then performed using an 
appropriate technique. Simple lacerations may be repaired with a lateral suture or patch 
angioplasty, while transected or debrided vessel edges, which can be approximated 
without any tension, may be reconstructed with an end-to-end anastomosis. If tension-
free approximation is not possible, an interposition graft is indicated. Autologous vein is 
the preferred interposition conduit for definitive reconstruction (Mitchell Iii and Thal, 
1990). However prosthetic grafts may have advantages in certain situations, for example 
as a temporary conduit during Damage Control procedures or when suitable autologous 
vein is not available (Feliciano et al., 1985, Vertrees et al., 2009). Concomitant deep 
venous injuries proximal to the trifurcation should also be reconstructed where possible 
(Kuralay et al., 2002). 
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The outcome of vascular reconstruction, and limb salvage, is critically dependant on the 
duration of ischaemia (Glass et al., 2009). Delayed reperfusion risks irreversible damage 
to the functional limb tissues, increased amputation rates, and potentially life-threatening 
reperfusion complications (Glass et al., 2009, Percival and Rasmussen, 2012). Therefore, 
extremity vascular injuries need to be recognised quickly and managed as a surgical 
emergency. The aim is to restore limb perfusion as quickly as possible, ideally within 
three to four hours of injury (Glass et al., 2009, Nanchahal J, 2009).  
Careful clinical examination remains the cornerstone of vascular injury diagnosis, with 
adjunct Doppler examination if necessary. Patients with hard signs of a vascular injury 
should undergo immediate surgical exploration (NICE, 2016, Nanchahal J, 2009). 
Revascularisation should not be delayed for formal angiography as this may worsen 
outcome (Glass et al., 2009, NICE, 2016). If imaging is required an on-table angiography 
is preferable. A CT angiogram may be considered in patients with multiple injuries that 
require a CT scan as part of their initial assessment, or in patients where the site of 
vascular injury is unclear (NICE, 2016). 
Temporary Vascular Shunts (TVS) are an important adjunct to vascular reconstruction 
that can reduce the duration of ischaemia significantly (Glass et al., 2009). By enabling 
early limb perfusion, TVS are particularly valuable in situations where the patient needs 
to be transferred to a higher level of care, other life-threatening injuries need to be 
managed (Damage Control), or time is required for safe skeletal fixation or careful wound 
assessment, prior to definitive vascular repair. TVS have proved safe and effective 
adjuncts to the management of both civilian (Subramanian et al., 2008) and military 
(Rasmussen et al., 2006b) extremity vascular trauma. In severe lower limb injuries with 
co-existing fractures, the most effective sequence of interventions, to reduce the duration 
of ischaemia and improve functional limb salvage, appears to be: direct exploration, TVS, 
skeletal fixation, followed by definitive vascular and soft tissue repair (Glass et al., 2009). 
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Skeletal reconstruction 
Skeletal stability is required to facilitate wound healing and protect vascular and soft 
tissue reconstructions (Nanchahal J, 2009). Intramedullary nailing is the procedure of 
choice for closed fractures of the femoral and tibial shaft (Giannoudis et al., 2006). Open 
fractures may be definitively treated with internal or external fixation (Bhandari et al., 
2001, Giannoudis et al., 2006). The choice is determined by the anatomy of the fracture, 
degree of tissue loss, degree of contamination, and timing of soft tissue cover (Nanchahal 
J, 2009). For severe open fractures, a combined orthoplastic approach, that allows 
immediate internal fixation and soft tissue coverage with muscle flaps, is safe and 
provides good results (Gopal et al., 2000). In physiologically compromised patients, who 
may not be able to withstand definitive fracture fixation, provisional skeletal stabilisation 
may be accomplished with a spanning external fixator. This strategy is termed Damage 
Control Orthopaedics (DCO) (Scalea et al., 2000, Giannoudis et al., 2009a). If DCO is 
used, definitive stabilisation should be performed as soon as possible after the patient has 
recovered, preferably within 72 hours of injury (Nanchahal J, 2009). 
 
Soft tissue reconstruction 
All exposed fractures, metalware, tendons, and neurovascular structures should be 
covered with vascularised soft tissue. Together with adequate wound debridement, early 
definitive soft tissue cover is essential to reduce infection complications and allow 
healing (Godina, 1986). For optimal results, definitive soft tissue cover should be 
achieved within 72 hours of injury. However, in situations where exposed vascular 
structures and metalware are present, definitive soft tissue cover should be achieved 
immediately (Liu et al., 2012). 
Small defects with a limited zone of injury may be covered with local fasciocutaneous or 
muscle flaps, while larger defects frequently require transfer of healthy donor tissue to 
achieve adequate cover (Nanchahal J, 2009). Microsurgery techniques that allow free 
tissue transfer have revolutionised lower limb reconstruction (Godina, 1986). These free 
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flaps, which may be fasciocutaneous, muscle, bone, or a combination (Chimeric), allow 
reconstruction of almost any defect. The choice of flap is determined by the injury 
characteristics. For example, defects around joints are best covered with fasciocutaneous 
flaps, while muscle flaps may improve healing of open shaft fractures (Nanchahal J, 
2009). Free flap reconstruction should, however, be performed by an experienced team, 
in a specialist centre, following adequate patient preparation (Nanchahal J, 2009). 
 
Nerve reconstruction 
Peripheral nerve injuries that produce loss of function may be classified according to the 
degree of nerve damage into neurapraxia (intact nerve), axonotmesis (disruption of axon 
with preservation of supporting structure), and neurotmesis (complete disruption of 
nerve) (Seddon, 1943, Sunderland, 1951). Full functional recovery is expected following 
neurapraxia and spontaneous recovery is possible following axonotmesis. Nerve injuries 
that do not recover spontaneously (neurotmesis and some axonotmesis) remain a 
challenging and difficult surgical reconstruction problem. Nerve reconstruction 
techniques include external neurolysis, end-to-end repair, nerve graft, and nerve transfer 
(Spinner and Kline, 2000). However, functional outcomes following attempts to repair 
injured lower limb nerves are generally poor (Lundborg, 2000), and a complete 
transection of a major lower limb nerve remains an important consideration for 
amputation (Lange et al., 1985). Although our understanding of nerve regeneration and 
brain plasticity continues to improve, new breakthroughs that allow us to translate this 
knowledge into clinical applications that improve outcomes are needed (Lundborg, 2000). 
 
Residual limb reconstruction 
Residual limb reconstruction should be planned once the wound appears clean and free 
from non-viable tissue. For optimal outcome, reconstruction should aim to preserve the 
maximum limb length possible with adequate soft tissue cover. Amputation in the zone of 
injury may increase the risk of wound complications in the short-term, but this is offset 
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by an improvement in overall outcome. Every effort should be made to preserve viable 
bone and functional joints. Amputation at the level of a fracture should be avoided if 
distal viable bone and soft tissue is present. These proximal fractures should be managed 
with standard fracture reduction and fixation techniques (Gordon et al., 2010, Clasper, 
2007).  
 
At the planned level of amputation, careful attention to the distal bone ends will avoid 
unnecessary morbidity. The tibia or femur should be beveled anteriorly and the edges 
carefully smoothed. The fibula should be shortened by three to four centimeters more 
than the tibia and sculpted smooth (Smith and Fergason, 1999, Bourke et al., 2010). The 
role of a bone bridge between the distal tibia and fibula in traumatic amputees is 
controversial (Pinzur et al., 2007). This technique may improve tibio-fibular instability, 
enhance weight bearing and improve functional outcome (Pinzur et al., 2006), although 
more reliable evidence supporting these benefits is required (Pinzur et al., 2008). 
 
Soft tissue reconstruction must provide sufficiently durable and comfortable padding over 
the residual bone to allow optimal prosthesis use. This is achieved with a firmly secured 
myocutaneous flap. The most distal level of viable soft tissue should dictate the level of 
amputation (Clasper, 2007). At this level standard amputation flaps are frequently 
compromised by the injury. To preserve length, the available soft tissue (“flaps of 
opportunity”) should be used to reconstruct the soft tissue envelope (Tintle et al., 2010b). 
This atypical flap coverage does not increase wound complications (MacKenzie et al., 
2004). Other reconstructive surgical techniques to preserve limb length include skin 
grafts (Anderson et al., 2002), tissue expansion (Wieslander et al., 1996), and tissue 
transfer with pedicled (Ghali et al., 2005) or free flaps (Kasabian et al., 1991, Erdmann et 
al., 2002). Length preservation must not however, be at the expense of adequate soft 
tissue coverage as this may result in a painful, non-healing residual limb that cannot be 
used. 
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A second function of the soft tissue reconstruction is to restore muscular control to the 
residual limb. Loss of normal muscle attachments results in muscular imbalance, 
contractures and reduced function (Gottschalk, 1999). This is most marked in trans-
femoral amputees where loss of adductor magnus attachment results in a flexion-
abduction deformity that contributes to an inefficient gait. Myodesis of detached muscle 
groups to the residual bone will preserve normal anatomic and mechanical alignment and 
optimise function (Gottschalk, 1999). Myodesis is achieved by suturing residual muscle, 
under physiological tension, directly to the periosteum or bone through drill holes (Tintle 
et al., 2010b). Myodesis is recommended for traumatic amputations as it improves 
outcome (Gottschalk, 1999, Pinzur et al., 2007, Persson, 2001). 
 
The management of nerves in a lower limb amputation 
Neuroma formation cannot be prevented following nerve transection. However, only 10 
to 25 percent of neuromas become symptomatic, usually because they are exposed to 
mechanical stimulation. Accurate surgical management of the nerve ending reduces the 
incidence of symptomatic neuromas. All named nerves should be identified. Using 
traction, each should be cut as proximal as possible, allowing the end to retract into the 
soft tissues, away from the stump. For trans-tibial amputations the sural nerve requires 
particular attention to prevent inclusion in the scar. A novel microsurgical technique, the 
sciatic nerve sling, may also reduce chronic post-amputation pain (Prantl et al., 2006). 
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1.3  Decision-Making following Severe Lower Limb Trauma 
 
1.3.1 Defining the Problem 
Deciding on the most beneficial method of treatment for a patient with a severely injured 
lower limb is complex and often difficult (Scalea et al., 2012, de Mestral et al., 2013). All 
patients want their injuries to be reconstructed, and their limbs to be salvaged. Major 
advances in reconstructive surgery have made this technically possible for the majority of 
injuries. However, there are a number of situations where this approach can cause 
significant harm. Patients with life-threatening injuries may not have the physiological 
reserve to tolerate complex and lengthy reconstructive procedures (Shapiro et al., 2000). 
Attempting definitive surgery in such patients may interfere with resuscitative 
interventions and result in deaths that could otherwise be prevented. Harm may also be 
caused in patients with injuries that are beyond repair. Prolonged and ultimately futile 
attempts at reconstruction may cause substantial physical and psychological morbidity 
that could be avoided with earlier amputation (Bondurant et al., 1988, Hansen Jr, 1989). 
Furthermore, some technically salvaged limbs may be more disabling than limb 
amputation combined with modern prostheses and rehabilitation.  
Recognising which situation applies to an individual patient is difficult because the risks, 
benefits, and outcomes of different treatment strategies are uncertain when these 
decisions need to be made. In particular, limb amputation is clearly an irreversible 
procedure that commits the patient to a definite functional and physical impairment, 
while the comparative risks of salvage may not be immediately evident. Furthermore, 
delaying decisions until risks are clear can worsen outcome, and errors in judgement may 
have considerable consequences including unnecessary amputation or death.  
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1.3.2  Goals of Contemporary Management 
The fundamental goal of the surgical management of severe lower limb trauma is to 
provide the patient with the most functional limb, or residual limb, possible. Implicit to 
this goal is the patient surviving their injury. So clinical decision-making is not simply 
whether salvage is technically possible but a more complex decision process that takes 
into account the risk of death with each treatment option and whether salvage will 
produce a better long-term functional outcome than an amputation with prosthesis would 
achieve. Not only do these decisions need to avoid unnecessary death or limb amputation, 
but also minimise the profound disability associated with prolonged attempts at futile 
limb salvage. 
 
1.3.3  Guidelines for the Management of Severe Lower Limb Trauma 
To aid in the complex decision-making, a number of guidelines have been developed that 
are relevant to the management of severe lower limb trauma (Table 1.3). 
 
The key principles common to these guidelines are: 
Resuscitation  
a) The initial evaluation of the patient with a severe lower limb injury remains the 
same as for any patient with serious injuries. A systematic approach that 
facilitates the rapid identification and simultaneous management of life-
threatening injuries should be used. 
b) The treatment of life-threatening injuries takes priority over limb-threatening 
injuries. 
c) Active haemorrhage is the only immediate life threat resulting from severe lower 
limb injuries and must be rapidly controlled with direct pressure. Uncontrolled 
haemorrhage requires emergency surgery. In these situations, the temporary 
application of a tourniquet, until surgical control is achieved, may be life saving.  
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d) Limb ischaemia is the most important limb-threatening condition. Injuries that 
result in limb ischaemia must be recognised promptly and treated as an 
emergency.  
 
Surgery 
a) Limb salvage is critically dependent on ischaemic time. Early insertion of 
temporary vascular shunts may significantly reduce ischaemic time allowing 
timely resuscitation, wound evaluation, fracture stabilisation and definitive 
vascular repair. 
b) Formal operative wound evaluation is essential to inform definitive limb 
management decision-making.  
c) Initial limb surgery should include liberal use of compartment faciotomies. 
d) Limb amputation may be a necessary procedure to achieve an optimal outcome 
and is not a failure of surgical management. 
e) Definitive limb or residual limb reconstruction should only be considered in 
patients with normal physiology, which has recovered from any initial 
derangements.  
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Table 1.3: Management guidelines relevant to severe lower limb trauma. 
Reference  Title Association 
NICE (2016)  Major Trauma: Complex Fractures (draft guideline) NICE 
Feliciano et al. (2013)  Western Trauma Association Critical Decisions in 
Trauma: Evaluation and management of peripheral 
vascular injury, Part II. 
WTA 
Fox et al. (2012)  Evaluation and management of penetrating lower 
extremity arterial trauma: An Eastern Association for the 
Surgery of Trauma practice management guideline. 
EAST 
Scalea et al. (2012)  Western Trauma Association Critical Decisions in 
Trauma: Management of the mangled extremity. 
WTA 
Feliciano et al. (2011)  Evaluation and Management of Peripheral Vascular 
Injury. Part 1. Western Trauma Association/Critical 
Decisions in Trauma 
WTA 
Feliciano (2010)  Management of peripheral arterial injury n/a 
Nanchahal J (2009)   Standards for the management of open fractures of the 
lower limb. 
BOA and 
BAPRAS 
Glass et al. (2009)  Improving lower limb salvage following fractures with 
vascular injury: a systematic review and new 
management algorithm. 
n/a 
Gillespie (2008)  Clinical practice guidelines for vascular injury JTTS 
ACS (2005)  Management of Complex Extremity Trauma ACS 
Feliciano (2002)  Management of the mangled extremity ACS 
EAST, Eastern Association for the Surgery of Trauma; WTA, Western Trauma Association; BOA, 
British Orthopaedic Association; BAPRAS, British Association of Plastic, Reconstructive and 
Aesthetic Surgeons; JTTS, Joint Theatre Trauma System; ACS, American College of Surgeons 
Committee on Trauma. n/a, not applicable 
 
 
1.3.4 Key Decisions in Severe Lower Limb Trauma Management 
The key management decisions emphasised in the lower-extremity trauma management 
guidelines are summarised in figure 1.2. For optimal decision-making, an understanding 
of the important elements of each decision is required. These include 1) the time frame 
available, 2) the ideal information required for optimal decision-making, 3) the actual 
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information available given the time frame, and 4) how an accurate decision will benefit a 
patient with severe lower limb injuries. 
 
 
Figure 1.2: Contemporary management of severe lower limb trauma and corresponding 
decision-making. DCS: Damage Control Surgery. 
 
Decision One: Is the patient’s life at Risk? 
The first decision involves deciding which patients will benefit from definitive care and 
which would benefit from a Damage Control approach to resuscitation and surgery. This 
decision needs to be made as soon as possible after injury, ideally within a few minutes of 
hospital arrival, or possibly even during the pre-hospital phase. Damage Control is of 
benefit to bleeding patients whose physiology is compromised by tissue hypoperfusion 
and coagulopathy (Roberts et al., 2015). This group of patients has a significantly 
increased risk of death (Brohi et al., 2003). Early identification of these patients enables 
timely access to the resources required, and has the potential to improve survival in these 
time-critical patients. Incorrect decisions will not only compromise survival but may also 
impact the potential for successful limb salvage.  
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Clinical markers of tissue perfusion, including blood gas analysis results, may be 
available within this time frame. However, these decisions are normally made without 
any objective evidence of the patient’s risk of coagulopathy or death. Laboratory 
coagulation test results are not available within a useful time frame (Davenport et al., 
2011) and accurate mortality predictions require information that is also not immediately 
available. 
Within the same time frame, it must be decided whether the limb injury is contributing to 
the life threat. This is based on clinical signs of major haemorrhage from the limb. In 
these patients emergency haemorrhage control is indicated. Emergency haemorrhage 
control may necessitate procedures that jeopardise the potential for limb salvage, for 
example vessel ligation or prolonged tourniquet application, while other life-threats are 
managed.  
 
Decision Two: Is the limb’s vascular supply compromised? 
Once management of life-threatening injuries is underway, the next priority is to decided 
whether the injured limb requires reperfusion. The duration of limb ischaemic is critical 
to salvage and one of the few variables that the treating team has some control over. Early 
identification of injuries resulting in vascular compromise will enable timely reperfusion 
and improve the potential for limb salvage. Clinical examination, ankle brachial pressure 
index measurements, and computerised tomographic angiography will usually provide 
sufficient information for accurate decision-making. 
 
Decision Three: Is the limb viable? 
During the initial operative evaluation of lower limb injuries, the surgeon needs to make 
decisions regarding the viability of the remaining tissues. Clinically non-viable tissue is 
debrided. As wounds are evolving, an assessment of the predicted viability of remaining 
tissues is made. Surgeons, and their patients, should use this operative information to 
make decisions on whether to pursue limb salvage or proceed with amputation. Operative 
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evaluation of severe lower limb injuries should occur within 24 hours of injury and 
definitive management decisions should be made soon thereafter, ideally within 72 hours 
(NICE, 2016).  
 
Decision Four: Does sufficient functional tissue remain? 
Finally, the treating team need to decide whether the reconstructed limb has the potential 
to provide a better functional outcome than an amputation with prosthesis would achieve. 
This requires an assessment of the functional capacity of the remaining healthy tissue 
together with an assessment of the patient’s preference. These decisions should be made 
as soon as possible after injury, usually within the first few days, because delayed 
amputation decisions, either because of a passive decision-making strategy or following 
prolonged attempts at unsuccessful limb salvage, are associated with significant physical 
and mental morbidity, and mortality (Bondurant et al., 1988). 
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1.4 Decision-Support for Severe Lower Limb Trauma 
 
1.4.1 Background to the Severe Lower Limb Trauma Decision-Support Tools 
In an attempt to assist surgeons with the complex decision-making, a number of scores 
have been developed to differentiate the group of patients that will benefit from limb 
salvage from those in whom limb salvage attempts may be harmful and likely futile (table 
1.4). These scores combine a number of prognostic factors to enable the categorisation of 
an individual patient into the most appropriate management pathway (table 1.5). 
 
 
Table 1.4: Predictive scores to assist surgical management decisions in patients with 
severe lower limb trauma. 
Reference Predictive Score Acronym  
Gregory et al. (1985) Mangled Extremity Syndrome Index MESI  
Howe et al. (1987) Predictive Salvage Index PSI  
Johansen et al. (1990) Mangled Extremity Severity Score MESS  
Russell et al. (1991) Limb Salvage Index LSI  
McNamara et al. (1994) Nerve injury, Ischaemia, Soft tissue injury, 
Skeletal injury, Shock, Age 
NISSSA  
Krettek et al. (2001) Hanover Fracture Scale HFS ‘98  
Rajasekaran et al. (2006) Ganga Hospital Score GHS  
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Table 1.5: Prognostic factors utilised by the lower limb predictive scores. 
Prognostic Factor MESI PSI MESS LSI NISSSA HFS ‘98 GHS 
Patient Factors        
Age X  X  X  X 
Co-morbidities X      X 
Injury Factors        
Mechanism of injury X  X  X   
Injury Severity X      X 
Limb injury factors        
Arterial injury X X X X X X  
Level of arterial injury  X      
Venous injury X   X    
Skeletal injury X X X X X X X 
Soft tissue injury X X X X X X X 
Nerve injury X  X X X X X 
Complications        
Shock X  X  X X X 
Duration of ischaemia X X X X X X  
Wound contamination   X   X X 
MESI, Mangled Extremity Syndrome Index; PSI, Predictive Salvage Index; MESS, Mangled 
Extremity Severity Score; LSI, Limb Salvage Index; NISSSA, Nerve injury, Ischaemia, Soft 
tissue injury, Skeletal injury, Shock, Age; HFS ’98, Hanover Fracture Scale; GHS, Ganga 
Hospital Score. 
X: Prognostic Factor included in score or score was developed for injuries with this prognostic 
factor present. 
 
 
1.4.2 Severe Lower Limb Trauma Predictive Scores 
 
Mangled Extremity Syndrome Index (MESI) 
Proposed by Gregory et al. (1985). 
Aim: To develop a simple grading system to objectively assess the severity of an 
extremity injury and identify, at initial evaluation, the functionally salvageable versus the 
probably unsalvageable extremity. 
Setting: Single US level-1 trauma centre: Eastern Virginia Medical School 
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Study population: Adults and children with upper- or lower-extremity trauma involving 
significant injuries to at least 3 of the 4 major limb tissues (integument, nerve, vessels or 
bone). Traumatic amputations excluded. 
Outcome definition: Limb salvage or amputation (primary or secondary). Duration of 
follow-up not reported. 
Development: Retrospective analysis of data from 17 patients with mangled extremities, 
five patients had upper-extremity injuries and some had multiple extremity injuries. 
Seven patients had their limbs salvaged and ten underwent amputation. Ten clinical 
variables 1) Age, 2) co-morbidities, 3) Injury severity, 4) shock, 5) ischaemic time, 6) 
skeletal injury, 7) arterial injury, 8) venous injury, 9) nerve injury and 10) integument 
injury, were selected as predictors based on what the authors believe to be pertinent to 
prognosis. The predictors were catagorised and a point score, increasing with increasing 
risk, attached to each category. The MESI score is a summation of these ten scores. A 
score of > 20 is suggested as predictive of the need for amputation. 
Validation: No validation was performed. 
Authors’ conclusion: MESI may be useful in identifying patients, at initial evaluation, 
with functionally salvageable limbs or limbs that require amputation. 
 
Predictive Salvage Index (PSI) 
Proposed by Howe et al. (1987). 
Aim: To identify all variables that might influence the ultimate outcome of combined 
vascular and orthopaedic injuries of the lower-extremity and develop a predictive score 
using these variables. 
Setting: Single US level-1 trauma centre: Wake Forest University Medical Centre, North 
Carolina. 
Study population: Adults with combined orthopaedic and vascular trauma of the lower-
extremity. 
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Outcome definition: Limb salvage or amputation (primary or secondary). Duration of 
follow-up not reported. 
Development: Retrospective analysis of data from 21 injured limbs. Twelve limbs were 
salvaged and nine limbs were amputated. Four clinical variables 1) level of arterial injury, 
2) degree of bone injury, 3) degree of muscle injury and 4) ischaemic time, were 
identified by univariate analysis and included as predictors in the index. The predictors 
were catagorised and a point score, increasing with increasing risk, attached to each 
category. The PSI score is a simple summation of these four scores. In the development 
cohort, a score of ≥ 8 had a sensitivity of 78 percent and a specificity of 100 percent for 
predicting the need for amputation. 
Validation: The authors did not validate their score. 
Authors’ conclusion: The PSI score may prevent surgeons from attempting to salvage a 
doomed or useless lower-extremity. This may permit earlier prosthetic rehabilitation after 
definitive primary amputation. 
 
Mangled Extremity Severity Score (MESS) 
Proposed by Johansen et al. (1990). 
Aim: To develop and validate a simple and accurate prognostic score using objective 
clinical criteria that can discriminate between salvageable lower limb injuries and those 
that warrant amputation. 
Setting: Two US level-1 trauma centres: Harborview Medical Centre and Tampa General 
Hospital. 
Study population: Open fractures of the lower-extremity with associated vascular 
compromise. Patients with a transection of the sciatic or posterior tibial nerve were 
excluded as these injuries were regarded as an absolute indication for primary amputation. 
Outcome definition: Limb salvage or amputation (primary or secondary). Patients were 
followed-up for 18 months after injury. 
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Development: Retrospective analysis of data from 26 injured limbs. Seventeen limbs 
were salvaged and nine limbs were amputated. Four clinical variables 1) skeletal/soft 
tissue injury, 2) limb ischaemia, 3) shock and 4) age, were selected as predictors based on 
what the authors believe to be pertinent to prognosis. They emphasise the selection of 
objective clinical criteria available early in the hospital course. The predictors were 
catagorised and a point score, increasing with increasing risk, attached to each category. 
The MESS score is a simple summation of these four scores. A score of ≥ 7 is suggested 
as predictive of the need for amputation. The authors acknowledge that this cut-off 
threshold is dependent on available technology and expertise. 
Validation: The score was internally validated using the development cohort and an 
additional form of temporal validation was performed using a second, prospectively 
collected, cohort combining subsequent patients at the same institution and patients from 
a different level-1 trauma centre. The prospective analysis consisted of data from 26 
injured limbs. Fourteen limbs were salvaged and twelve limbs amputated. All salvaged 
limbs had a score of 6 or less, and all amputations, 7 or more. Accuracy is reported as 100 
percent. The authors assessed discrimination by comparing the mean MESS scores for 
salvaged and amputated limbs using an unpaired students t-test. A statistically significant 
(p<0.001) difference between mean scores in both arms of the study exists. 
Authors’ conclusion: MESS may be useful in selecting patients whose lower-extremity 
injuries warrant amputation. 
 
Limb Salvage Index (LSI) 
Proposed by Russell et al. (1991). 
Aim: To develop an objective index that will assist surgical decisions during the initial 
and operative evaluation of severe lower-extremity injuries by predicting which patients 
would benefit from limb salvage and which should undergo early amputation. 
Setting: Single US Level-1 trauma centre: Erlanger Medical Centre, Tennessee. 
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Study population: Adults and children with lower-extremity arterial injuries. Half the 
population had a blunt mechanism of injury and the other half penetrating. Traumatic 
amputations were excluded. 
Outcome definition: Limb salvage or amputation (primary or secondary). Patients whose 
limbs were salvaged but underwent elective amputation for functional indications were 
included as amputations.  
Development: Retrospective analysis of data from 70 injured limbs. Fifty-one limbs were 
salvaged and 19 amputated. Seven prognostic variables 1) Arterial injury, 2) Nerve injury, 
3) skeletal injury, 4) skin injury, 5) muscle injury, 6) venous injury and 7) ischaemic time, 
were identified by univariate analysis and included as predictors in the index. The 
predictor variables were catagorised and a point score, increasing with increasing risk, 
attached to each category. Ischaemic time was weighted by having the most categories. 
The LSI is a summation of these seven scores. A score of ≥ 6 is suggested as an absolute 
indication for amputation. 
Validation: The index was internally validated using the development cohort. All 
salvaged limbs had a score of 5 or less, and all amputations, 6 or more. The authors 
assessed performance by comparing the mean (student’s t-test) and median (Mann-
Whitney U test) LSI scores for salvaged and amputated limbs. The differences were 
statistically significant. The correlation between outcome and LSI score was calculated 
using the Pearson correlation co-efficient. 
Authors’ conclusion: The LSI is a valuable objective tool for the evaluation of severe 
limb injuries that can accurately identify patients that would benefit from limb salvage. 
 
Nerve injury, Ischaemia, Soft tissue injury, Skeletal injury, Shock, Age (NISSSA) 
Proposed by McNamara et al. (1994). 
Aim: To modify the MESS score so as to improve the predictive performance for patients 
with open tibial fractures. 
Setting: Single US Level-1 trauma centre: Medical Centre Hospital, San Antonio, Texas. 
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Study population: Adults and one child with open tibial fractures graded as type IIIB or 
IIIC according to the classification system of Gustilo and Anderson (Gustilo et al., 1984). 
Outcome definition: Salvage or amputation (primary or secondary). Patients with 
salvaged limbs were followed-up for an average of 21.6 months. 
Development: Retrospective analysis of data from 24 injured limbs. Thirteen limbs were 
salvaged and eleven amputated. Six clinical variables 1) Nerve injury, 2) Ischaemia, 3) 
Soft tissue injury, 4) Skeletal injury, 5) Shock and 6) Age, were selected as predictors 
based on a stepwise logistic regression analysis of individual variables. This represents a 
modification of the MESS score by adding a nerve injury variable and separating the 
MESS skeletal/soft tissue variable into its components to give them greater weight in the 
score. The predictor variables were catagorised and a point score, increasing with 
increasing risk, attached to each category. The NISSSA score is a summation of these six 
scores (range 0 – 19).  A score of ≥ 9 is the optimal threshold for predicting the need for 
amputation. 
Validation: Performance was assessed on the development cohort. Treating surgeons 
were not aware of score results. At the optimal threshold of NISSSA score ≥ 9, sensitivity 
was 82 percent and specificity 92 percent with a positive predictive value of 90 percent. 
Authors’ conclusion: Modification of the MESS score to the NISSSA score resulted in 
improved performance at predicting amputation in severe open tibial fractures. 
 
Hanover Fracture Scale (HFS ’98) 
Proposed by Krettek et al. (2001). 
Aim: 1) To modify an existing extremity salvage score, the Hanover Fracture Scale 1983, 
to include only variables with prognostic significance that are available during initial 
operative debridement. 2) To validate the modified score.  
Setting: Single Specialist Trauma Centre: Unfallchirurgische Klinik, Hannover, Germany. 
Study population: Adults with open long-bone fractures of upper and lower limbs. 
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Outcome definition: Primary amputation was defined as an amputation occurring within 
48 hours of injury and secondary amputation occurring after this. Only primary 
amputation predictive performance was validated.  
Development: Retrospective analysis of data from 182 injured limbs. Twenty limbs were 
amputated (eleven primary amputations) and 162 salvaged. Eight clinical variables: 1) 
Bone loss, 2) Periosteal stripping, 3) skin injury, 4) Muscle injury, 5) Limb Neurology, 6) 
Wound contamination, 7) Ischaemic time and 8) shock, were selected as predictors based 
on a multivariate analysis of variables from the original score and additional variables 
which included shock, periosteal stripping and AO classification. The level of 
significance for consideration was p < 0.05. The predictor variables were catagorised and 
a point score, increasing with increasing risk, attached to each category. The HFS ’98 
score represents a summation of these eight scores (range 0 – 22). Using a Receiver 
Operating Characteristic (ROC) analysis, a score of ≥ 11 was calculated as the optimal 
threshold for predicting amputation.  
 
Validation: The score’s performance was temporally validated on a prospective dataset 
of 87 limb injuries from the same centre. Seventeen limbs were amputated (twelve 
primary amputations) and 70 salvaged. At the optimal threshold score, sensitivity was 82 
percent, specificity 99 percent, positive predictive value 99 percent, negative predictive 
value 96 percent and accuracy 97 percent. 
Authors’ conclusion: HFS ’98 is a reliable extremity salvage score for all open long-
bone fractures. 
 
Ganga Hospital Score (GHS) 
Proposed by Rajasekaran et al. (2006). 
Aim: To develop a score for the prediction of limb salvage or amputation in patients with 
Gustilo type III A and B injuries. 
Setting: Single Specialist Trauma Centre: Ganga Hospital, Coimbatore, India. 
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Study population: Adults and children with open tibial fractures graded as type IIIA or 
IIIB according to the classification system of Gustilo and Anderson (Gustilo et al., 1984). 
Outcome definition: Salvage and amputation (primary and secondary). Patients with 
salvaged limbs were followed-up for an average of 43 (36 – 60) months. 
Development: Retrospective analysis of data from 109 injured limbs. Seven limbs were 
amputated and 102 salvaged. Four clinical variables: 1) skin injury, 2) skeletal injury, 3) 
functional tissue (muscle and nerve) injury and 4) co-morbidity, were selected as 
predictors based on what the authors’ believe to be pertinent to prognosis. The predictor 
variables were catagorised and a point score, increasing with increasing risk, attached to 
each category. The GHS score is a summation of these four scores (range 0 – 29). A GHS 
score of ≥ 14 was calculated, using a Receiver Operating Characteristic (ROC) analysis, 
as the optimal threshold for predicting amputation. At this threshold the models 
predictive performance on the development data was a sensitivity of 98 percent, 
specificity 100 percent, positive predictive value 100 percent, negative predictive value 
70 percent and Area Under the Receiver Operator Characteristic curve (AUROC) of 
0.998. 
 
Validation: GHS predictive performance on the development data was compared to the 
performance of the MESS score and the Gustilo classification on the same data. A binary 
logistic regression analysis, with amputation as the dependent variable, and the three 
scores as the independent variables, showed that the GHS score was independently 
associated with amputation. 
Authors’ conclusion: The GHS is a practical score that may assist surgeons make 
appropriate decisions by predicting in which patients salvage will be successful and 
which will undergo amputation. 
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1.4.3 Critique of the Predictive Scores 
 
Prognostic model development 
Study population: The lower-extremity prognostic models were developed to predict 
outcomes in patients with lower extremity vascular injuries (LSI), orthopaedic injuries 
(HFS ’98, GHS) and combined vascular/orthopaedic injuries (MESI, PSI, MESS, 
NISSSA). The majority of scores were developed using information from injured children 
and adults. Two studies (MESI, HFS ’98) included patients with injuries to both the 
upper and lower extremities in their development populations, despite the criteria for 
reconstruction or amputation of upper and lower extremities being entirely different 
(Tintle et al., 2010a). 
 
Study design: All seven prognostic models were developed by retrospective analysis of 
clinical data. The accuracy of this information and amount of missing data may affect the 
reliability of study results.  
 
Sample size: The power of a prognostic model study depends on the number of observed 
events and not the number of patients (Altman, 2009). To overcome problems associated 
with multiple comparisons in the selection of variables and over-fitting the model to the 
development data, it is suggested that the number of observed events should be at least 
five to ten times the number of prognostic factors in the model (Peduzzi et al., 1995, 
Vittinghoff and McCulloch, 2007, Moons et al., 2009). None of the lower-extremity 
models achieved this. Observed events (amputations) ranged from seven to nineteen, yet 
none of the scores contained less than four variables. Sample size is therefore a major 
source of unreliability in these studies. 
 
Setting: All models were developed at specialist trauma centres. This performance bias 
may impact the generalisability of the models. To overcome this, the MESS authors 
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suggested the model threshold might need to be adjusted according to available expertise 
and resources. 
 
Selection of prognostic factors: No study described how potential prognostic factors 
were identified. Three studies did not describe any method of selecting prognostic factors 
(MESI, MESS, GHS) and factors included in these models may have been selected based 
on the authors’ opinions. Prognostic factors were selected by univariate analysis (PSI, 
LSI) and multivariate analysis (NISSSA, HFS ‘98) for two models respectively. All 
models catagorised prognostic factors. In the majority of cases this was based on 
pragmatic rather than prognostic criteria. Furthermore, subjective descriptions were used 
to define categories for many factors. 
 
Outcome: All scores were developed to predict primary and secondary amputations. The 
prediction of primary amputations is, however, flawed because the outcome, should 
salvage have been attempted, is not known. Four studies (MESI, PSI, LSI, HFS ’98) did 
not report the duration of followed-up for salvaged limbs. Without adequate duration of 
follow-up it is possible that some limbs, regarded as successfully salvaged, required 
eventual amputation for functional reasons. 
 
Model performance: The authors of the MESI score did not analyse their models 
predictive performance. In the other scores model performance was assessed on the 
development cohort. 
 
Prognostic model validation 
Only the MESS and HFS ’98 authors validated the performance of their model on patient 
data not used in the development process. The statistical methods used to validate the 
MESS are not recognised methods of assessing model performance. 
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1.4.4 External Validity of the Predictive Scores 
The severe lower limb trauma predictive scores were developed to assist surgeons with 
the complex decisions on the most beneficial management of these injuries. The most 
important information on the clinical usefulness of a predictive score is the validation of 
the scores performance on patient data that was not used in the development process. An 
ideal score would have a high sensitivity (accurate identification of patients that will 
benefit from amputation) to avoid prolonged and potentially harmful attempts at limb 
salvage, a high specificity (accurate identification of patients that will benefit from limb 
salvage) to avoid unnecessary amputation, and an AUROC of 1 (perfect accuracy) when 
applied to any population of patients with severe lower limb injuries.  
A number of investigators have externally validated the lower-extremity predictive scores. 
These studies consistently show that the scores perform poorly on external patient data 
(Bonanni et al., 1993, Bosse et al., 2001, Brown et al., 2009, Dagum et al., 1999). 
Furthermore, the scores are unable to predict the functional recovery of patients that 
undergo limb reconstruction (Durham et al., 1996, Ly et al., 2008). 
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1.5 Aims and objectives 
 
The overall aim of this thesis was to improve the understanding of decision-making 
following severe lower limb trauma, and develop accurate prognostic tools that can help 
identify those patients whose limb can be safely and effectively salvaged, and also 
identify those for whom attempts at limb salvage would be dangerous or fail. The long-
term goal is that these tools will be used to support informed and evidence-based 
decisions, and thereby improve the quality of care and outcome from these devastating 
injuries. Specifically, the research objectives were: 
 
1) To describe contemporary surgical decision-making in patients with severe lower 
limb trauma, and determine the rationale for, and characteristics of, these 
decisions.  
 
2) To develop and validate an evidence-based prognostic model that can identify 
those patients who would benefit from immediate life-saving intervention, and 
those that may be harmed by attempts at definitive limb reconstruction. 
 
3) To develop and validate an evidence-based prognostic model that can accurately 
predict the outcome of limb salvage in terms of viability. 
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CHAPTER TWO 
 
Clinical Decision Support 
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2.1 Surgical Decision Making 
 
Good judgement and sound decision-making are essential to safe and effective surgical 
practice (Yule et al., 2006). However, surgical decisions are often made under 
challenging conditions that may affect the accuracy of judgement. This is especially true 
for trauma and emergency surgery, where inadequate information, high degrees of 
uncertainty, critical time constraints, and high levels of risk, are common (Hirshberg and 
Mattox, 2004). 
Naturalistic Decision-Making (NDM) is the science of studying how experts make 
decisions in these demanding, real-world situations (Zsambok and Klein, 2014). Using 
NDM concepts, two key stages in surgical decision-making have been identified. These 
are: 1) Situation assessment and 2) Choosing a course of action (Flin et al., 2007). 
Situation assessment, or situational awareness, is a cognitive process that involves 
continuous perception and comprehension of the environment, thereby allowing potential 
problems to be recognised and defined (Rousseau et al., 2004). This includes diagnosing 
problems, assessing the level of risk the problem poses, estimating the time available to 
solve the problem, and identifying possible solutions. Accurate identification of potential 
problems is paramount to good surgical judgement, and misinterpreting the situation 
during this stage of decision-making is the most common cause of surgical errors (Way et 
al., 2003). 
Once a problem is identified, the next stage is to decide on an appropriate course of 
action or treatment. If the situation is interpreted correctly, then decisions on appropriate 
action have a much greater chance of being correct too (Croskerry, 2013). 
Theoretically, the decision-making stage is thought to involve two predominant processes 
of reasoning (Evans, 2003, Kahneman, 2011). Type 1 processes are fast, automatic, and 
based on learnt pattern recognition (Klein, 1993). While type 2 are slower, conscious, 
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analytical processes that require cognitive ability. Effective type 2 reasoning usually 
consists of a sequence of logical steps (Table 2.1).  
 
Table 2.1: Key steps for good analytical decision-making (HBS, 2013) 
Step 1 Define the problem including the risks and timeframe available for 
decisions (situational awareness). 
Step 2 Establish clear objectives. 
Step 3 Identify possible alternative solutions. 
Step 4 Evaluate risks and benefits of the available alternatives. 
Step 5 Determine the strategy most likely to achieve objectives. 
 
Other methods of decision-making also exist (Flin et al., 2007). Rule-based decision-
making involves identifying the situation, followed by looking-up, or remembering, the 
action specified in an appropriate guideline or standard operating procedure. A fourth 
strategy is creative decision-making, whereby a novel solution is devised for an 
unfamiliar problem. 
 
Depending on the situation, experienced surgeons generally use pattern recognition (type 
1) or analytical (type 2) decision-making strategies (Pauley et al., 2011). Simple 
decisions, that are familiar to the surgeon, are made using type 1 processes, while 
complex decisions, that require comparison of multiple options with similar risks and 
benefits, are made using type 2 reasoning. Junior clinicians frequently use rule-based 
decision-making, however, with repetition the actions are learnt, and become automatic 
pattern-recognition (Type 1) processes. Creative decision-making is rarely used in 
clinical surgery due to the risks and time constraints involved (Flin et al., 2007, Pauley et 
al., 2011). 
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2.2 Difficult decisions 
 
What determines the difficulty of decision-making is the way the alternatives relate 
(Chang, 2014). When one alternative is better than the others, decision-making is 
straightforward and a rational decision can be made. Using a logical decision-making 
process maximises the chance of being able to make a rational choice. When it is unclear 
which alternative is better, or when neither alternative is better than the other, then 
decision-making becomes difficult. 
 
Difficult decisions, where the best option is uncertain, may be the result of a number of 
vulnerabilities in the decision-making process. In particular, making decisions with 
uncertain or incomplete information, or not establishing clear objectives, may impede 
good judgement. In addition, a decision maker may not be able to accurately estimate the 
risks and benefits of alternatives to allow comparisons, or have difficulty communicating 
these estimates to colleagues, and the patient, to allow informed and shared decision-
making. Each of these elements of the decision-making process provides important 
targets for future decision-support research. 
 
The second situation, when neither alternative is better than the other, is a true difficult 
decision. Ruth Chang describes this as when two options are neither better, worse, nor 
equal to each other in value, but rather they are on a par (Chang, 2002).  For example, 
two options for treating a limb injury may result in the same degree of disability, but a 
different kind of disability, and neither option is better than the other. A rational choice 
means an attempt is made to choose the best option. If the options are on a par, then a 
rational choice is not possible. In these situations, only the patient can decide which 
option best suits their needs and values. As clinicians in these situations, it is important 
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that we are able to communicate the implications of each option clearly, to allow the 
patient to make the most informed decision possible.  
 
 
2.3 Uncertainty 
 
“Medicine is a science of uncertainty and an art of probability” 
(Sir William Osler) 
 
Uncertainty is defined as the state of being uncertain, and refers to a circumstance where 
a present or future state, event, or outcome is not known, not definite, or not able to be 
relied upon. Medical information is inherently uncertain. Patients cannot describe exactly 
what they experience. Clinicians cannot interpret exactly what they observe. Diagnostic 
tests report with some degree of error, and medical research can only estimate the truth. 
Medical knowledge does not completely explain how the human body behaves, both 
normally and when injured, and patients may have variable responses to treatment. 
Moreover, nobody can precisely determine prognosis. As a result of this imperfect 
information, the true state of a patient, and the best treatment for a patient, are never 
completely certain. Uncertainty is thus a fundamental feature of medical decision-making  
(Sox et al., 2013). 
 
It is essential that clinicians are able to understand and reason with uncertainty (Sox et al., 
2013). Good clinical judgement is necessary to make accurate decisions using uncertain 
information and to recognise when uncertainty needs to be reduced to a point where a 
decision can be made. One approach to reducing uncertainty is to delay decision-making, 
allowing time for the situation to evolve and more reliable information to become 
available. Another approach is to gain additional information by performing further tests. 
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Although these approaches may make decision-making simpler by reducing uncertainty, 
they may also expose the patient to further harm, especially in emergency situations. 
Weighing up these risks and benefits is not straightforward. 
 
Patients are also increasingly active in decisions about their care. The UK governments 
“no decision about me, without me” vision, aims to make shared decision-making 
between clinicians and patients the norm in the National Health Service (Coulter and 
Collins, 2011). To make this a reality, clinicians will need to be able to communicate 
uncertainty in a way that patients can understand and reason with, to enable informed 
decisions. However, both patients and clinicians are uncomfortable reasoning with 
uncertainty (Ofri, 2013). This is understandable, as medicine is taught, and expected to 
be, an exact science, with verified facts and definitive conclusions. In addition, 
communicating and reasoning with uncertainty generates a number of problems. 
Uncertainty is usually expressed in words or statements. For example, the likelihood of 
an uncertain state or outcome may be communicated in terms such as “I think that...”, “it 
is likely that...”, “there is a chance that...”, or “it is possible that...”. These words and 
statements are imprecise, and make understanding and reasoning with them difficult (Sox 
et al., 2013, Tversky and Kahneman, 1974). Furthermore, similar phrases may be used to 
communicate quiet different degrees of uncertainty (Bryant and Norman, 1980). This 
problem becomes even more complicated when a clinician tries to communicate changes 
in the degree of uncertainty, as new information becomes known (Sox et al., 2013). 
Intuitive reasoning with uncertainty is also prone to cognitive biases (Tversky and 
Kahneman, 1974). This is because people naturally rely on a limited number of practical, 
but imperfect, problem solving techniques to make judgements under uncertainty. 
Although these techniques can be useful, they may also lead to systematic and serious 
judgement errors (Kahneman, 2011, Gigerenzer, 2002).  
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Despite the rapid expansion in medical knowledge, clinical decisions will continue to be 
based on uncertain information. The remainder of this chapter describes methods to 
understand, communicate, and reason with uncertainty and how these methods can be 
used to reduce judgement errors and support rational decision-making. 
 
 
2.4 Probability 
 
The Oxford English Dictionary (2015) defines probability as a measure of the extent to 
which something is likely to happen or be the case. It is expressed as a continuous 
number between zero and one, and allows any degree of uncertainty to be specified on 
this scale. Notably, probability may apply to the present state of a patient or the future 
state of a patient. The higher the number, the more certain we are that the state is present 
or will occur, with a probability of one representing absolute certainty. The lower the 
number, the more certain we are that the state is absent or will not occur, with a 
probability of zero representing an impossible event. 
Probability is key to understanding, communicating, and reasoning with uncertainty (Sox 
et al., 2013). It provides a language that allows the degree of uncertainty to be quantified 
and expressed precisely, thus overcoming the ambiguity associated with words and 
phrases. By being able to express uncertainty precisely, it becomes possible to measure 
the effect of new information and adjust our belief accordingly. Probability therefore 
provides a framework that enables reasoning with uncertainty (Sox et al., 2013). 
 
While probability may overcome many of the fundamental difficulties inherent to 
reasoning with uncertainty, it does not solve them all. Accurately estimating probabilities 
can be confusing and difficult, even for experienced clinicians (Casscells et al., 1978, 
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Gigerenzer and Edwards, 2003). In particular, intuitive probability estimates are prone to 
cognitive bias and errors (Tversky and Kahneman, 1974).  
Published evidence, such as prevalence estimates, or the frequency of an event in a 
population, provides a more objective source of information for initial probability 
estimates than intuition (Sox et al., 2013). However, published evidence is not without 
limitations (Greenhalgh, 2014). The most important limitations affecting probability 
estimates from published evidence are selection bias and the generalisability of findings 
to the person or population of interest. Furthermore, published evidence can be reported 
in ways that are confusing to apply directly to probability estimation, which can also 
result in errors (Gigerenzer and Edwards, 2003).  
In most real world problems, multiple factors will influence the probability of an event. 
Calculating probabilities, while taking into account the joint effects of multiple factors, is 
extremely difficult, and possibly beyond normal human mental ability (Fenton and Neil, 
2012b). Fortunately, mathematics and computer technology can be used to accurately and 
reliably estimate probabilities and may help to prevent estimation errors. 
 
 
2.5 Bayes Theorem 
 
Bayes theorem is a simple, yet powerful, equation that allows initial probability estimates 
to be precisely updated when new evidence becomes available. The theorem was deduced 
by the minister and mathematician, the Reverend Thomas Bayes (1701 – 1761), and was 
published posthumously in 1763 (Bayes and Price, 1763). The theorem is stated as: 
! ! ! =  ! ! ! ! !! !  
Where A is the event of interest and B the new evidence. P(A) and P(B) are the 
probabilities of events A and B independent of each other. P(A|B) is the conditional 
probability of event A given B, and P(B|A) is the conditional probability of B given A. 
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The theorem demonstrates how a prior belief about the probability of an event should 
change to account for new evidence.  
This is best explained with an example. Suppose that the prevalence of serious injury in a 
population of deployed soldiers is three percent. In the same population, approximately 
20 percent of soldiers don’t wear their protective body armour. By examining the combat 
hospital records, it is discovered that two thirds of seriously injured soldiers were not 
wearing body armour. Military leaders would like to know the probability of a soldier 
suffering a serious injury, if they do not wear their body armour.  
Answering this simple question with the available information is actually quite difficult, 
but this probability can easily be calculated using Bayes theorem.  
Let S represent the event ‘serious injury’ and B represent ‘no body armour’. Then the 
probability of suffering a serious injury when body armour is not used can be calculated 
as: 
! ! ! =  ! ! ! !(!)!(!) =  0.66 × 0.030.2  ≅ 0.1  
In this example, Bayes theorem shows how our initial belief in the probability of serious 
injury increased from three percent to ten percent when we took into account new 
information that soldiers did not wear their body armour. This updated probability is 
termed the posterior probability, while the initial probability of three percent is termed the 
prior probability. 
 
Bayes theorem provides a simple, consistent, and rational method to calculate 
probabilities while avoiding common errors associated with reasoning with uncertainty 
(Fenton and Neil, 2012b). It is an extremely powerful theorem. However, when Bayes 
theorem is applied to problems with multiple influential variables, the mathematical 
complexity increases exponentially, and these problems become exceedingly difficult and 
time-consuming to calculate (Spicer, 1980). Bayesian Networks were developed to 
overcome this problem. 
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2.6 Bayesian Networks 
 
Bayesian Networks (BNs) are powerful mathematical models that enable accurate 
probability calculations, using Bayes theorem, in complex problems involving multiple 
influential variables.  
 
2.5.1 Components of Bayesian Networks 
BNs consist of two parts: 1) a network structure that graphically describes the models’ 
variables and their relations, and 2) a set of parameters that captures the strength of the 
relationships between variables. 
 
2.5.1.1 Network Structure 
 
The network structure has two components: nodes and edges (Figure 2.1).  
Nodes: Nodes represent the individual variables included in the model. Each node has a 
defined set of values or states that it may take. These values or states are determined by 
the variable the node represents and may either be discrete or continuous.  Discrete nodes 
can be further catagorised into Boolean nodes, Labelled nodes, Ranked nodes, and 
discrete Numeric nodes. Boolean nodes take on exactly two states, such as True / False, 
or Present / Absent. Labelled nodes take on more than two states but have no inherent 
order, for example branches of the armed forces may be army / navy / air force. Ranked 
nodes take on more than two states but these states have an order, for example, mild / 
moderate / severe. Discrete numeric nodes can take on any whole number in a range of 
numbers. For example, a patient’s age in years could be expressed as a number with a 
possible value between zero and 110.  
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An important rule in BNs is that discrete nodes must be defined by a set of mutually 
exclusive and collectively exhaustive states. This means the variable must take on exactly 
one of the defined states at any time. 
Nodes may also represent numeric variables that are measured on a continuous scale 
(Neil et al., 2007). Using expert knowledge, it is often possible to apply logical 
constraints to a continuous node. For example, systolic blood pressure may be limited to a 
range between zero and 300 mmHg, as it is not possible to have a negative blood pressure 
and the maximum pressure a human heart can generate is approximately 300 mmHg. 
 
Edges: Edges represent the relationship between variables (nodes). Two variables are 
connected by an edge if one of the variables has a direct effect on the other. The direction 
of the edge indicates the direction of the effect. In this way the network structure can 
indicate which variables are related, and just as important, which variables are not 
directly related. Variables can then be classified by their relationship to each other. If a 
directed edge connects two variables A and B, as in A g B, then A is a parent of B and B 
is a child of A. Similarly, in chains of variables, as in A g B g C, A is an ancestor of C 
and C is a descendant of A. Within this structure, a variable is dependant on the state of 
its parents and children but is conditionally independent of its non-descendants given its 
parents. An important constraint in the network structure is that the directed edges 
between nodes must not form a cycle, that is, it must not be possible to return to a node 
simply by following directed edges. For this reason the network structure of a BN is often 
called a Directed Acyclical Graph or DAG. 
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2.5.1.2 Parameters 
 
Each node in a BN has an accompanying set of parameters that quantifies the relationship 
between that node and the nodes connected to it. These parameters are probability values 
assigned to each of the possible states of the variable that the node represents. The initial 
nodes in a BN do not have parent nodes. The probability value for each possible state of 
these initial nodes is estimated from the prior probability of the respective state occurring 
in the population. For example, a BN node may represent the variable gender, with the 
possible states defined as male or female. The probability of either of these states in the 
general population may be estimated at 0.5, or 50 percent. All other nodes in a BN have 
parent nodes. The probability value for each state of these nodes is defined, given every 
possible state of the parent nodes. This means that the probability distributions of all 
nodes with parent nodes are conditional on the state of the parent nodes. For discrete 
nodes, a probability value is set for each of the possible individual node states and a Node 
Probability Table (NPT) is constructed containing a set of all the possible probability 
values related to that node. The size of a given node’s NPT depends on the number of 
states the node can take and the number of parent nodes the node has. Increases in these 
two factors result in an exponential increase in the NPT size. For continuous nodes, a 
statistical probability distribution is used. The statistical probability distribution has a 
range between zero and one and is characterised by its mean and variance. 
 
2.5.2 Bayesian Network reasoning 
Once the network structure and parameters have been defined, the BN can be used to 
calculate the probability of any variable in the modelled domain. Known information is 
entered into the BN and used to update the probabilities of unknown variables. This 
process uses Bayes Theorem and is termed propagation. The flow of information through 
the BN can be in any direction and is not limited by the direction of the edges. 
Furthermore, new information for any number of variables from any part of the BN 
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model can be entered, and propagation will be used to update the probabilities of all the 
unknown variables. 
This process enables some powerful types of reasoning: 
 
1. Predictive (Causal) reasoning: Predictive reasoning follows the direction of the 
edges, from cause to effect. Entering new information into a ‘cause’ node will 
update the probabilities in its ‘effect’ node. In the example BN fragment shown 
in figure 2.1, knowing that a soldier sustained a traumatic injury will increase the 
probability of receiving a blood transfusion or undergoing surgery. 
2. Diagnostic reasoning: Diagnostic reasoning occurs in the opposite direction to 
the edges, from effect to cause. Entering known information into an ‘effect’ node 
will update the probabilities in its ‘cause’ nodes. In the example BN, knowing 
that a soldier underwent surgery will increase the probability that he/she was 
injured or developed appendicitis. 
3. Explaining away: This reasoning occurs if there are two or more causes for an 
effect. If the effect is present, the probabilities of all the causes will increase 
(diagnostic reasoning). However, if one of the causes is known to be present, the 
probabilities of the other causes will decrease (explaining away). For example, if 
we know that a soldier required emergency surgery, knowing that they suffered a 
traumatic injury will make appendicitis less likely. 
4. Combined reasoning: Within the BN, the above types of reasoning can be 
combined in any way to update the probability of unknown variables. 
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Figure 2.1: A simple Bayesian Network model showing possible reasons for needing 
emergency surgery. 
 
2.5.3 Advantages of Bayesian Networks 
BNs provide a number of additional, and unique, benefits that support good judgement 
and sound, evidence-based, decision-making. 
Firs, the graphical structure of a BN allows all the variables and relationships in a domain 
to be clearly presented. BNs are therefore able to encode and reflect domain knowledge 
in a simple and coherent way. This explicit representation helps the user understand the 
reasoning process and what’s more, it allows the reasoning process to be clearly 
communicated. 
 
Second, a BN will update the probability distributions of unknown variables when any 
new information for any number of variables is entered. There is therefore no specific set 
of inputs that is required to calculate the probability of an unknown variable. Indeed, if no 
information is entered, the model simply assumes the prior probability distribution for 
each unknown variable. By contrast, traditional statistical techniques, such as regression 
modelling, require all of the independent variable inputs to be entered into the model 
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before the value of the dependant variable can be calculated. This ability to handle 
missing data is a major advantage of BNs over traditional techniques, especially when 
reasoning with uncertainty in emergency situations, where incomplete information is 
common.  
 
Third, BNs provide a framework that allows a range of evidence to be combined and used 
to reason with uncertainty. Types of evidence include, but are not limited to, expert 
opinion, data, and published literature. This has beneficial implications for the 
generalisability of these models and evidence-based decision-making. 
 
 
2.7 Summary 
Good decision-making requires strong situational awareness and astute reasoning skills. 
For complex decisions, an analytical reasoning strategy that allows comparison of the 
risks and benefits of alternate solutions is necessary. Uncertainty is common, and rational 
decisions are difficult if the risks and benefits are uncertain. Probability provides a 
language that allows us to understand, communicate, and reason with uncertainty. While 
Bayes theorem and Bayesian Networks provide the tools needed to accurately estimate 
and update probabilities using available information and existing knowledge. Using these 
tools to accurately estimate the probability of uncertain risks and benefits has the 
potential to improve situational awareness and support rational and evidence-based 
decisions. 
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CHAPTER THREE 
 
A Contemporary Analysis of Severe 
Lower Limb Trauma Decision-Making
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3.1 Introduction 
Deciding between amputation and salvage of a severely injured limb is one of the most 
difficult decisions a surgeon can face (Lange, 1989, Hansen Jr, 1989, Busse et al., 2007, 
Scalea et al., 2012). A clear understanding of the clinical reasoning behind these 
decisions, including the complex trade-off between estimated risks and benefits, is central 
to accurate decision-making (Hirshberg and Mattox, 2004, Sox et al., 2013, Kahneman, 
2011). This fundamental knowledge, however, is poorly described and contributes to 
difficulties in making rational and timely decisions (NICE, 2016). 
 
Lower limb trauma is the predominant injury in modern warfare and an important cause 
of preventable death and marked disability including limb loss (Owens et al., 2007, 
Owens et al., 2008, Eastridge et al., 2012, MacKenzie et al., 2005, Doukas et al., 2013). 
Surgical management of severe injuries is complex, with an array of resuscitation, 
reperfusion, and reconstruction strategies possible (Nanchahal J, 2009, Scalea et al., 
2012, Schreiber, 2012, Glass et al., 2009). The aims of surgery are first to ensure survival 
and then to reconstruct the most functional limb or residual limb possible (Nanchahal J, 
2009, Clasper, 2007).  
Major advances in limb reconstruction have made salvage technically possible in all but 
the most severe injuries (Wagels et al., 2013, Whitaker et al., 2011). However, in some 
situations, prolonged attempts at limb salvage may be dangerous or result in outcomes 
that are worse than what an early amputation with prosthesis would achieve (Bondurant 
et al., 1988, Hansen Jr, 1989). Optimal patient outcome depends on sound surgical 
judgement and timely decision-making (Lange, 1989, Hansen Jr, 1989). But despite the 
considerable impact amputation/salvage decisions may have on health (Bosse et al., 2002, 
Doukas et al., 2013), there has been minimal progress understanding how to choose 
between them (Johansen and Hansen Jr, 2015).  
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A number of predictive scores have been developed to assist surgeons with these complex 
decisions (Johansen et al., 1990, Gregory et al., 1985, Russell et al., 1991, McNamara et 
al., 1994, Krettek et al., 2001, Rajasekaran et al., 2006). None, however, have been 
shown to provide any clinically reliable decision support or allow an accurate assessment 
of the risks that influence decisions (Bonanni et al., 1993, Bosse et al., 2001, Brown et al., 
2009, Durham et al., 1996). Moreover, there are significant differences in experienced 
surgeons’ beliefs regarding the most important factors influencing the decision to 
amputate or reconstruct injured lower limbs (MacKenzie et al., 2002). 
A clear understanding of the rationale for amputation decisions will provide fundamental 
knowledge to support surgeons and their patients in making informed choices. This has 
the potential to improve the quality of care and outcomes from these devastating injuries.  
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3.2 Aims and objectives 
The overall aim of this study was to analyse the decision-making of trauma surgeons 
treating casualties with major lower extremity vascular injuries.  
The first objective was to determine what treatment decisions were made and the time 
frames these decisions were made in. 
Second, to establish the rationale for these decisions. 
Third, to analyse the relationships between clinical characteristics and treatment 
decisions. 
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3.3 Methods 
 
3.3.1 Study design and setting 
This was a retrospective cohort study of US military servicemen who sustained lower 
extremity vascular injuries while serving in Iraq or Afghanistan between March 2003 and 
February 2012.  
 
3.3.2 Study population 
Potentially eligible participants were identified from the Global War on Terror Vascular 
Injury Initiative (GWOT-VII) database. GWOT-VII is a cohort study that maintains 
prospective follow-up of US military servicemen who sustained extremity vascular 
trauma while serving in the wars in Iraq and Afghanistan (Stannard et al., 2012). Cases 
are identified from the Joint Theatre Trauma Registry (JTTR), which is a comprehensive 
database of all injured casualties treated at US Military treatment facilities. Servicemen 
who sustained a vascular injury are identified from the JTTR using Abbreviated Injury 
Scale (AIS) and International Classification of Diseases, Ninth Revision (ICD-9) codes 
for vascular injury (arterial and venous) and vascular injury repair. Before inclusion in the 
GWOT-VII database, specially trained research nurses reviewed the corresponding 
military medical records to confirm vascular injury and JTTR data accuracy. Both 
registries are held and maintained by the United States Army Institute of Surgical 
Research (USAISR) at Fort Sam Houston, Texas. GWOT-VII was reviewed and 
approved by the US Army Medical Research and Materiel Command Institutional 
Review Board. Informed agreement to undertake long-term follow-up, patient interviews, 
health-related quality of life surveys, and grant researchers access to relevant medical 
records, is obtained from patients enrolled in the initiative.  
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US servicemen who sustained a major lower extremity injury involving at least one 
named lower extremity artery, distal to the aortic bifurcation, were included in this study. 
Servicemen with iatrogenic vascular injuries, isolated venous injuries, and complete 
traumatic amputations were excluded.  
 
Lower extremity vascular trauma (LEVT) was used as a representative population to 
study amputation / salvage decision-making for a number of reasons. First, these injuries 
pose a threat to the patients’ life and the limbs viability, in addition to the risks posed by 
severe limb injuries without a vascular component. As a result, these injuries often 
require immediate intervention, and decisions regarding amputation and salvage are more 
common and generally more complex. Second, LEVT is associated with high amputation 
rates (Kauvar et al., 2011, Mullenix et al., 2006) and accurate decision-support may have 
the most utility in this population. Last, the population can be clearly defined allowing 
accurate analysis.   
 
3.3.3 Data collection 
Data on patient demographics, mechanism of injury, injury characteristics, injury severity 
scores, management, and outcome were extracted from the GWOT-VII database and the 
JTTR. This was supplemented and corroborated with additional information from the 
Armed Forces electronic medical records and patient interviews. Injury severity was 
classified by trained personnel according to the Injury Severity Score (ISS) (Baker et al., 
1974) and Mangled Extremity Severity Score (MESS) (Johansen et al., 1990).  Outcome 
data, including the timing of, and rationale for amputation were collected from operative 
records, clinic letters, and records of multi-discipline meetings.  
 
3.3.4 Outcomes 
The outcome of interest was the treatment decision in terms of limb salvage or major 
lower extremity amputation, and the rationale for these decisions. A major lower 
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extremity amputation was defined as an amputation above the level of the ankle. Primary 
amputation was defined as the surgical amputation of an injured limb at the first operative 
procedure and secondary amputation was defined as the surgical amputation of an injured 
limb as a secondary procedure following an initial attempt at limb salvage. For limbs that 
underwent amputation, additional outcomes included the timing of, and anatomical level 
of amputation. The timing of amputation was measured in days after injury. Secondary 
amputation was further catagorised as early (≤ 30 days after injury) and late (> 30 days 
after injury). For the purposes of this study, follow-up was complete up until 01 February 
2013, one year after the end of the study period. This duration of follow-up has been 
suggested to be sufficient for lower extremity trauma research (Castillo et al., 2011). 
 
3.3.5 Definitions 
Arterial injuries were categorized into four zones according to the anatomical level of 
injury: iliac, including common and external iliac arteries; femoral, including common 
and superficial femoral arteries; popliteal arteries; and tibial arteries. Profunda Femoris 
injuries were considered as a separate group. Soft tissue injuries were catagorised by level 
(above-knee, knee, below-knee, and ankle/hindfoot) and degree of tissue injury. The 
degree of tissue injury was catagorised as none/minor (no tissue loss), moderate (≤ 25 
percent tissue loss), and severe (> 25 percent tissue loss including partial traumatic 
amputations). Initial blood transfusion requirements were measured in units of blood 
(whole blood or packed red blood cells) transfused within 24 hours of injury (units 
blood/24 hours). A massive blood transfusion was defined as the transfusion of 10 or 
more units of blood (whole blood or packed red blood cells) within 24 hours of injury 
(Malone et al., 2006). The degree of shock prior to surgery was catagorised as normal 
(SBP always > 90mmHg, ≤ 2 units blood/24 hours), compensated (SBP transiently below 
90mmHg, > 2 units blood/24 hours), or uncompensated (SBP consistently below 
90mmHg, massive blood transfusion, coagulopathy).  
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3.3.6 Statistical analyses 
Statistical analyses were performed using GraphPad PRISM v6 (GraphPad, La Jolla, CA, 
USA) and SPSS v20 (SPSS, Chicago, Il, USA). Normal-quartile plots were used to test 
for normality. Non-parametric data are reported as median with interquartile range (IQR) 
and categorical data as frequency (n) and percentage (%). The Mann–Whitney U test was 
used to compare numerical data and Fisher’s Exact test was used to compare categorical 
data. Freedom from limb amputation was estimated using the Kaplan-Meier method 
(Kaplan and Meier, 1958). Univariate analysis was used to assess the association between 
patient and injury characteristics and the timing of amputation. Results are reported as a 
crude Odds Ratio (OR) with 95 percent Confidence Intervals (CI). Statistical significance 
was set as a two tailed p-value of < 0.001. 
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3.4 Results 
 
Between 01 March 2003 and 01 February 2012, 576 US soldiers sustained lower 
extremity vascular injuries in battle and were included in the GWOT-VII registry. 
Nineteen soldiers were excluded as the injury resulted in a complete traumatic limb 
amputation, and three soldiers with iatrogenic vascular injuries were excluded. Of the 
remaining 554 soldiers, twenty-five sustained bilateral lower extremity vascular injuries. 
In total, we analysed the decision-making for 579 injured lower limbs.  
 
3.4.1 Baseline characteristics 
The 554 casualties had a median age of 23 (range: 18 – 54) years, and blast was the most 
common mechanism of injury (n=395, 68.2 percent). The baseline characteristics of the 
study population are presented in Table 3.1. Median duration of follow-up was 6.3 years, 
ranging from 345 days to 10.5 years. 
 
3.4.2 Therapeutic decisions 
Of the 579 injured limbs, salvage was attempted in 530 (91.5 percent) and 49 (8.5 
percent) underwent primary amputation. Of the limb salvage attempts, 440 limbs (83.0 
percent) were successfully salvaged and 90 limbs (17.0 percent) underwent secondary 
amputation. Overall, 139 injured lower limbs (24.0 percent) underwent amputation.   
 
3.4.3 Timing of therapeutic decisions 
All primary amputations were performed within 24 hours of injury. Secondary 
amputations were performed between one day and five years (1848 days) after injury. 
Two thirds of secondary amputations (60 limbs) were performed within 30 days of injury 
(early amputations), with 24 procedures (26.6 percent) performed within 72 hours of 
injury.  
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Table 3.1: Baseline characteristics of 554 soldiers with 579 injured lower limbs. 
Characteristic 
Missing 
Data (%) 
Overall 
(n = 579) 
Salvage 
(n = 440) 
Amputation 
Primary 
(n = 49) 
Secondary 
(n = 90) 
Age (range) 0 23 (18 – 54) 23 (18 – 54) 23 (19 – 46) 24 (19 – 44) 
Mechanism of injury      
Blast 0 395 (68.2) 277 (63.0) 46 (93.9) 72 (80.0) 
Blunt 0 18 (3.1) 14 (3.2) 0 4 (4.4) 
Penetrating 0 166 (28.7) 149 (33.9) 3 (6.1) 14 (15.6) 
Injury Severity      
Injury Severity Score 27 (4.7) 14 (10 – 22) 14 (10 – 18) 24 (17 – 33) 17 (11 – 24) 
MESS 32 (5.5) 6 (5 – 7) 6 (5 – 6) 7 (6 – 8) 7 (6 – 7) 
Arterial Injury a      
Iliac Artery 0 20 (3.5) 13 (3.0) 6 (12.2) 1 (1.1) 
Femoral Artery b 0 182 (31.4) 139 (31.6) 19 (38.8) 24 (26.7) 
Popliteal Artery 0 129 (22.3) 86 (19.5) 17 (34.7) 26 (28.9) 
Tibial arteries 0 253 (43.7) 187 (42.5) 19 (38.8) 47 (52.2) 
Profunda Femoris Artery 0 32 (5.5) 31 (7.1) 1 (2.0) 0 
Multiple arterial injuries 0 35 (6.0) 15 (3.4) 9 (18.4) 11 (12.2) 
Associated Limb Injuries      
Venous injury 0 246 (42.5) 181 (41.1) 26 (53.1) 39 (43.3) 
Nerve injury 74 (12.8) 179 (35.4) 119 (31.6) 21 (50.0) 39 (44.8) 
Fracture 20 (3.5) 320 (57.2) 191 (45.5) 48 (98.0) 81 (90.0) 
Soft tissue injury c 132 (22.8)     
None / minor   105 (23.5) 102 (32.2) 2 (4.3) 1 (1.2) 
Moderate  208 (46.5) 186 (58.7) 3 (6.5) 19 (22.6) 
Severe  134 (30.0) 29 (9.1) 41 (89.1) 64 (76.2) 
Complications      
Shock d 15 (2.6)     
None  265 (47.0) 231 (53.7) 7 (14.9) 27 (31.0) 
Compensated  146 (25.9) 119 (27.7) 8 (17.0) 19 (21.8) 
Uncompensated  153 (27.1) 80 (18.6) 32 (68.1) 41 (47.1) 
Compartment syndrome 0 34 (5.9) 25 (5.7) 2 (4.1) 7 (7.1) 
Ischaemic time > 6 hours 273 (47.2) 18 (5.9) 1 (0.4) 7 (35.0) 10 (20.8) 
Arterial Repair 17 (2.9)     
Ligation  198 (35.2) 146 (34.3) 31 (63.3) 22 (25.3) 
Primary repair  89 (15.8) 75 (17.6) 3 (6.1) 11 (12.6) 
Interposition graft  267 (47.5) 205 (48.1) 8 (16.3) 54 (62.1) 
Data presented as number (percent) or median (IQR) unless otherwise stated. a Percentages may not add up 
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One third of secondary amputations (30 limbs) were performed beyond 30 days of injury 
(late amputations), with sixteen procedures (11.5 percent of all lower limb amputations) 
performed more than one year after injury, and four amputations performed more than 
two years after injury. The probability of limb amputation increased rapidly in the first 
few days after injury (Figure 3.1) with a continued but more gradual increase beyond 30 
days after injury (Figure 3.2).  
 
 
Figure 3.1: Kaplan-Meier estimates of freedom from limb amputation during the first 30 
days following injury. 
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to 100 percent as some patients had multiple vascular injuries. b Common and Superficial femoral artery. 
c None/minor = no tissue loss; Moderate = < 25 percent tissue loss; Severe = ≥ 75 percent tissue loss/ partial 
traumatic amputations/mangled extremities. d Compensated = Systolic Blood Pressure transiently below 
90mmHg, > 2 units blood/24 hours; Uncompensated = Systolic Blood Pressure consistently below 
90mmHg, massive blood transfusion, coagulopathy. MESS, Mangled Extremity Severity Score 
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Figure 3.2: Kaplan-Meier estimates of freedom from limb amputation during the first ten 
years following injury. 
 
3.4.4 The rationale for primary amputation 
Forty-nine injured limbs (8.5 percent) underwent primary amputation and these 
procedures accounted for 35 percent of all amputations. The average age of patients 
undergoing primary amputation was 23 (range: 19 – 46) years, which was similar to the 
average age of those undergoing salvage or secondary amputation (Table 3.1). In 
univariate analysis, patients who underwent primary amputation were more likely injured 
by a blast mechanism (OR 8.25), had more severe limb injuries as evidenced by more 
frequent multiple level arterial injuries (OR 6.38), associated fractures (OR 57.55), and 
severe soft tissue injury (OR 72.10), and were more likely to have uncompensated 
haemorrhagic shock (OR 24.92) (Table 3.2). Although uncommon, delayed access to 
surgical revascularisation of ischaemic limbs was also strongly associated with primary 
amputation (OR 127.0).  
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The rationale for primary amputation was clearly documented in all cases (Table 3.3). 
Twenty-three limbs underwent primary amputation because there was insufficient tissue 
for limb (fifteen patients) or foot (eight patients) reconstruction. Nineteen limbs 
underwent primary amputation as part of resuscitation to save the patients life (Damage 
Control). And fourteen limbs underwent primary amputation because of non-viable limb 
tissue. Seven cases had more than one indication and the overlap is shown in Figure 3.3. 
 
All 23 limbs (100 percent) that underwent primary amputation because there was 
insufficient tissue for limb reconstruction had severe soft tissue injuries (> 25 percent 
tissue loss) at the injured level, compared to eighteen of 26 limbs (69 percent) that 
underwent primary amputation for other reasons (p = 0.005). 
 
All nineteen soldiers that underwent primary amputation for resuscitation had 
uncompensated haemorrhagic shock, including eight soldiers (42 percent) who suffered a 
period of traumatic cardiac arrest. By comparison, only thirteen of the 30 (43 percent) 
primary amputations performed for reasons other than resuscitation had uncompensated 
haemorrhagic shock (p < 0.0001) and none suffered a cardiac arrest. Soldiers that 
underwent primary amputation for resuscitation were transfused significantly more blood 
products (70 (IQR: 48 – 114) units vs. 22 (IQR: 8 – 47) units; p < 0.0001), including 
Packed Red Blood Cells (33 (IQR: 20 – 42) units vs. 9 (IQR: 5 – 28) units; p = 0.0003), 
during the first 24 hours following injury, than patients that underwent primary 
amputation for other reasons. 
 
All fourteen limbs that underwent primary amputation for non-viable tissue had clearly 
non-viable tissue identified at first operative examination. Seven (50 percent) of these 
patients had a prolonged duration of ischaemia (> 6 hours) before surgical care. No cases 
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of prolonged ischaemia were identified in patients that underwent primary amputation for 
other reasons. 
 
Table 3.2: Univariate analysis of factors associated with primary amputation. 
 
 
 
 
Factor 
Salvage 
(n = 440) 
Primary 
Amputation 
(n = 49) 
Univariate analysis 
Crude OR 
(95% CI) p-value 
Age (Range)  23 (18 – 54) 23 (19 – 46) 0.99 (0.95 – 1.04) 0.726 
MOI Penetrating 149  (33.9) 3 (6.1) 1.0  
 Blunt 
Blast 
14 (3.2) 
277 (63.0) 
0 
46 (93.9) 
- 
8.25 (2.52 – 26.97) 
- 
< 0.0001 
Arterial injury site Femoral 139 (31.6) 19 (38.8) 1.0  
 Popliteal 86 (19.5) 17 (34.7) 1.25 (0.58 – 2.70) 0.575 
 Tibial 187 (42.5) 19 (38.8) 0.59 (0.28 – 1.25) 0.165 
 Iliac 13 (3.0) 6 (12.2) 3.72 (1.25 – 11.07) 0.018 
Multiple arterial injury  15 (3.4) 9 (18.4) 6.38 (12.62 – 15.49) < 0.0001 
Associated injury Venous Injury 181 (41.1) 26 (53.1) 1.62 (0.90 – 2.93) 0.112 
 Nerve Injury 119 (31.6) 21 (50.0) 2.16 (1.14 – 4.11) 0.019 
 Fracture 191 (45.5) 48 (98.0) 57.55 (7.87 – 420.83) < 0.0001 
Soft tissue injury None / minimal 102 (32.2) 2 (4.3) 1.0  
 Moderate 186 (58.7) 3 (6.5) 0.83 (0.35 – 5.00) 0.823 
 Severe 29 (9.1) 41 (89.1) 72.10 (16.45 – 316.12) < 0.0001 
Shock None 246 (69.7) 7 (14.9) 1.0  
 Compensated 68 (19.3) 8 (17.0) 3.15 (1.11 – 8.90) 0.031 
 Uncompensated 39 (11.0) 32 (68.1) 24.92 (10.43 – 59.52) < 0.0001 
Compartment syndrome  25 (5.7) 2 (4.1) 0.71 (0.16 – 3.08) 0.643 
Ischaemic time  > 6 hours 1 (0.4) 7 (35.0) 127.1 (14.5 – 1111.2) < 0.0001 
Arterial repair Primary repair 75 (17.6) 3 (6.1) 1.0  
 Interposition graft 205 (48.1) 8 (16.3) 0.98 (0.25 – 3.78) 0.971 
 Ligation 146 (34.3) 31 (63.3) 5.14 (1.52 – 17.38) 0.009 
Data is presented as number (percent) and Odds Ratio (95 percent Confidence Interval) unless otherwise specified. 
OR, Odds Ratio; CI, Confidence Interval; MOI, Mechanism Of Injury. 
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Table 3.3: Indications for amputation in 579 severely injured lower limbs. Indications are 
divided according to the timing of the decision to perform the amputation. 
Primary Amputation  (n = 49) 
Resuscitation (Damage Control) 19 (38.8) 
Non-viable tissue 14 (28.6) 
Insufficient tissue for functional reconstruction 15 (30.6) 
Non-reconstructable foot 8 (16.3) 
Secondary Amputation (Early) (n =60) 
Non-viable tissue 44 (73.3) 
Infected tissue 21 (35.0) 
Insufficient tissue for functional reconstruction 7 (11.7) 
Resuscitation – Graft haemorrhage 2 (3.3) 
Functional limitation 1 (1.6) 
Unclear 2 (3.3) 
Secondary Amputation (Late) (n = 30) 
Functional limitation 24 (80.0) 
Chronic pain 15 (50.0) 
Chronic infection 6 (20.0) 
Non-healing wounds 3 (10.0) 
Other 1 (3.3) 
Data presented as number (percent). Percentages do not add up to 100 percent as some 
cases had more than one reason for amputation. 
 
 
3.4.5 The rationale for secondary amputation 
Ninety injured limbs (17.0 percent) underwent secondary amputation following an 
attempt at limb salvage. These procedures accounted for 65 percent of all lower limb 
amputations.  
Compared to patients with salvaged limbs, patients that underwent secondary amputation 
were more likely injured by a blast mechanism (OR 2.77), had more severe limb injuries 
as evidenced by more frequent multiple level arterial injuries (OR 3.95), associated 
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fractures (OR 10.79), and severe soft tissue injury (OR 54.29), and were more likely in 
uncompensated haemorrhagic shock (OR 4.39) (Table 3.4). Delayed access to surgical 
revascularisation of ischaemic limbs was again strongly associated with amputation (OR 
28.83). Patients with a lower limb nerve injury had a small increase in risk of amputation 
(OR 1.76). Injury factors associated with secondary amputation were similar to those 
associated with primary amputation, however, the magnitude of the relationship was less 
for secondary amputations. 
 
The rationale for secondary amputation was clearly documented for 88 injured limbs 
(97.8 percent) and are presented in Table 3.3. The main reasons for early secondary 
amputation were non-viable tissue (73.3 percent), infected tissue (35.0 percent), and 
insufficient tissue for functional reconstruction (13.3 percent). In many limbs there was 
more than one indication for amputation, the overlap between the key indications is 
shown in Figure 3.3. 
 
The causes of non-viable tissue leading to secondary amputation were: failure of the 
revascularisation graft due to thrombosis (n = 27, 61.4 percent) or haemorrhage (n =1, 2.3 
percent); progressive necrosis of the wound following initial operative debridement (n = 
14, 31.8 percent); and iatrogenic complications (n =2, 4.6 percent). Ten soldiers who 
underwent secondary amputation because of a non-viable limb had a prolonged duration 
of ischaemia (> 6 hours) before surgical care. No cases of prolonged ischaemia were 
identified in patients that underwent secondary amputation for other reasons. 
 
Late secondary amputations (30 limbs) were performed because of functional limitation 
(24 limbs, 80.0 percent), chronic pain (15 limbs, 50.0 percent), chronic infection (6 limbs, 
20.0 percent), non-healing wounds (3 limbs, 10.0 percent), and following a second 
traumatic injury to a salvaged limb (1 limb, 3.3 percent). 
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Table 3.4: Univariate analysis of factors associated with secondary amputation. 
 
Factor 
Salvage 
(n = 440) 
Secondary 
Amputation 
(n = 90) 
Univariate analysis 
Crude OR 
(95% CI) p-value 
Age (Range)  23 (18 – 54) 24 (19 – 44) 1.00 (0.97 – 1.04) 0.936 
MOI Penetrating 149  (33.9) 14 (15.6) 1.0  
 Blunt 
Blast 
14 (3.2) 
277 (63.0) 
4 (4.4) 
72 (80.0) 
3.04 (0.88 – 10.50) 
2.77 (21.51 – 5.07) 
0.079 
0.001 
Arterial injury site Femoral 139 (31.6) 24 (28.9) 1.0  
 Popliteal 86 (19.5) 26 (24.4) 1.50 (0.79 – 2.83) 0.217 
 Tibial 187 (42.5) 47 (52.2) 1.37 (0.79 – 2.37) 0.258 
 Iliac 13 (3.0) 1 (1.1) 0.44 (0.06 – 3.51) 0.438 
Multiple arterial injury  15 (3.4) 11 (12.2) 3.95 (1.75 – 8.91) 0.001 
Associated injury Venous Injury 181 (41.1) 39 (43.3) 1.09 (0.69 – 1.73) 0.700 
 Nerve Injury 119 (31.6) 39 (44.8) 1.76 (1.09 – 2.82) 0.020 
 Fracture 191 (45.5) 81 (90.0) 10.8 (5.3 – 22.1) < 0.0001 
Soft tissue injury None / minimal 102 (32.2) 1 (1.2) 1.0  
 Moderate 186 (58.7) 19 (22.6) 2.65 (0.97 – 7.23) 0.058 
 Severe 29 (9.1) 64 (76.2) 54.3 (20.1 – 147.0) < 0.0001 
Shock None 231 (53.7) 27 (31.0) 1.0  
 Compensated 119 (27.7) 19 (21.8) 1.37 (0.73 – 2.56) 0.330 
 Uncompensated 80 (18.6) 41 (47.1) 4.39 (2.53 – 7.59) < 0.0001 
Compartment syndrome  25 (5.7) 7 (7.1) 1.40 (0.59 – 3.34) 0.449 
Ischaemic time  > 6 hours 1 (0.4) 10 (20.8) 28.8 (8.1 – 103.1) < 0.0001 
Arterial repair Primary repair 75 (17.6) 11 (12.6) 1.0  
 Interposition graft 205 (48.1) 54 (62.1) 1.80 (0.89 – 3.62) 0.101 
 Ligation 146 (34.3) 22 (25.3) 1.03 (0.47 – 2.23) 0.946 
Data is presented as number (percent). 
OR, Odds Ratio; CI, Confidence Interval; MOI, Mechanism Of Injury. 
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Figure 3.3: Venn diagrams demonstrating the key reasons for lower limb amputation in 
579 soldiers with limb threatening injuries. A) 49 soldiers who underwent primary 
amputation, B) 60 soldiers who underwent early (≤ 30 days) secondary amputation, and 
C) 30 soldiers who underwent late (> 30 days) secondary amputation. Five soldiers in the 
early secondary amputation group and one soldier in the late secondary amputation group 
underwent amputation for reasons other than the three key reasons presented. 
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3.4.6 Level of Amputation 
The most common level of amputation was trans-tibial (n=79, 56.8 percent), followed by 
trans-femoral (n=42, 30.2 percent), through-knee (n=9, 6.5 percent), and hip-
disarticulation (n=9, 6.5 percent). Compared to primary amputations, a higher proportion 
of secondary amputations were performed at the trans-tibial level (p = 0.210), while hip-
disarticulation was a significantly less common secondary procedure (p = 0.009) (Figure 
3.4). 
 
 
 
Figure 3.4: Anatomical level at which limb amputation was performed, according to the 
timing of the procedure. * Indicates a significant (p < 0.05) difference between groups. 
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3.5 Discussion 
Key findings 
While the majority of severe lower limb injuries sustained in battle are salvaged 
(Stansbury et al., 2008), nearly one quarter of those that involve a lower limb vascular 
injury may ultimately be treated with limb amputation. This study describes fundamental 
elements of clinical reasoning and surgical decision-making following these injuries, 
including the treatment decisions (what), the rationale for these decisions (why), the 
clinical characteristics associated with decisions (who), and the time-frames that 
decisions were made in (when).  
 
Within hours of injury, approximately eight percent of injured limbs underwent primary 
amputation. A further seventeen percent of limbs underwent secondary amputation 
following an attempt at limb salvage. Two thirds of secondary amputations were 
performed early, within 30 days of injury, while a third were performed more than 30 
days after injury (late). Approximately ten percent of lower limb amputations were 
performed more than one year after injury. 
 
There were clear differences in the rationale for primary, early secondary, and late 
secondary amputations. Nearly half of primary amputations were performed because 
insufficient tissue remained for limb salvage. The remainder required amputation to 
facilitate resuscitation from uncontrolled haemorrhage or to remove non-viable tissue. 
This latter group of patients is important as they represent potentially avoidable 
amputations with advances in trauma systems and Damage Control Resuscitation. 
The key reasons for early secondary amputation were non-viable limb tissue and sepsis, 
whilst the key reasons for late secondary amputations were functional limitation, chronic 
pain, and chronic infection. 
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Comparison to existing literature 
The Lower Extremity Assessment Project (LEAP) studied a prospective cohort of 601 
civilians with high-energy lower limb-threatening injuries, treated at eight US level-1 
trauma centres (Bosse et al., 2002). The primary amputation rate was 11.3 percent and the 
secondary amputation rate after long-term follow-up was 17 percent (Bosse et al., 2001, 
MacKenzie et al., 2005). While this study was performed more than 15 years ago, it 
remains the best evidence to date informing the management of severe lower limb trauma 
and forms an important benchmark. A more recent analysis of the management of 1354 
severe lower limb injuries across 222 US trauma centres, demonstrated a primary 
amputation rate of 9 percent and an early secondary amputation rate of 11 percent (de 
Mestral et al., 2013). This study did not report outcomes after hospital discharge, which 
may explain the low secondary amputation rate. Delayed amputations make up an 
important proportion of the overall amputation rate. In both the LEAP study and our 
study, the delayed amputation rate was approximately five percent.  
Although not directly comparable, the primary amputation rate in our study is lower than 
the rate in these civilian studies, despite the more severe military injuries. This may 
reflect military advances in trauma care. The military have led developments in early 
haemorrhage control, haemostatic resuscitation, and limb reperfusion (Kragh et al., 2009, 
Holcomb et al., 2007a, Rasmussen et al., 2006b). Together, these interventions may make 
limb salvage attempts feasible in a greater proportion of casualties (Schreiber, 2012, Fox 
et al., 2010). 
 
Despite the extensive medical literature on limb salvage versus amputation following 
trauma, the reasoning behind decision-making is rarely described (NICE, 2016).  Two 
studies, both published more than 25 years ago, describe the rationale for amputation 
decisions in an adequate sample of injured patients (Pozo et al., 1990, Robertson, 1991). 
In a series of 35 secondary amputations following civilian trauma, Pozo et al. found that 
all early procedures (<30 days following injury) were performed to remove necrotic 
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tissue, whereas late amputations (≥ 30 days following injury) were performed for reasons 
including sepsis (79 percent), non-union (75 percent), and pain or poor function (18 
percent).  Similarly, in a series of 65 secondary amputations following civilian trauma, 
Robertson found the most common reasons for early amputation were tissue necrosis (67 
percent) and sepsis (17 percent), while the most common reasons for late amputation 
were sepsis (51 percent) and poor function (29 percent). While tissue necrosis and sepsis 
remain the key reasons for early secondary amputation in our cohort, functional 
limitations and chronic pain have become the predominant reasons for late amputation. 
 
Implications of findings 
The difficulty in amputation/ salvage decisions following severe limb trauma are well 
recognised (Lange, 1989, Busse et al., 2007, Hansen Jr, 1989). However, approximately 
70 percent of primary amputations in this study were performed because of non-viable or 
insufficient remaining limb tissue. These decisions do not necessarily represent complex 
decision-making, as there are no feasible alternatives to amputation. If there is any doubt, 
contemporary guidance is to preserve all viable tissue and delay amputation decisions 
until more information and expertise is available (Clasper, 2007, Nanchahal J, 2009). 
 
By contrast, over one third of primary amputations were performed as damage control 
procedures to facilitate the resuscitation of shocked patients. The majority of these cases 
had both viable and sufficient limb tissue for salvage; but all had life-threatening 
haemorrhagic shock, with some experiencing a period of traumatic cardiac arrest. 
Primary limb amputation may be necessary as a life-saving intervention in these 
situations. However, not all such cases require immediate amputation and alternative 
strategies, that retain limb salvage potential, are sometimes possible (Fox et al., 2010, 
Schreiber, 2012, Gruen et al., 2012). Indeed, 80 percent of severely shocked casualties in 
this study had an initial attempt at limb salvage, and two thirds of these attempts were 
successful. These decisions typify the classic ‘life over limb’ maxim and are amongst the 
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most difficult a surgeon can face. The information available to estimate risks and inform 
clinical judgement is frequently uncertain or incomplete, and errors or delays in decision-
making may have profound consequences including death or unnecessary amputation.  
 
Central to immediate decision-making, in severely injured patients, is the state of their 
coagulation function (Roberts et al., 2015, Brohi et al., 2003, Kashuk et al., 2010). 
Patients that develop an acute coagulopathy are at substantially increased risk of 
exsanguination and death (Brohi et al., 2003, Brohi et al., 2007a, Frith et al., 2010). In 
these patients resuscitation must take precedence over all other treatment goals (Jansen et 
al., 2009, Duchesne et al., 2010b). However, coagulation function is usually unknown at 
the time of decision-making as routine coagulation tests are unable to identify 
coagulopathy in a useful time frame, and clinical estimation of coagulopathy is unreliable 
(Davenport et al., 2011, Brohi, 2011, Mitra et al., 2011). The ability to rapidly identify 
coagulopathic trauma patients is therefore a key objective of current trauma research, 
which has the potential to significantly influence trauma care and informed decision-
making (Gruen et al., 2012, Stanworth et al., 2010). 
 
There were clear temporal differences in the reasons for secondary amputation. Early 
amputation decisions were predominantly influenced by clinical course, while late 
decisions were influenced by patient preference. The majority of early secondary 
amputations were performed because of non-viable limb tissue. The principle causes were 
failed revascularisation and progression of tissue necrosis, and in many cases non-viable 
tissue also became a source of sepsis. By contrast, late amputations were most frequently 
due to functional limitations, with many patients also suffering from chronic pain. 
Together, tissue viability and limb function were decisive factors in more than 80 percent 
of amputation decisions. These risks are often unclear early in the patients’ course, 
making timely decision-making difficult. A means to accurately estimate the risk of 
developing a non-viable or poorly functioning limb would support informed and shared 
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decision-making, allow earlier and better quality decisions, and reduced internal conflict 
about treatment decisions. 
 
Limitations 
This study has a number of limitations. The retrospective design predisposes to a risk of 
information bias; however, every effort was made to ensure complete and high quality 
data. Database information was corroborated with contemporaneous medical records and, 
in some cases, the patient. Furthermore, a team of specially trained GWOT-VII research 
nurses worked to assure data quality and accuracy.  
Missing data is an important cause of information bias. Overall, there was minimal 
missing data in this cohort. However, three variables (nerve injury, degree of soft tissue 
injury, and ischaemic time) had more than ten percent missing data despite a complete 
search of the related medical records. The results of analyses of these variables should 
therefore be interpreted with caution. Very few patients had coagulation data and it was 
therefore not possible to analyse the relationship between coagulopathy and surgical 
decisions in this cohort. This does however affirm that surgical decisions are frequently 
made blind to coagulation state. There is also potential for selection bias because it was 
not possible to locate, contact, and gain consent from all eligible US servicemen.  
The findings of this study relate to the decisions and management of predominantly 
young and healthy military servicemen with high-energy blast mechanisms of injury, 
treated in well-resourced US military trauma facilities. These findings may therefore not 
be generalizable to civilian populations and less resourced trauma systems. However, in 
many respects the findings do represent best-case scenario decision-making, with 
minimal influence from additional factors such as co-morbidities, cost, and resource 
limitations.
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CHAPTER FOUR 
 
Early Prediction of Trauma-Induced 
Coagulopathy
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4.1 Introduction 
 
4.1.1 Lower Limb Trauma Decision-Making During Resuscitation 
Following severe lower limb trauma, initial therapeutic decisions centre on saving life, 
and to a large degree are based on intuitive predictions of the patients’ physiological 
condition and their risk of death. Bleeding patients at risk of developing a coagulopathy 
are particularly important to identify, as this complication exacerbates haemorrhage and 
substantially increases the risk of preventable death (Brohi et al., 2003). Early activation 
of Damage Control protocols, to control haemorrhage and correct coagulopathy, improve 
survival in these patients (Holcomb et al., 2013, Rotondo et al., 1993, Cotton et al., 2008). 
These life-saving interventions take priority over limb salvage, and impact lower-
extremity injury management. Early initiation of Damage Control Resuscitation in at risk 
patients may prevent an established coagulopathy and limit physiological disturbance 
(Gruen et al., 2012). This may enable definitive limb salvage surgery at the first 
operation, including complex limb salvage techniques (Holcomb et al., 2007a, Schreiber, 
2012). However, Damage Control Surgery may be necessary in those that remain 
coagulopathic. These strategies may abbreviate or delay limb salvage attempts, 
potentially jeopardising limb outcome. In certain situations, life-saving haemorrhage 
control may necessitate primary resuscitative limb amputation. The key indication for a 
damage control approach is the development of coagulation abnormalities in a bleeding 
patient (Kashuk et al., 2010, Roberts et al., 2015). It is therefore important to be able to 
identify coagulopathic patients when making damage control decisions, to ensure the best 
possible outcomes. 
 
4.1.2 Trauma Induced Coagulopathy 
Trauma is a global public health problem and a leading source of the world’s burden of 
disease (Lozano et al., 2012, Murray et al., 2012, Vos et al., 2012). A key complication 
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following trauma is the early development of clotting disorders (Brohi et al., 2003). 
Patients that develop a coagulopathy suffer substantially worse outcomes, with 
significantly higher rates of mortality, organ injury and infections (Brohi et al., 2003, 
Casstevens et al., 2010, Cohen et al., 2012). Furthermore, this patient group place a 
considerable demand on hospital resources with greater blood transfusion and ventilator 
requirements, and longer critical care and hospital length of stay (Brohi et al., 2007b, 
Maegele et al., 2007). 
 
Effective therapeutic strategies, that target Trauma-Induced Coagulopathy (TIC), exist 
and the earlier these interventions are applied the greater the benefit (Roberts et al., 2011, 
Gruen et al., 2012, Duchesne et al., 2009, Sorensen and Fries, 2012, Rossaint et al., 
2010). These damage control strategies focus on rapid haemorrhage control and early 
haemostatic resuscitation. They frequently involve abbreviated surgical procedures and 
the transfusion of large volumes of blood components. These strategies are life saving in 
patients at risk of coagulopathy, however, they may be harmful to patients if not indicated 
(Roberts et al., 2015). 
 
Early identification of coagulopathic patients is needed for the effective initiation of these 
treatments (Kashuk et al., 2010). This enables rapid mobilisation of the required 
resources and allows targeted resuscitation of the patients most likely to benefit. 
Furthermore, in patients with normal coagulation, who derive no additional benefit from 
these therapies, the risks of unnecessary interventions and waste of precious resources 
may be minimised. 
 
Although necessary, early identification of coagulopathic patients is not yet possible. 
Routine laboratory coagulation tests have limited accuracy in TIC, and results are not 
available in a useful timeframe to guide therapy (Davenport et al., 2011).  Point-of-care 
prothrombin time assays are also imprecise in trauma (Davenport et al., 2011, Mitra et al., 
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2012b). Thromboelastometry is better able to diagnose TIC and can provide results 
within a few minutes of collecting a blood sample (Davenport et al., 2011, Rugeri et al., 
2007). However, although these complex devices are promising, they are not ideally 
suited to the emergency setting and are unlikely to be routinely available worldwide.  
 
In the absence of a useful test, investigators have attempted to predict TIC (Mitra et al., 
2011, Cosgriff et al., 1997). However, at the high sensitivities required to be clinically 
useful, these logistic regression models have poor specificity and are no better than 
clinical conjecture (Brohi, 2011). As a result, current practice relies on blind, unguided 
protocols, and the early identification of coagulopathic trauma patients remains a key 
research objective. 
 
Advances in artificial intelligence provide the opportunity to develop accurate predictive 
models that can assist clinical decision-making. Bayesian Networks (BN’s) are one 
example of these powerful technologies. BN’s provide a framework for combining 
multiple sources of available information to compute the probability of an unknown 
outcome (Fenton and Neil, 2012b). They are particularly suited to situations were 
information may be missing or uncertain, as is often the case in the emergency setting. 
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4.2 Study Aims 
The overall aim of this study was to develop a predictive model for the early 
identification of TIC in injured patients’.  
The first objective was to develop a classification method for TIC that can serve as the 
reference standard to predict and test model performance against. 
Second, to establish the clinical relevance of TIC in terms of resuscitation requirements 
and mortality. 
Third, to systematically review the existing literature on causal mechanisms of TIC and 
construct an evidence-based causal network using the identified knowledge. 
Finally, to develop a model that can accurately predict TIC from information that is 
normally available following an initial patient assessment. 
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4.3 Methods 
 
4.3.1 Study design 
The predictive model was developed using Bayesian Networks (BNs), a powerful 
technology that permits multiple sources of information to be used to calculate 
predictions (Fenton and Neil, 2012b). BNs consist of two parts: a network structure that 
graphically describes the models variables and their relations, and a set of parameters that 
captures the strength of the relationship between variables. The BN structure and 
parameters were developed using a novel method that combines information from 
published evidence, expert knowledge, and data from a prospective cohort study (Yet et 
al., 2014a). 
 
4.3.2 Study population 
The Activation of Coagulation & Inflammation in Trauma (ACIT) study is a multi-
national, prospective cohort study designed to identify the mechanisms by which the 
body’s coagulation pathways are activated immediately following injury. Adult patients 
(>15 years) presenting directly to participating Major Trauma Centres, who meet local 
criteria for trauma team activation, are included. Exclusion criteria include: arrival in the 
emergency department > 2 hours after injury; prehospital administration of > 2000ml 
intravenous fluid; and burns covering > 5% of body surface area. Patients are 
retrospectively excluded if they decline consent, take anticoagulation medication, have 
moderate or severe liver disease, or a bleeding diathesis. The study was reviewed and 
approved by the National Research Ethics Committee of participating countries and 
written informed consent was obtained for all participants. 
The development cohort consisted of data from the first 600 consecutive patients enrolled 
in the London ACIT study (The Royal London Hospital, London, UK) between January 
2007 and October 2011.  
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4.3.3 Data collection 
For the purposes of this study, data was prospectively collected on patient demographics, 
mechanism of injury, injury characteristics, prehospital and admission vital signs, 
treatment administered, and outcome. Blood samples were collected immediately on 
hospital arrival and used for standard laboratory coagulation tests, rotational 
thromboelastometry (ROTEM), and blood gas analysis. Anatomical injuries were 
described and classified according to the Abbreviated Injury Scale (AIS) and Injury 
Severity Score (ISS) by certified coders (Gennarelli, 2008, Baker et al., 1974). All 
patients were followed-up daily until hospital discharge or death. 
 
4.3.4 Definitions 
Massive transfusion was defined as a requirement of ten or more units of Packed Red 
Blood Cells (PRBCs) in the first 24 hours (Malone et al., 2006). For the purposes of this 
study, DCS was defined as immediate resuscitative surgery aimed at controlling active 
haemorrhage and restoring normal physiology. DCS procedures included resuscitative 
thoracotomy, emergency laparotomy, extra-peritoneal pelvic packing, temporary vascular 
shunts, and primary (life-saving) amputations, but excluded emergency craniotomy, 
exploratory laparotomy in patients’ with normal physiology, wound debridement, and 
definitive fracture fixation. 
 
4.3.5 Outcome 
The primary outcome was a clinically relevant coagulopathy on arrival at hospital. 
We used a systematic approach to classify each patient’s coagulation status into normal 
or abnormal because standard coagulation assays have significant limitations in TIC 
(Davenport et al., 2011). Our approach consisted of three steps. First, all patients were 
classified according to the clinically accepted laboratory definition of Acute Traumatic 
Coagulopathy (ATC), an admission Prothrombin Time ratio (PTr) > 1.2 (Frith et al., 
2010). Second, all patients were independently clustered into normal and abnormal 
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coagulation status using an expectation-maximisation (EM) algorithm (Lauritzen, 1995). 
As standard laboratory coagulation tests have recognised limitations when used to 
diagnose ATC (Brohi, 2011, Davenport et al., 2011), this machine-learning step was used 
to identify potential diagnostic errors (Yet et al., 2014a). The algorithm clustered patients 
according to their expected coagulation state based on the their admission clinical profile, 
PTr, Activated Partial Thromboplastin Time ratio (APTTr) and thromboelastometry 
(ROTEM, Pentapharm GmbH, Munich, Germany). Cases where the laboratory and 
machine-learning methods agreed were assigned the corresponding coagulation state as 
their final classification. Cases where the two methods disagreed, or the PTr sample had 
haemolysed, underwent expert review to determine a final classification.  
The third step was an expert review. The coagulation experts were Dr Ross Davenport 
(Ph.D.), Mr Imran Raza, Dr Simon Glasgow (Ph.D.), and Dr Sirat Khan (Ph.D.), each 
investigating aspects of bleeding and coagulation following trauma at a doctorate or post-
doctorate level. Two of four trauma coagulopathy experts independently reviewed the 
admission clinical, laboratory, and thromboelastometry information of discrepant cases to 
determine an overall coagulation state. Disagreement was resolved by consensus with a 
third expert. Experts had no knowledge of the structure or predictors of the diagnostic 
model, or the EM algorithm result. Inter-reviewer agreement was evaluated with the 
kappa statistic and expert consistency was evaluated on a random sample of 20 patients 
with known coagulation status. 
 
4.3.6 Clinical relevance of outcome 
A fundamental determinant of the clinically value of a predictive model is the relevance 
of the outcome it is developed to predict. The relevance of the trauma coagulopathy 
classification was assessed for a range of important clinical outcomes. Firstly, mortality 
within 24 hours of injury, in-hospital mortality, and survival time were compared 
between injured patients classified as having normal coagulation and those classified as 
coagulopathic. Survival time was measured in hours, for the first 24 hours after injury, 
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and then days following injury. Next, blood transfusion requirements in the first 24 hours 
following injury, and damage control surgery requirements, were compared between the 
two groups. Finally, the critical care length of stay and hospital length of stay was 
compared. The relative risk for each outcome was calculated to compare the difference 
between injured patients classified as coagulopathic and those classified as normal. All 
patients were followed up until either hospital discharge or death.  
 
4.3.7 Model development 
The BN model was developed using a novel methodology that allows the combination of 
data and existing knowledge	 (Yet et al., 2014a).	The methodology follows an iterative, 
step-wise approach that is described below: 
 
Step 1) Causal structure 
The BN structure was derived from existing knowledge. This was informed by a review 
of causal relationships between trauma and development of coagulopathy. Articles were 
identified by an electronic search of the MEDLINE and EMBASE databases using a 
combination of the terms “trauma” and “coagulopathy”, and limited to English 
publications. Original studies that provided evidence of the causal mechanisms of TIC 
were reviewed. A revised structure of Bradford Hill’s criteria for causation was used to 
identify relevant evidence (Hill, 1965, Howick et al., 2009). The reference lists of 
relevant articles were searched manually for additional relevant studies. The reviewed 
articles were used to 1) identify possible causal factors of traumatic coagulopathy and 
therefore the variables to include in the model, 2) define clinically relevant states for 
identified variables and 3) define the relationships between variables. 
 
Step 2) Predictors 
The model is designed to provide an early prediction, following an initial patient 
assessment, of the risk of traumatic coagulopathy. The initial assessment of an injured 
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patient is known as the primary survey and is described in the American College of 
Surgeons Advanced Trauma Life Support manual (2012). Potential predictors were 
therefore limited to information that would normally be available following a standard 
primary survey. Predictors were then selected based on evidence-based coherence with 
the causal structure of traumatic coagulopathy identified in Step 1. To minimise the risk 
of over-fitting, and in contrast to traditional methods of developing predictive models, 
data-driven methods of selecting predictors were not used. Furthermore, collinear 
predictors were retained as they may strengthen the network and provide users with 
flexibility when predictor information is missing or uncertain. 
 
Step 3) Parameter learning and cross-validation 
A set of parameters, that quantifies the relationship between a variable and those 
variables related to it, was defined for each node. These parameters are probability values 
assigned to each of the possible states of the variable that the node represents. The 
parameters of a given node are conditioned on the possible states of its parent nodes. For 
nodes without parents, the parameter is estimated from the prior probability of the 
respective state occurring in the population of interest. 
The models parameters were learned form ACIT data. Probability values were calculated 
for each node in the network using the standard Expectation-Maximisation (EM) 
algorithm (Lauritzen, 1995). The EM algorithm is an established method of computing 
parameters from incomplete datasets (Dempster et al., 1977). However, missing data for 
the majority of predictor variables was less than one per cent.  
Following parameter learning, the predictive performance of the model was tested on the 
development dataset using ten-fold cross validation (Kohavi, 1995). In this approach, the 
development cohort is randomly divided into ten equal size samples. Nine samples are 
used to train the model and the performance is then tested on the remaining sample. The 
process is repeated ten-fold, with each sample used once as test data. The results are then 
combined to calculate a performance estimate. Using this method, the model is trained 
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and internally validated on two statistically independent cohorts containing all of the 
development data. 
 
Step 4) Expert review and model refinement 
The inaccurate predictions of a predictive model offer valuable lessons for model 
refinement. Following cross-validation, cases with inaccurate predictions were identified 
and reviewed. Possible causes of inaccuracies were investigated to identify 1) potential 
opportunities to improve the models structure, 2) potential data errors and 3) limitations 
in the models scope. Where potential opportunities to improve the model were identified, 
the development process returned to step 1, with any changes supported by published 
evidence. Where potential data errors were identified, the original clinical or research 
sources were examined to verify data accuracy. Limitations to the scope of the model 
were documented and are presented in the discussion section. 
 
4.3.8 Performance 
The model’s predictive performance was assessed using multiple measures of 
discrimination, calibration and accuracy. Accurate predictions can discriminate between 
patients at low risk and high risk of an outcome. Discrimination was measured using the 
Area Under the Receiver Operating Characteristic curve (AUROC), sensitivity, and 
specificity. As early identification of traumatic coagulopathy may have such an impact on 
subsequent outcome, it is important that a predictive model operates at a high sensitivity 
for the condition (Brohi, 2011). For this reason we assessed performance at a pre-
specified sensitivity of 90 percent. 
Calibration measures whether the predicted probability agrees with that observed. 
Calibration was evaluated using the Hosmer-Lemeshow test statistic (HL) (Hosmer and 
Lemesbow, 1980) and by visual assessment of the predicted and observed frequency of 
coagulopathy in 10 equal groups stratified by risk. A low HL p-value indicates poor 
calibration. 
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Accuracy combines features of discrimination and calibration to measure how close, on 
average, predicted outcomes are to actual outcomes. Accuracy was evaluated with the 
Brier Score (BS) and the Brier Skill Score (BSS) (Brier, 1950, Weigel et al., 2007). The 
BS has a value between 0 (perfect model) and 1 (worst possible model) and the BSS has a 
range from - ∞ to 1 where a negative value indicates a worse prediction than the average 
probability, and 1 indicates a perfect model. 
 
4.3.9 Sensitivity analysis 
The impact of individual predictors on the models probability calculations was assessed 
using one-way sensitivity analyses. The results were plotted on a tornado graph to allow 
visual comparisons of the relative impact of each predictor variable in the final model 
(Fenton and Neil, 2012b). 
 
4.3.10 Statistical analysis  
Normal-quartile plots were used to test for normality. Numerical data are reported as 
median with interquartile range (IQR) and categorical data as frequency (n) and 
percentage (%). The Mann–Whitney U test was used to compare numerical data and 
Fisher’s Exact test was used to compare categorical data. Outcome comparisons between 
groups are reported as a Relative Risk (RR) with their corresponding 95 percent 
Confidence Intervals (CI). The time from injury to death between groups was compared 
with the log-rank (Mantel-Cox) test, and the results are presented as Kaplan-Meier 
curves. AUROC results are reported with their corresponding 95 percent confidence 
intervals (CI). Inter-reviewer agreement for expert outcome classification was evaluated 
with the kappa statistic. Statistical analyses were performed using GraphPad PRISM v6 
(GraphPad Software Inc., San Diego, CA, USA) and R statistical software (version 
2.15.2). Statistical significance was set as a two tailed p-value of < 0.05. The Bayesian 
Network model was developed with, and is powered by, AgenaRisk software (Agena, 
London, UK). 
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4.4 Results 
 
4.4.1 Baseline characteristics 
Data from 600 patients included in the ACIT study were used to develop the model. Their 
median age was 35 (range: 16 - 95) years, 486 (81.0 percent) were male, and 475 (79.2 
percent) suffered a blunt mechanism of injury. Baseline characteristics of the 
development cohort are shown in Table 1. The median time from injury to hospital 
admission was 83 (63 – 103) minutes. With the exception of admission body temperature, 
missing data for clinical variables was minimal (Table 4.1).  
 
4.4.2 Outcome classification 
Five hundred twenty nine (88.2 percent) patients had normal coagulation and 71 (11.8 
percent) patients developed a coagulopathy following injury. Baseline characteristics of 
patients who developed a coagulopathy were significantly different to those with normal 
coagulation (Table 4.1).  
Classification of coagulation status was achieved by agreement between laboratory and 
EM methods in 565 (94.2 percent) patients and by expert review in the remaining 35 (5.8 
percent) patients. The reasons for expert review were 1) no available PTr result due to 
haemolysis of the blood sample (10 cases, 1.7 percent) and 2) a discrepancy between the 
laboratory and EM classification (25 cases, 4.2 percent). Inter-reviewer agreement on the 
coagulation status of patients requiring expert review was excellent (κ = 0.94 [95 percent 
CI: 0.88 – 1.0]) and expert consistency in a random sample of 20 patients with known 
coagulation status was perfect. 
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Table 4.1: Baseline characteristics of the development population. 
Characteristic 
Missing 
Data 
(%) 
Development 
cohort 
(N=600) 
Normal 
coagulation 
(N=529) 
Coagulopathy 
(N = 71) P-valueb 
Age – years (range) <1 35 (16 – 95) 35 (16 – 95) 38 (16 – 86)  0.354 
Gender - male 0 486 (81.0) 434 (82.0) 52 (73.2)  0.079 
Mechanism of Injury - Blunt 0 475 (79.2) 414 (78.3) 61 (85.9)  0.162 
Pre-Hospital fluid (ml) <1 0 (0 – 500) 0 (0 – 250) 850 (500 – 1500) < 0.0001 
Primary Survey:      
Respiratory Rate a 3 20 (16 – 24) 19 (16 – 24)  20 (11 – 28) 0.649 
Heat Rate 0 95 (76 – 118) 93 (76 – 114)  122 (90 – 139)  < 0.0001 
Systolic Blood Pressure 2 130 (107 – 148) 132 (115 – 150) 87 (60 – 111) < 0.0001 
Body Temperature (°C) 40 35.8 (35.1 – 36.5)  35.9 (35.1 – 36.5) 34.9 (33.7 – 35.6) < 0.0001 
Glasgow Coma Scalea <1 15 (11 – 15) 15 (12 – 15)  10 (4 – 13) < 0.0001 
Suspected Haemothorax <1 89 (14.9) 69 (13.0) 20 (28.2) 0.002 
Suspected pelvic fracture <1 58 (9.7) 37 (7.0) 21 (29.6)  < 0.0001 
Suspected long bone fracture <1 132 (22.2) 107 (20.2) 25 (35.2) 0.006 
FAST - Positive <1 49 (8.2) 33 (6.2) 16 (22.5) < 0.0001 
Baseline Blood Gas Analysis:      
pH 2 7.35 (7.30 – 7.40) 7.36 (7.32 – 7.41) 7.15 (6.99 – 7.27) < 0.0001 
Lactate 5 2.1 (1.3 – 3.6) 2.0 (1.2 – 3.1) 6.2 (3.2 – 10.8) < 0.0001 
Base Deficit 2 1.8 (-0.2 – 4.4) 1.4 (-0.5 – 3.4)  10.8 (5.4 – 18.7) < 0.0001 
Baseline Thromboelastometry:      
EXTEM CA5 (mm) 3 44 (38 – 49) 45 (40 – 49) 28 (20 – 35)  < 0.0001 
EXTEM MCF (mm) 3 61 (56 – 65) 61 (57 – 65)  49 (40 – 54)  < 0.0001 
FIBTEM MCF (mm) 3 14 (10 – 17) 14 (11 – 18)  7 (5 – 9)  < 0.0001 
Baseline laboratory values:      
INR 2 1.1 (1.0 – 1.1) 1.1 (1.0 – 1.1)  1.3 (1.3 – 1.6)  < 0.0001 
APTT (seconds) 3 23 (22 – 26) 23 (22 – 25) 39 (29 – 61)  < 0.0001 
Haemoglobin (g/dL) 5 13.9 (12.4 – 14.9) 14.1 (12.8 – 14.9)  11.4 (9.0 – 12.9) < 0.0001 
Platelet count (x109 /L) 5 231 (193 – 272) 234 (200 – 277)  173 (130 – 242)  < 0.0001 
Injury severity:      
Injury Severity Score 0 16 (9 – 29) 13 (5 – 25)  34 (25 – 43) < 0.0001 
Head AIS ≥ 3 0 173 (28.8) 132 (25.0) 41 (57.8) < 0.0001 
Chest AIS ≥ 3 0 257 (42.8) 199 (37.6)  58 (81.7) < 0.0001 
Abdomen AIS ≥ 3 0 62 (10.3) 45 (8.5) 17 (23.9) 0.0003 
Extremity AIS ≥ 3 0 198 (33.0) 156 (29.5) 42 (59.2)  < 0.0001 
Data presented as number (%) or median (IQR) unless otherwise stated. a Admission measurement or, if patient arrived 
intubated, pre-hospital measurement prior to sedation and intubation. b  P-value refers to difference between normal 
coagulation and coagulopathy groups. FAST, Focused Assessment with Sonography for Trauma; CA5, Clot Amplitude at 5 
minutes; MCF, Maximum Clot Firmness; INR, International Normalised Ratio; APTT, Activated Partial Thromboplastin 
Time; AIS, Abbreviated Injury Score. 
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4.4.3 Clinical relevance of coagulopathy 
 
Mortality 
The mortality rate in the first 24-hours following injury was 36.6 percent in patients that 
developed a coagulopathy compared to 1.3 percent in patients with normal coagulation 
(RR: 27.7  (12.5 – 61.4); P < 0.0001). Similarly, in-hospital mortality was also 
substantially higher in coagulopathic patients compared to those with normal coagulation 
(53.7 percent versus 5.6 percent; RR: 10.2 (6.8 – 15.2); P < 0.0001) (Table 4.2). Injured 
patients that developed a coagulopathy were significantly less likely to survive their 
injuries than those with normal coagulation and the majority of deaths in coagulopathic 
patients occurred soon after injury (Figure 4.1). 
 
Consumption of health care resources 
In the first 24-hours after injury, coagulopathic patients more frequently required a blood 
transfusion (90.1 percent versus 23.2 percent; RR: 3.9  (3.3 – 4.6); P < 0.0001) and a 
massive transfusion (40.9 percent versus 1.3 percent; RR: 30.6  (13.9 – 67.3) P < 0.0001) 
when compared to non-coagulopathic patients (Table 4.2). On average, each 
coagulopathic patient was transfused 8 (5 – 15) PRBC units and 6 (3 – 9) Fresh Frozen 
Plasma (FFP) units, compared to a median of 0 (0 – 0) units of either in non-
coagulopathic patients (p < 0.0001). Coagulopathic patients were also more likely to 
require immediate DCS than non-coagulopathic patients (45.1 percent versus 4.0 percent; 
RR: 11.4  (6.9 – 18.6); P < 0.0001). Additionally, coagulopathic patients that survived 
had significantly longer critical care (8 (4 – 16) days versus 0 (0-2) days; p < 0.0001)) 
and hospital (33 (20 – 47) days versus 8 (2 – 21) days; p < 0.0001) length of stay, 
compared to survivors with normal coagulation. 
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Table 4.2: Comparison of outcomes and resuscitation resource requirements in 600 
injured patients stratified by coagulation status. 
Outcome 
Missing 
Data 
(%) 
Coagulopathy 
(N=71) 
Normal 
Coagulation 
(N=529) 
Relative Risk 
(95% CI) P-value 
Mortality:      
24-hour 0 26 (36.6) 7 (1.3) 27.7  (12.5 – 61.4) < 0.0001 
Hospital 0 41 (57.8) 30 (5.7) 10.2  (6.8 – 15.2) < 0.0001 
Emergency intervention in first 24 hours:    
Transfusion <1 64 (90.1) 122 (23.2) 3.9  (3.3 – 4.6) < 0.0001 
Massive transfusion <1 29 (40.9) 7 (1.3) 30.6  (13.9 – 67.3) < 0.0001 
DCS 0 32 (45.1) 21 (4.0) 11.4  (6.9 – 18.6) < 0.0001 
Data presented as number (%) 
Risk Ratios are for the coagulopathic group, as compared with the normal coagulation group. 
DCS, Damage Control Surgery 
 
 
 
Figure 4.1: Kaplan-Meier estimates of the probability of survival for 600 injured patients 
with either normal coagulation or a coagulopathy. The P-value was calculated using the 
log-rank (Mantel-Cox) test. 
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4.4.4 Model development 
 
Literature search 
The literature search identified 1421 citations. These were screened and 262 potentially 
relevant full-text articles were reviewed. A further eleven articles were identified from 
the reference lists of reviewed articles. Eighty-five articles were excluded because of an 
ineligible study type: narrative review (78), letter or editorial (5), survey or guideline (2). 
Forty-one original articles were excluded as they only described the diagnosis (10) or 
treatment (22) of coagulopathy, or had no description of the causal mechanisms of 
traumatic coagulopathy (9). Overall, 147 original studies were included (Figure 4.2). 
These consisted of 87 observational studies (51 retrospective and 36 prospective), 58 
experimental studies (35 Animal, 20 human, and 3 computer simulation), and two 
systematic reviews. 
Figure 4.2: PRISMA flow chart of study selection process. 
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Causal structure 
Evidence from the included studies was used to inform the causal structure of the 
Bayesian Network. The review identified several possible causes of traumatic 
coagulopathy that are frequently interrelated. These causes are related to characteristics of 
the injury, degree of physiological derangement, and subsequent medical intervention. 
Some causal factors (tissue injury and tissue hypoperfusion) may immediately effect 
coagulation, while others (acidaemia, hypothermia, haemodilution) may take time to 
develop and therefore take time to exert their effect. Evidence supporting the identified 
causal factors is presented in Table 4.3 and qualitatively described below. These causal 
factors formed the core structure of the prognostic model. (Fig 4.3) 
 
Hypoperfusion 
Systemic tissue hypoperfusion following trauma appears to be a principal cause of an 
early endogenous coagulopathy. The predominant cause of tissue hypoperfusion after 
trauma is haemorrhagic shock but tension pneumothorax, cardiac tamponade and central 
nervous system injury may occasionally contribute (ACS, 2012). Observational studies of 
heterogeneous trauma populations, from a wide spectrum of geographic and 
socioeconomic settings, repeatedly demonstrate a strong correlation between systemic 
markers of tissue hypoperfusion and acute coagulation dysfunction. These markers 
include heart rate (Cohen et al., 2013), systolic blood pressure (Cohen et al., 2013, 
Cosgriff et al., 1997, Cotton et al., 2011, Kashuk, 2012, Mitra et al., 2011, Raza et al., 
2013, Talving et al., 2009, Wafaisade et al., 2010), lactate (Kashuk, 2012) , and base 
deficit (Brohi et al., 2007b, Brohi et al., 2008, Brophy et al., 2013, Cap and Spinella, 
2011, Casstevens et al., 2010, Cheddie et al., 2013, Cohen et al., 2007, Cohen et al., 2012, 
Cohen et al., 2013, Cotton et al., 2011, Davis et al., 1996, Frith et al., 2010, Kapsch et al., 
1984, Kashuk, 2012, Nardai et al., 2009, Simmons et al., 2011, Sixta et al., 2012, 
Wafaisade et al., 2010, Xu et al., 2013, Raza et al., 2013). Furthermore, experimental 
animal models that combine trauma and haemorrhagic shock are able to consistently 
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induce an endogenous acute traumatic coagulopathy (Burruss et al., 2012, Chesebro et al., 
2009, Darlington et al., 2012a, Frith et al., 2012, Frith et al., 2010, Harr et al., 2011, 
Letson et al., 2012, Martini et al., 2005a, Park et al., 2013, White et al., 2010b, Darlington 
et al., 2013, White et al., 2010a). Many of these models carefully control for known 
exogenous confounders including hypothermia and haemodilution (Chesebro et al., 2009, 
Darlington et al., 2012a, Darlington et al., 2013, Frith et al., 2012, Frith et al., 2010, 
White et al., 2010a). In addition, endogenous coagulopathy only appears to occur in the 
presence of tissue hypoperfusion (Brohi et al., 2007b, Brohi et al., 2008, Cohen et al., 
2007, Frith et al., 2011) and there is a clear dose-response relationship between the 
degree of tissue hypoperfusion and coagulation dysfunction (Brohi et al., 2007b, Davis et 
al., 1996, Frith et al., 2010, Jansen et al., 2011, Kapsch et al., 1984, Raza et al., 2013).  
Although tissue hypoperfusion alone can cause coagulation dysfunction, this seems to be 
greatly amplified when combined with some degree of tissue injury (Frith et al., 2010). 
Tissue hypoperfusion appears to cause coagulopathy by activation of anticoagulant and 
fibrinolytic pathways (Brohi et al., 2007b, Brohi et al., 2008, Cohen et al., 2012, Jansen et 
al., 2011, Kashuk, 2012, Martini et al., 2005a, Raza et al., 2013). These mechanisms 
appear to be mediated through the effects of thrombomodulin on thrombin, activation of 
protein C and endothelial release of tissue plasminogen activator (Brohi et al., 2007b, 
Brohi et al., 2008, Kashuk, 2012, Raza et al., 2013, Cohen et al., 2012, Hrafnkelsdottir et 
al., 2001). In parallel, coagulopathy is also commonly observed following other causes of 
systemic hypoperfusion such as severe sepsis (Walsh et al., 2010), severe burns (Sherren 
et al., 2013) and cardiac arrest (Lee et al., 2012, White et al., 2011b, Adrie et al., 2005). 
The similarity of these findings strongly supports a causal hypothesis between systemic 
tissue hypoperfusion and coagulopathy. 
 
Tissue Injury 
Tissue injury activates normal coagulation pathways by exposing tissue factor to blood 
(Banner et al., 1996, Hoffman and Monroe, 2001). By definition, all trauma patients have 
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some degree of tissue injury. The extent depends on the mechanism of injury, the amount 
of energy transferred, and the proportion of the body involved. As no validated biomarker 
exists, the extent of tissue injury is commonly estimated using the Injury Severity Score 
(ISS). The ISS is an anatomical score that measures the overall severity of injured 
patients (Baker et al., 1974). Each distinct injury in an individual patient is assigned an 
Abbreviated Injury Scale (AIS) score (Gennarelli, 2008). AIS scores range from 1 
(minor) to 6 (lethal) and are defined in an internationally recognised dictionary. The ISS 
then divides the body into six regions (head, face, chest, abdomen, extremities including 
pelvis, and external) and the score is calculated by adding the square of the highest AIS 
score in the three most severely injured body regions. 
 
There is a significant association between coagulopathy and the extent of tissue injury, as 
measured by ISS (Affonseca et al., 2007, Brohi et al., 2003, Brophy et al., 2013, Cheddie 
et al., 2013, Cohen et al., 2012, Cosgriff et al., 1997, Cotton et al., 2011, Floccard et al., 
2012, Frith et al., 2010, Genet et al., 2013, Johansson et al., 2011, Kapsch et al., 1984, 
Nardai et al., 2009, Niles et al., 2008, Raza et al., 2013, Shaz et al., 2011, Simmons et al., 
2011, Sixta et al., 2012, Wafaisade et al., 2010, Xu et al., 2013). Furthermore, there 
appears to be a dose-response relationship between ISS and the proportion of patients that 
develop a coagulopathy (Brohi et al., 2003, Floccard et al., 2012, Kapsch et al., 1984, 
Lustenberger et al., 2010). The components of the ISS that appear to contribute to this 
relationship are increasingly severe injuries to the head, chest, abdomen, and extremity 
AIS body regions, but not isolated face and external injuries (Brohi et al., 2003, Talving 
et al., 2009, Wafaisade et al., 2010). Coagulation dysfunction appears to only develop, 
however, when tissue injury is combined with tissue hypoperfusion (Brohi et al., 2007b, 
Cohen et al., 2007). Animal models confirm this observation: animals subjected to a 
combination of tissue injury and tissue hypoperfusion predictably develop an early 
coagulopathy, while coagulation remains normal in animals subjected to tissue injury 
alone (Frith et al., 2010). Although ISS is designed to reflect the extent of tissue injury, it 
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may also act as a marker of the volume of blood loss and shock. This is a potentially 
important confounder when using ISS as a measure of tissue injury. 
 
A number of specific injuries are associated with an increased risk of coagulopathy. 
Traumatic Brain Injury is strongly associated with coagulopathy (Cap and Spinella, 2011, 
Chhabra et al., 2013, Lustenberger et al., 2010, Zehtabchi et al., 2008, Carrick et al., 
2005, Greuters et al., 2011, Harhangi et al., 2008). The severity of the brain injury, as 
measured with the Glasgow Coma Scale or head AIS score, directly correlates with the 
risk of developing coagulopathy (Affonseca et al., 2007, Cap and Spinella, 2011, Chhabra 
et al., 2013, Cohen et al., 2013, Talving et al., 2009, Xu et al., 2013, Keller et al., 2001, 
Lozance et al., 1998, Peiniger et al., 2012, Brohi et al., 2003, Lustenberger et al., 2010). 
Major pelvic fractures (Cordts et al., 2011, Filho et al., 2011, Poole et al., 1992) and 
severe intra-abdominal haemorrhage (Rotondo et al., 1993, Garrison et al., 1996) are also 
associated with a high risk of developing coagulopathy. Indeed, even clinically suspected 
pelvic fractures or intra-abdominal injuries are predictive of coagulopathy (Mitra et al., 
2011). These injuries may be markers of overall tissue injury severity, risk factors for 
haemorrhage and shock, or instigators of specific causal mechanisms. Thus, tissue injury 
appears to be an important initiator of coagulation and fibrinolysis, but alone, does not 
appear to cause coagulation dysfunction. 
 
Acidaemia 
Acidaemia is defined as a blood pH less than 7.35 - the lower limit of normal. Following 
injury, acidaemia is usually caused by a lactic acidosis resulting from shock and tissue 
hypoperfusion. Other potential causes of acidaemia in trauma patients include excess 
chloride administration, respiratory failure, and a lactic acidosis due to intense physical 
exertion. 
A strong association between acidaemia and coagulopathy is observed in injured patients 
(Cosgriff et al., 1997, Engels et al., 2011, Ferrara et al., 1990, Kashuk, 2012, Aucar et al., 
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2003). Furthermore, severe acidaemia (pH 7.1), induced by controlled haemorrhage and 
tissue hypoperfusion, causes a coagulopathy in animal models (Darlington et al., 2011, 
Dubick et al., 2009). It is difficult, however, to separate the effects of acidaemia and those 
of tissue hypoperfusion on coagulation function. Experimentally inducing acidaemia, 
using exogenous acid, impairs coagulation in both animal models (Darlington et al., 2011, 
Frith et al., 2012, Martini et al., 2006, Martini et al., 2005b) and human blood (Engstrom 
et al., 2006). These derangements seem to be the result of impaired coagulation protease 
and platelet function (Dubick et al., 2009, Martini et al., 2006, Martini et al., 2007, 
Martini et al., 2005b). Worsening acidaemia has a dose-dependant effect on clotting 
function (Engstrom et al., 2006, Kashuk, 2012). However, reversal of the acidaemia does 
not appear to correct the coagulopathy (Martini et al., 2007, Martini et al., 2006, 
Darlington et al., 2011, Dubick et al., 2009). 
 
Hypothermia 
Hypothermia is defined as a core body temperature of less than 35°C (ACS, 2012). 
Following injury, hypothermia may be caused by 1) an increase in heat loss resulting 
from environmental exposure, infusion of cold fluids, or the administration of anaesthetic 
drugs; and/or 2) a decrease in heat production due to tissue hypoperfusion and reduced 
metabolism in shocked patients. 
Observational studies have identified a significant association between hypothermia and 
coagulopathy in trauma patients (Cohen et al., 2013, Cosgriff et al., 1997, Ferrara et al., 
1990, Ferraro et al., 1992, Ireland et al., 2011, Mitra et al., 2011, Wafaisade et al., 2010, 
Xu et al., 2013). Hypothermia inhibits coagulation proteases and platelet function (Watts 
et al., 1998, Wolberg et al., 2004, Kermode et al., 1999, Martini et al., 2005b) in a dose-
dependant and reversible manner (Kashuk, 2012, Mitrophanov et al., 2013, Shcherbina et 
al., 2013, Michelson et al., 1994). These changes prolong clotting times but do not seem 
to affect the strength of formed clots (Darlington et al., 2012b, Martini et al., 2008, Park 
et al., 2013). However, clinically significant effects on coagulation function are only 
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observed at temperatures below 33°C (Wolberg et al., 2004, Martini et al., 2005b, Meng 
et al., 2003). Above this temperature, mildly hypothermic trauma patients have similar 
coagulation function to normothermic patients (Brohi et al., 2008, Mohr et al., 2013, 
Watts et al., 1998). Temperatures below 33°C are uncommon in trauma patients (Martin 
et al., 2005, Wang et al., 2005), suggesting that alternative causes of coagulopathy are 
also involved in injured patients. 
 
Dilution 
In hypovolaemic shock, intracellular and extracellular fluid shifts into the plasma 
resulting in dilution of the blood constituents. This haemodilution is greatly compounded 
by resuscitation with intravenous fluids. Early trauma coagulopathy is associated with 
haemodilution as measured by admission haemoglobin concentration (Kashuk, 2012), 
haematocrit (Shaz et al., 2011), and the volume of pre-hospital fluid administered (Cohen 
et al., 2013, Hubetamann et al., 2011, Maegele et al., 2007, Rourke et al., 2011, Shaz et 
al., 2011, Sixta et al., 2012, Wafaisade et al., 2010). Furthermore, the degree of 
coagulation dysfunction correlates with the degree of haemodilution and the volume of 
pre-hospital fluid administered in a dose-dependant manner (Darlington et al., 2010, 
Maegele et al., 2007, Kashuk, 2012). The degree of shock and haemodilution, however, 
are closely correlated and it is again difficult to separate the clinical effects of tissue 
hypoperfusion from those of haemodilution on coagulation function. The independent 
coagulopathic effects of haemodilution have been demonstrated in experimental animal 
models (Dickneite et al., 2010, Dickneite and Pragst, 2009, Frith et al., 2012, Grottke et 
al., 2010), computer simulation models (Hirshberg et al., 2003, Ho et al., 2009), in-vitro 
human blood (Darlington et al., 2010, Darlington et al., 2012b, Bolliger et al., 2010, 
Ogweno and Gwer, 2013, Brazil and Coats, 2000), and in healthy human volunteers 
(Coats et al., 2006). As expected, administration of large volumes of intravenous fluid has 
a clear dilution effect on platelets and coagulation proteases, which results in a decrease 
in thrombin generation, prolonged clot formation, and reduced clot strength (Dickneite et 
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al., 2010, Dickneite and Pragst, 2009, Frith et al., 2012, Ogweno and Gwer, 2013). 
Furthermore, crystalloid dilution may increase fibrinolysis and colloids may directly 
interfere with clotting function (Bolliger et al., 2010, Brummel-Ziedins et al., 2006, Coats 
et al., 2006). The effects of haemodilution may be minimised or reversed by volume 
resuscitation with blood products in ratios that replicate whole blood (Hirshberg et al., 
2003, Ho et al., 2009). Haemostatic resuscitation principles aim to minimise 
haemodilution and its negative effects, however, significant early coagulopathy 
frequently occurs in patients with no haemodilution and who receive minimal 
resuscitation fluid, suggesting alternative causes may be more important in early 
coagulopathy (Brohi et al., 2003). 
 
Table 4.3: Evidence supporting the identified causal factors presented according to a 
revised framework of the Bradford Hill criteria (Howick et al., 2009). 
Causal evidence 
Tissue 
Hypoperfusion 
Tissue 
Injury Acidaemia Hypothermia Haemodilution 
Direct evidence      
Association      
No confoundinga      
Temporality      
Dose-responsiveness      
Reversibility      
Mechanistic evidence      
Plausible mechanism      
Parallel evidence      
Replicability      
Similarity      
a Have plausible confounders been adjusted for? 
Supporting evidence, unclear evidence, no supporting evidence 
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Predictors 
The literature search identified a number of potential predictors that would normally be 
available following a standard primary survey. Additional predictors were identified from 
the Advanced Trauma Life Support (ATLS) primary survey guidelines (ACS, 2012). The 
estimated energy and mechanism of injury provide valuable information that can be used 
to identify patients with severe injuries and at high risk of severe haemorrhage (Spahn et 
al., 2013, Schreiber et al., 2007, Sasser et al., 2012). Furthermore, the primary survey 
prioritises the identification of certain “life-threatening” injuries because of their 
association with significant haemorrhage and shock. These include injuries that result in 
haemothorax, cardiac tamponade, and intra-abdominal bleeding, as well as major pelvic 
and long bone fractures. Aside from clinical examination, X-ray of the chest and pelvis in 
conjunction with ultrasonography are recommended diagnostic modalities during the 
primary survey to assist with the identification of these injuries.  
Fourteen predictor variables were incorporated in the final model (Table 4.4). The 
relationships between predictor variables, causal variables and outcome are captured by 
the network structure of the final model (Fig 4.3). Full details of the literature search 
results and the evidence supporting the final models structure are presented in an 
evidence browser (Yet et al., 2014b). The browser is available at 
http://www.traumamodels.com/atcbn/ATC_EBase/index.html. 
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Figure 4.3: Structure of the Bayesian Network predictive model. The black variable 
represents the primary predicted outcome. Grey variables represent the five identified 
causal factors, and white variables represent identified predictors associated with the 
causal factors. HR, Heart Rate; SBP, Systolic Blood Pressure; BD, Base Deficit; °C, 
measured temperature in degrees Celsius; Fluid, volume of prehospital resuscitation fluid 
administered; GCS, Glasgow Coma Scale; MOI, Mechanism Of Injury; Temp, 
Temperature. 
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Table 4.4: Definitions of predictor variables in the Bayesian Network model. 
Predictor Variable Type of Node Definition 
Heart rate Continuous Heart rate in beats per minute 
Systolic blood pressure Continuous Systolic Blood Pressure in mmHg 
Temperature Boolean  ≥ 34 °C / < 34 °C  
Haemothorax Boolean Present: Clinically suspected, based on examination or 
CXR findings. 
Absent: Not suspected 
FAST result Boolean Positive: Free peritoneal fluid identified. 
Negative: No free peritoneal fluid or investigation not 
clinically indicated. 
Unstable pelvic fracture Boolean Present: Clinically suspected, based on examination or 
PXR findings. 
Absent: Not suspected 
Long bone fracture Boolean Present: Clinically suspected fracture of femur, tibia or 
humerus. Traumatic amputation proximal to ankle or 
elbow. 
Absent: Not suspected 
GCS Ranked Glasgow Coma Score on admission or prior to intubation 
Lactate Continuous Admission Arterial or Venous Blood Gas Analysis 
Base Deficit Continuous Admission Arterial or Venous Blood Gas Analysis 
pH Continuous Admission Arterial or Venous Blood Gas Analysis 
Mechanism of Injury Boolean Blunt / Penetrating 
Energy Boolean High-Energy: High-velocity GSW; fall > 20 feet (6 
meters); Pedestrian or cyclist versus vehicle > 20mph; 
Road Traffic Collision with mechanical entrapment, 
ejection from vehicle or death in same passenger 
compartment; Entrapment under a train or vehicle; Crush 
injury; Blast injury. 
Low-Energy: Stab; low-velocity GSW; and blunt injury 
excluding injuries above. 
Volume of fluid 
administered 
Ranked 1) < 500ml, 2) 500 – 2000ml, 3) > 2000ml crystalloid or 
colloid fluid. 
CXR, Chest X-Ray; PXR, Pelvic X-Ray; GSW, Gun Shot Wound 
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4.4.5 Performance 
The model had excellent overall performance at predicting traumatic coagulopathy in the 
development cohort. The AUROC was 0.927 (95 percent CI: 0.902 – 0.953) and at a 
sensitivity set at 90 percent, the specificity was 82 percent (Figure 4.4). The predicted 
risk of coagulopathy calibrated well with observed risk (Figure 4.5) and the Hosmer-
Lemeshow goodness-of-fit test result was non-significant (P = 0.3). Furthermore, the 
models predictions were accurate, with a Brier Score of 0.06 (95 percent CI: 0.05 – 0.08) 
and a Brier Skill Score of 0.39 (95 percent CI: 0.28 – 0.50). 
 
 
Figure 4.4: Overall accuracy of the trauma-induced coagulopathy predictive model. 
Overall accuracy was assessed using the Receiver Operating Characteristic (ROC) curve 
for coagulopathy predictions in the development cohort. This plots the true positive rate 
(sensitivity) against the false positive rate (1 – specificity). The Area under the ROC 
curve (AUROC) was 0.927. At a sensitivity of 90 percent the false positive rate was 18 
percent. 
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Figure 4.5: Model calibration in the development cohort. There was no significant 
difference between the predicted and observed frequency of coagulopathy in each risk 
group (p = 0.3). 
 
4.4.6 Sensitivity analysis 
All predictor variables contributed to the model’s performance. Continuous variables 
related to hypoperfusion – specifically blood gas variables (Base Deficit, Lactate, pH), 
systolic blood pressure and heart rate – had the greatest impact on the models result 
(Figure 4.6). 
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Figure 4.6: One-way sensitivity analyses of the impact individual predictor variables 
have on the models result. 
 
4.4.7 Model presentation and application 
A preview version of the complete model is available at 
http://valinor.agena.co.uk:8080/atcbn/atcbn.html. Entering predictor variable values 
allows the calculation of an individual patients probability of having traumatic 
coagulopathy. The tool is specifically designed to provide an individualised risk 
assessment that allows clinicians to exercise their own informed judgement and choice. 
The tool is not designed to predict decisions or prescribe treatments at a prespecified 
threshold.  
This version of the model should not be used to inform clinical decisions until its 
performance in new patients has been adequately validated and the impact of predictions 
on decision-making and patient outcomes has been assessed. 
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4.4 Discussion 
 
Key findings 
A clinically relevant coagulopathy is common after traumatic injury and associated with 
significantly worse outcomes and greater consumption of health care resources. We have 
developed a model that can accurately predict Trauma Induced Coagulopathy from 
routine baseline findings. This early identification of coagulopathy has important 
implications for safe and effective trauma resuscitation, and efficient use of resources. 
 
Benefits of early identification of coagulopathy 
Early identification of coagulopathy enables early initiation of treatment. This is 
important because therapies that target Trauma Induced Coagulopathy, such as 
haemorrhage control (Gruen et al., 2012), tranexamic acid (Roberts et al., 2011), and 
haemostatic resuscitation with high ratios of blood products (Holcomb et al., 2013), are 
significantly more effective when initiated early. The benefit of specialist trauma care to 
patients with life-threatening injuries is also established (MacKenzie et al., 2006). Early 
identification, ideally in the pre-hospital phase, can be used to triage patients at risk of 
coagulopathy directly to specialist trauma centres capable of delivering optimal trauma 
care. Furthermore, pre-hospital identification of high-risk patients could be used to 
objectively activate in-hospital pathways and protocols, thereby minimising logistical 
delays in the provision of critical therapies such as blood component transfusions, 
emergency surgery, and interventional radiology. Indeed, pre-hospital activation of in-
hospital major haemorrhage protocols has been shown to result in earlier access to 
haemostatic resuscitation and surgical haemorrhage control, and improved outcomes 
(Khan et al., 2013, Perkins et al., 2014). 
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Thus, a tool that accurately identifies patients at high-risk of coagulopathy, and that is 
used to accelerate access to optimal trauma care, has the potential to significantly 
improve trauma outcomes. 
 
Early identification of coagulopathy also enables targeted treatment. Haemostatic 
resuscitation and abbreviated ‘damage control’ surgery procedures are life-saving 
interventions in the severely injured, but this benefit comes with a morbidity cost 
(MacLennan and Williamson, 2006, Watson et al., 2009, Johnson et al., 2010, Miller et 
al., 2005), and inappropriate use of these interventions may result in considerable and 
unnecessary harm (Mitra et al., 2012a, Hatch et al., 2011). 
Accurate identification of patients that will benefit from a damage control approach is 
therefore essential to achieve optimal outcomes. The central physiological abnormality 
that defines the need for a damage control approach to resuscitation and surgery is the 
development of coagulopathy (Kashuk et al., 2010, Roberts et al., 2015). However, 
current haemostatic resuscitation strategies rely on blind, unguided protocols for blood 
component therapy. While these strategies improve blood product delivery and outcome 
in the coagulopathic patient, they expose patients with normal coagulation to unnecessary 
transfusion risk and may place an undue burden on hospital transfusion services. 
 
Although coagulopathy is the key indication for damage control surgery, these procedures 
are almost always performed without any objective evidence of coagulation function. 
This is because it is not yet possible to identify coagulopathy within the optimal time 
frame available for damage control surgery decision-making. As a result, current DCS 
decisions rely on crude indicators of TIC (Roberts et al., 2015). Early and accurate 
identification of patients that will benefit from a damage control approach is essential for 
optimal outcomes, as delayed or inaccurate decisions may have major consequences for 
the patient. A model that allows early identification of patients at high-risk of 
coagulopathy could be used to identify patients most likely to benefit from the early 
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initiation of haemostatic resuscitation and damage control interventions, while 
minimising the risk of unnecessary harm in patients that are unlikely to derive any 
additional benefit. 
 
Comparison with existing models 
Two models have previously been developed to identify trauma patients with early 
coagulopathy (Cosgriff et al., 1997, Mitra et al., 2011). Cosgriff and colleagues (1997) 
derived a simple score from trauma registry data of patients who received a massive 
blood transfusion. They found that the increasing presence of four predictors (systolic 
blood pressure < 70mmHg, temperature < 34 °C, pH <7.1, and ISS > 25) directly 
correlated with the risk of developing coagulopathy, ranging from 1% (none present) to 
98% (all four present).	Their study was the first to demonstrate that early coagulopathy 
may be predictable from clinical information, and the authors suggest that their score may 
assist damage control surgery decision-making. This study, however, has a number of 
limitations that may impact its clinical relevance. Notably, one of the four variables in 
this score, ISS, is not known during the time frame the score is intended for use.  
Consequently, a subjective estimate of the ISS value would be required, which would 
affect the score’s clinical reliability. 
 
More recently, Mitra and colleagues (2011) developed a score from a large trauma 
registry database (n = 1680). Using regression analysis, they selected five predictors that 
are all available during the early phase of care (entrapment; systolic blood pressure < 
100mmHg; temperature < 35 °C; suspected abdominal or pelvic injury; and chest 
decompression). At the suggested threshold, this Coagulopathy of Severe Trauma 
(COAST) score was able to identify 64 percent of patients with early coagulopathy and 
95 percent of patients with normal coagulation in the development cohort.  
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The COAST score represents a number of improvements on Cosgriff’s original score. 
Besides all the constituent variables being available at the intended time frame of use, the 
score was also developed from a substantially larger dataset, and the performance was 
prospectively validated in a new sample of patients. 
 
However, neither of these scores is accurate enough to reliably support clinical decision-
making (Brohi, 2011). The moderate predictive performance may be the result of a 
number of methodological limitations. Firstly, simple scores may not be sufficiently 
powerful to accurately predict complex pathophysiological processes. Second, by limiting 
the number of predictors and dichotomising continuous variables, much of the prognostic 
potential of available information is lost (Altman and Royston, 2006, Steyerberg et al., 
2001). Lastly, although developed to predict patients with early coagulopathy, both scores 
actually predict a diagnostic test result. Using a surrogate outcome may affect the clinical 
relevance of the score (Grimes and Schulz, 2005). 
 
Importance of predicting a relevant patient outcome 
No matter how accurate a predictive model, it will have little clinical value if it is not 
developed to predict a relevant patient outcome. Coagulation dysfunction following 
trauma is a key outcome that precedes organ failure and death, and early identification 
provides an opportunity for effective intervention. However, the true state of the 
coagulation system cannot be directly observed and is therefore estimated using 
laboratory measures of coagulation function. The most widely used tests measure the clot 
formation time of plasma (PT, INR, APTT), but these measures have important 
limitations when used to estimate trauma coagulopathies. Furthermore, there is no clear 
measurement threshold for these tests that separate patients with normal coagulation from 
those with coagulopathy. As a result, current laboratory measures lead to some 
uncertainty in the diagnosis of coagulopathy. 
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Although developing a model that predicts laboratory test results is convenient, it is quite 
different from predicting the true coagulation state. A model developed to accurately 
predict the result of an imperfect laboratory test would need to replicate the 
measurement’s diagnostic errors, further compounding uncertainty of the true state. 
Additionally, even accurate models may predict a non-relevant threshold of the diagnostic 
test. For example, Cosgriff and colleagues (1997) developed a score to predict an early 
‘life-threatening’ traumatic coagulopathy. This was defined as a Prothrombin Time and a 
Partial Thromboplastin Time more than twice the upper limit of normal laboratory 
controls. Although their score is able to identify patients that meet these criteria, the 
clinical relevance of this outcome is questionable. In their study population, there was no 
significant difference in mortality, emergency surgery, or blood transfusion requirements 
between patients classified as coagulopathic and those regarded as having normal 
coagulation (Table 4.5). Indeed, it could be argued that the majority of patients classified 
as normal in their study also required urgent haemostatic intervention and damage control 
surgery. 
 
Table 4.5: Outcomes in 58 trauma patients who required a massive blood transfusion, 
according to a laboratory based classification of coagulopathy (Cosgriff et al., 1997). 
Traumatic coagulopathy was classified as a Prothrombin Time (PT) and a Partial 
Thromboplastin Time (PTT) of more than twice the upper limit of normal. 
Outcome 
Coagulopathy 
(n = 27) 
Normal Coagulation 
(n = 31) P - value 
Mortality 12 (44.4) 13 (41.9) 1.0 
Emergency Surgery 27 (100) 31 (100) 1.0 
PRBC/24hr 26.2 ± 2.7 22.4 ± 1.9 0.24 
FFP/24hr 13.9 ± 1.6 14.1 ± 1.9 0.90 
Platelets/24hr 16.5 ± 3.1 15.8 ± 2.7 0.86 
Data presented as number (%) or mean ± standard deviation. 
PRBC/24hr, units of Packed Red Blood Cells transfused in 24 hours; FFP/24hr, units of Fresh 
Frozen Plasma transfused in 24 hours; Platelets/24hr, units of platelets transfused in 24 hours. 
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Scope of model 
Although the model accurately predicts coagulopathy in the majority of injured patients, 
the scope of the model may be limited in certain circumstances. Firstly, although the 
models structure was learned from knowledge, the parameters were learned from ACIT 
data. The ACIT study is a prospective cohort study designed to investigate early 
coagulation changes following trauma and provides an optimal source of data for 
developing a model to predict traumatic coagulopathy. The model’s performance, 
however, may not be accurate in populations excluded from the ACIT study. Injured 
patients on anticoagulation medication or those with significant liver disease were 
excluded from the ACIT study and the model is not designed to predict coagulation 
abnormalities resulting from these causes. Patients who could not be recruited into the 
ACIT study within two hours of injury were also excluded. The predominant causes of 
traumatic coagulopathy change during the clinical course, with exogenous causes having 
an increasing influence with time. Although the model includes predictors for all known 
causes of traumatic coagulopathy, the accuracy may be affected following prolonged 
periods of resuscitation.  
Haemodilution with resuscitation fluids is an important iatrogenic cause of coagulopathy 
following trauma and the model is designed to predict coagulopathy following any 
volume of resuscitation fluid administration. However, patients who were administered 
more than two litres of intravenous fluid prior to recruitment were excluded from the 
ACIT study. ACIT data was used to learn the relationship for volumes less than two litres 
and published evidence was used to learn the relationship for higher volumes. Adequate 
published evidence of the relationship between increasing fluid administration and the 
development of coagulopathy exist. For example, Maegele et al. (2007) describe this 
relationship, stratified by injury severity, in an observational study of 8724 injured 
patients. The model’s performance, however, was evaluated using ACIT data and 
therefore has not been validated in patients who received greater than two litres of 
prehospital fluid. 
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Secondly, during model development, subgroups of injured patients in which the model 
performed less well were identified. Although the model accurately predicts 
coagulopathy in the majority of patients with a head injury, it underestimates the degree 
of coagulopathy in patients with catastrophic head injuries. Indeed, patients with 
catastrophic head injuries account for over 80 percent of the model’s false negative 
predictions. This subgroup of patients all had Head AIS scores of 5 with extensive 
intracranial bleeding and skull fractures. The majority had major abnormalities on CT 
imaging including signs of severely raised intracranial pressure, brain herniation, or 
pneumocephalus. Furthermore, these patients had no evidence of major extracranial 
bleeding or severe extracranial injuries (AIS > 3).  
Coagulopathy is common following head injury and in patients with an isolated head 
injury, coagulopathy is more common in those with Traumatic Brain Injury (TBI) than 
those without (Zehtabchi et al., 2008). The mechanisms of coagulopathy following TBI 
are uncertain (Laroche et al., 2012). Classically, TBI coagulopathy was believed to be the 
result of systemic tissue factor release resulting in disseminated intravascular coagulation 
(Keimowitz and Annis, 1973). More recently, some investigators have argued that the 
mechanisms of traumatic coagulopathy in TBI patients are the same as in non-TBI 
patients: that TBI coagulopathy is primarily driven by tissue hypoperfusion and will not 
occur in its absence (Cohen et al., 2007). As the model is derived from existing 
knowledge, the incomplete understanding of the causes of coagulopathy in patients with 
isolated severe brain injuries is reflected in the model’s performance in this subgroup of 
injured patients. The clinical value of accurately predicting coagulopathy in patients with 
catastrophic head injuries, however, is questionable, as these injuries have universally 
poor outcomes. 
 
Patients who suffered an assault, with a relatively minor injury, but presented with a 
marked metabolic acidosis following extreme physical exertion, also resulted in some 
inaccurate predictions (false positive). In these patients the model was unable to 
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accurately differentiate the acute physiological changes resulting from decreased oxygen 
delivery in compensated haemorrhagic shock from those caused by increased oxygen 
requirements following extreme physical exertion. This is a common diagnostic difficulty 
in trauma care. 
 
4.6 Strengths and Limitations 
 
Strengths 
This study has a number of strengths. Most important is that the model is developed to 
predict a key clinical outcome that is central to early therapeutic decision-making, and is 
not measurable during this time frame by any other methods. Second, the model’s 
structure is developed from existing knowledge and represents an evidence-based 
understanding of traumatic coagulopathy. This is in contrast to traditional ‘black-box’ 
mathematical algorithms, which are the predominant prognostic modelling method in 
medicine. An evidence-based structure affords a number of potential advantages over 
traditional methods. These include improved face validity, which may lead to improved 
clinical credibility and user confidence, and reduced risk of data over-fitting that will 
enhance the models generalisability. Finally, data used for parameter learning was 
collected in a standardised way as part of a prospective cohort study, designed to assess 
early coagulation activation following injury. A prospective cohort study represents the 
optimal source of data for developing prognostic models, as this method should limit 
missing data and information bias. 
 
Limitations 
A Bayesian Networks predictive performance depends on how accurately its causal 
structure and network parameters approximate reality. The causal structure was informed 
by existing knowledge. However, our current understanding of the causes and 
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mechanisms of traumatic coagulopathy is incomplete. This may explain the model’s 
underperformance in specific injury subgroups, such as patients with catastrophic head 
injuries, where knowledge of the mechanism of coagulopathy is weak. The excellent 
performance in the majority of injured patients, however, provides strong evidence that 
the understanding of the key causes of traumatic coagulopathy is accurate. 
 
Network parameters were learned from data. How accurately these parameters estimate 
reality will depend on the quality of the data and how closely the study population 
represents the general trauma population. Data was collected using a standardised method 
as part of a prospective observational study, therefore limiting information bias. 
However, the study population came from a single Major Trauma Centre in a high-
income country and this may affect the model’s performance in other settings. The effect 
of this bias on the generalisability of the model may be minimal for two reasons. Firstly, 
the majority of parameters describe physiological relationships between variables that are 
unlikely to be influenced by the setting. And secondly, the most important component of 
the Bayesian network is the causal structure, which was derived from global knowledge 
of the condition. Ultimately, the generalisability of the model will need to be validated in 
new populations before clinical use. 
 
The model is developed to predict a highly relevant clinical outcome and because of the 
importance of early identification of traumatic coagulopathy, we suggest that the model is 
operated at a highly sensitive threshold. Although the model has excellent predictive 
performance, it is not perfect, and the compromise for a high sensitivity is an increase in 
over-triage. As the majority of injured patients have normal coagulation, even a small 
increase in the over-triage rate will have a notable impact on the positive predictive value 
of the model. Furthermore, any over-triage rate will have both a clinical resource and cost 
impact. How acceptable this is, will need to be assessed under the conditions the model is 
intended for use. 
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CHAPTER FIVE 
 
Validation of a Predictive Model for Trauma-
Induced Coagulopathy 
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5.1 Introduction 
 
A common problem in developing predictive models is over-fitting the model to the 
development data (Steyerberg, 2008). The result is an overly optimistic estimation of the 
models performance in the development population and weak performance in new 
patients. For this reason, validation of a model’s predictive performance in a population 
that is different from the development population is an essential step before a model can 
be considered for clinical use (Altman et al., 2009, Steyerberg et al., 2013). Prognostic 
models are at particular risk of over-fitting when data-driven methods are used to 
determine the model structure, select predictors, and categorise predictors (Steyerberg, 
2008). The risk is especially high when these methods are combined with small 
development datasets (Steyerberg et al., 2001).  
The risk of over-fitting may be reduced if knowledge of the condition, rather than data, is 
used to derive the model structure and select predictors (Younesi and Hofmann-Apitius, 
2013, Steyerberg et al., 2001). In addition to the potential for improved performance in 
new patients, integrating biomedical knowledge into predictive models may also improve 
face validity and user confidence. Knowledge-driven methods of developing predictive 
models are not well-described and, compared to data-driven methods, are labour 
intensive. As a result, integrating knowledge into predictive models is a challenging task 
and one that is seldom undertaken. 
 
A second important limitation of traditional prognostic models is their inability to 
perform without a complete set of predictor information. This is especially relevant in 
emergency settings where incomplete and uncertain information is common. To be 
clinically useful, applications designed for emergency use should ideally be able to 
handle missing and uncertain predictor information. Advances in mathematical modelling 
have made it possible to develop models that can handle missing or uncertain predictor 
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information (Fenton and Neil, 2012b), however these techniques are not easily accessible 
and as a result there has been a slow adoption of these models in clinical practice. 
 
In Chapter Four, we developed a model to predict Trauma Induced Coagulopathy (TIC) 
in the emergency setting. This condition is a key determinant of management strategies, 
health resource requirements, and outcome. The model was developed using Bayesian 
Networks, a technology capable of handling missing or uncertain information. 
Furthermore, to minimise over-fitting and enhance generalisability, the model was 
developed using a combination of knowledge and data-driven methods. 
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5.2 Study Aims 
 
The overall aim of this study is to validate the model’s predictive performance in an 
independent sample of injured patients.  
The first objective was to validate the clinical relevance of the outcome that the model is 
developed to predict, in a new patient population. 
Second, to validate the predictive performance of the model in a new patient population.  
Third, to test the model’s performance when predictor information is missing. 
Last, to compare the models performance to that of accepted diagnostic blood tests, at 
predicting a clinically relevant coagulopathy. 
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5.3 Methods 
 
5.3.1 Study design 
This was a validation study for a TIC predictive model. Data from injured patients 
presenting directly to three Major Trauma Centres in Europe were used to assess the 
performance of the model.  
 
5.3.2 Study population (validation cohort) 
The Activation of Coagulation & Inflammation in Trauma (ACIT) study is a multi-
national, prospective cohort study designed to identify the mechanisms by which the 
body’s coagulation pathways are activated immediately following injury. Adult patients 
(>15 years) presenting directly to participating Major Trauma Centres, who meet local 
criteria for trauma team activation, are included. Exclusion criteria include: arrival in the 
emergency department > 2 hours after injury; prehospital administration of > 2000ml 
intravenous fluid; and burns covering > 5% of body surface area. Patients are 
retrospectively excluded if they decline consent, take anticoagulation medication, have 
moderate or severe liver disease, or a bleeding diathesis. The study was reviewed and 
approved by the National Research Ethics Committee of participating countries and 
written informed consent was obtained for all participants. 
 
Two cohorts of injured patients enrolled in the ACIT study were used to validate the 
models ability to predict a clinically relevant coagulopathy. Both cohorts were 
independent of the model’s development process and population. The temporal validation 
cohort consisted of consecutive patients enrolled in the London ACIT study following 
completion of model development (November 2011 to January 2014).  
The external validation cohort consisted of consecutive patients enrolled into the ACIT 
study at two different trauma centres (John Radcliffe, Oxford, United Kingdom, and 
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Cologne-Merheim Medical Centre, Cologne, Germany) between January 2007 and 
January 2014. 
 
5.3.3 Data collection 
Data were prospectively collected on patient demographics, mechanism of injury, injury 
characteristics, prehospital and admission vital signs, prehospital fluid administration, 
primary survey findings, transfusion requirements in the first 24 hours of admission, 
surgery requirements, and outcome. Blood samples were collected immediately on 
hospital arrival and used for standard laboratory coagulation tests (PTr and APTT), 
thromboelastometry (ROTEM) and blood gas analysis. Anatomical injuries were 
described and classified by certified coders according to the AIS (Gennarelli, 2008) and 
Injury Severity Score (ISS) (Baker et al., 1974). Patients were followed-up daily until 
hospital discharge or death.  
 
5.3.4 Outcome classification 
The coagulation status of patients in the validation cohort was classified using the same 
method as described and used in Chapter 4. In brief, the steps were as follows: 
1) All patients were classified according to the laboratory definition of acute traumatic 
coagulopathy, an admission PTr > 1.2. 
2) Independently, all patients were classified using an expectation-maximisation 
algorithm based on the their admission clinical profile, PTr, Activated Partial 
Thromboplastin Time ratio (APTTr) and thromboelastometry (ROTEM, Pentapharm 
GmbH, Munich, Germany). 
3) Cases where the laboratory and machine-learning methods agreed were assigned the 
corresponding coagulation state as their final classification. 
4) Cases where the two methods disagreed, or the PTr sample had haemolysed, 
underwent expert review to determine a final classification.  
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Experts had no knowledge of the EM algorithm result or the structure of the prognostic 
model. Inter-reviewer agreement was evaluated with the kappa statistic and expert 
consistency was evaluated on a random sample of 30 patients with known coagulation 
status. 
 
5.3.5 Clinical relevance of outcome 
The clinical relevance of the coagulopathy classification was assessed in terms of 
mortality (24-hour mortality, in-hospital mortality); consumption of health care resources 
(blood transfusion, massive blood transfusion, and Damage Control Surgery (DCS) 
requirements); and number of days admitted to hospital (ITU length of stay, hospital 
length of stay) in the validation population. 
 
5.3.6 Performance 
The models prognostic performance was assessed in terms of discrimination, calibration 
and accuracy using multiple performance measures. Discrimination was assessed with the 
Receiver Operating Characteristic (ROC) curve, Area Under the ROC (AUROC) curve, 
sensitivity, and specificity. Calibration was evaluated using the Hosmer-Lemeshow test 
statistic (HL) and by visual assessment of the predicted and observed frequency of 
coagulopathy in 10 equal groups stratified by risk (Hosmer and Lemesbow, 1980). 
Accuracy was evaluated with the Brier Score (BS) and the Brier Skill Score (BSS) (Brier, 
1950, Weigel et al., 2007). Performance in the temporal and external validation cohorts 
was compared to performance in the development cohort. 
 
5.3.7 Sensitivity analyses 
 
Individual predictors 
The strength of the relationship between individual predictor variables and traumatic 
coagulopathy was calculated in the validation data. The AUROC was calculated for 
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continuous and ordinal predictor variables, and an Odds Ratio (OR) was calculated for 
binary predictor variables. This allowed an assessment of the relative importance of each 
predictor variable in the model. The AUROC for the complete model in the validation 
data and an OR for the complete model, using the threshold that achieved 90 percent 
sensitivity in the development data, were also calculated to allow comparison of 
individual predictor variables to the overall model. 
 
Missing information 
A major advantage of Bayesian Networks, compared to traditional prognostic models, is 
their ability to perform with missing or uncertain information. To assess the models 
sensitivity to missing information, the models overall performance in the validation data 
was compared to the performance when each predictor variable, in turn, was omitted as 
an input. Overall performance was also compared to the model’s performance when 
clinically associated groups of variables, for example all blood gas variables (pH, lactate 
and base deficit), were omitted as inputs. 
 
5.3.8 Comparison with diagnostic tests 
The model’s ability to identify injured patients with a clinically relevant coagulopathy 
was compared to laboratory (PTr) and rotational thromboelastometry (EXTEM CA5) 
diagnostic tests. The predictive model was operated at the threshold that achieved 90 
percent sensitivity for traumatic coagulopathy in the development cohort. The diagnostic 
tests were operated at validated thresholds for identifying traumatic coagulopathy: a PTr 
> 1.2 (Frith et al., 2010) and a rotational thromboelastometry clot amplitude at 5 minutes 
of ≤ 35mm (Davenport et al., 2011). Both diagnostic tests were attempted in all validation 
patients. 
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5.3.9 Statistical Analysis 
Normal-quartile plots were used to test for normality. Numerical data are reported as 
median with interquartile range (IQR) and categorical data as frequency (n) and 
percentage (%). The Mann–Whitney U test was used to compare numerical data and 
Fisher’s Exact test was used to compare categorical data. Outcome comparisons between 
groups are reported as a Relative Risk (RR) with their corresponding 95 percent 
Confidence Intervals (CI). The time from injury to death between groups was compared 
with the log-rank (Mantel-Cox) test, and the results are presented as Kaplan-Meier 
curves. The area under ROC curves was calculated and compared using the method 
described by Hanley and McNeil (1982). The area under correlated ROC curves was 
compared using a non-parametric method that accounts for the paired test design 
(DeLong et al., 1988). Area under ROC curves are reported with their corresponding 95 
percent CI. Inter-reviewer agreement for expert outcome classification was evaluated 
with the kappa statistic. Statistical analyses were performed using GraphPad PRISM v6 
(GraphPad Software Inc., San Diego, CA, USA) and R statistical software (version 
2.15.2). Statistical significance was set as a two tailed p-value of < 0.05. 
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5.4 Results 
 
5.4.1 Baseline characteristics 
The model’s predictive performance was validated on a total of 491 patients recruited 
into the ACIT study at three specialist trauma centres in Europe. The temporal validation 
cohort consisted of 373 injured patients, of which 39 patients (10.5 percent) developed an 
acute coagulopathy. The external validation cohort consisted of 118 injured patients, of 
which fourteen patients (11.9 percent) developed coagulopathy. The baseline 
characteristics of the temporal and external validation cohorts had significant differences 
when compared to the development cohort (Table 5.1). The incidence of coagulopathy in 
the two cohorts, however, was similar (p = 0.734). 
 
5.4.2 Clinical relevance of coagulopathy 
Overall, 53 of the 491 injured patients in the validation population (10.8 percent) 
developed a coagulopathy. These coagulopathic patients had outcomes an order of 
magnitude worse than patients with normal coagulation (Table 5.2). 
 
Mortality 
In the first 24-hours following injury, the mortality rate was 24.5 percent in patients that 
developed a coagulopathy compared to 0.2 percent in patients with normal coagulation 
(RR: 11.07 (7.96 – 15.41); P < 0.0001). 
In-hospital mortality was also substantially higher in coagulopathic patients compared to 
those with normal coagulation (49.1 percent versus 5.2 percent; RR: 8.69 (5.54 – 13.63); 
P < 0.0001). Injured patients in the validation cohort that developed a coagulopathy were 
significantly less likely to survive their injuries than those with normal coagulation, and 
the majority of deaths in coagulopathic patients occurred soon after injury (Figure 5.1). 
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Table 5.1: Baseline characteristics of the development and validation populations. 
Characteristic 
Missing 
Data 
(%) 
Development  
cohort 
(N=600) 
Validation cohort 
Temporal 
(N=373) 
External 
(N = 118) 
Age – years (range) <1 35 (16 – 95) 38 (16 – 93) 45 (16 – 92)§ 
Gender - male 0 486 (81.0) 309 (82.8) 78 (66.1)§ 
Mechanism of Injury - Blunt 0 475 (79.2) 299 (80.2) 116 (98.3)§ 
Pre-Hospital fluid (ml) <1 0 (0 – 500) 0 (0 – 100) 100 (0 – 350) 
Primary Survey findings:     
Respiratory Rate (bpm)a 2 20 (16 – 24) 18 (15 – 20)§ 17 (14 – 22) 
Heat Rate (bpm) <1 95 (76 – 118) 87 (75 – 104)§ 84 (74 – 108)§ 
Systolic Blood Pressure (mmHg) 2 130 (107 – 148) 134 (116 – 149) 136 (114 – 150) 
Body Temperature (°C) 40 35.8 (35.1 – 36.5)  36.1 (35.7 – 36.7)§ 36.0 (35.3 – 36.6) 
Glasgow Coma Scalea <1 15 (11 – 15) 15 (13 – 15)§ 15 (10 – 15) 
Suspected Haemothorax <1 89 (14.9) 49 (13.2) 13 (11.1) 
Suspected unstable pelvic fracture <1 58 (9.7) 31 (8.3) 23 (19.5) § 
Suspected long bone fracture <1 132 (22.2) 89 (23.9) 28 (24.4) 
FAST - Positive <1 49 (8.2) 26 (7.0) 15 (12.7) 
Baseline Blood Gas Analysis:     
pH 5 7.35 (7.30 – 7.40) 7.36 (7.31 – 7.39) 7.34 (7.25 – 7.39) 
Lactate 6 2.1 (1.3 – 3.6) 2.3 (1.4 – 3.5) 2.6 (1.6 – 3.5) 
Base Deficit 6 1.8 (-0.2 – 4.4) 0.6 (-1.5 – 3.3)§ 1.6 (-0.7 – 5.1) 
Baseline Thromboelastometry:     
EXTEM CA5 (mm) 8 44 (38 – 49) 44 (39 – 50) 46 (42 – 52)§ 
EXTEM MCF (mm) 8 61 (56 – 65) 63 (59 – 68)§ 63 (57 – 68)§ 
FIBTEM MCF (mm) 8 14 (10 – 17) 15 (11 – 20)§ 16 (11 – 20)§ 
Baseline laboratory values:     
INR 7 1.1 (1.0 – 1.1) 1.1 (1.0 – 1.1)§ 1.0 (1.0 – 1.1)§ 
APTT (seconds) 7 23 (22 – 26) 23 (22 – 26) 27 (25 – 30)§ 
Haemoglobin (g/dL) 4 13.9 (12.4 – 14.9) 14.1 (12.9 – 15.0)§ 13.7 (12.2 – 14.8) 
Platelet count (x109 /L) 5 231 (193 – 272) 219 (182 – 264)§ 245 (209 – 288)§ 
Injury severity:     
Injury Severity Score 2 16 (9 – 29) 13 (5 – 25)§ 17 (9 – 29) 
Head AIS ≥ 3 2 173 (28.8) 89 (25.9) 33 (28.0) 
Chest AIS ≥ 3 2 257 (42.8) 106 (30.8)§ 50 (42.4) 
Abdomen AIS ≥ 3 2 62 (10.3) 44 (12.8) 15 (12.7) 
Extremity AIS ≥ 3 2 198 (33.0) 100 (29.1) 52 (44.1)§ 
Data presented as number (%) or median (IQR) unless otherwise stated. 
a Admission measurement or, if patient arrived intubated, pre-hospital measurement prior to sedation and intubation. 
§  The characteristic differs significantly (p < 0.05) compared with the development cohort. 
FAST, Focused Assessment with Sonography for Trauma; CA5, Clot Amplitude at 5 minutes; MCF, Maximum Clot 
Firmness; INR, International Normalised Ratio; APTT, Activated Partial Thromboplastin Time; AIS, Abbreviated 
Injury Score. 
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Consumption of health care resources 
In the first 24-hours after injury, coagulopathic patients more frequently required a blood 
transfusion (96.2 percent versus 16.0 percent; RR: 77.98 (19.26 – 315.6); P < 0.0001) and 
a massive blood transfusion (47.2 percent versus 0.9 percent; RR: 14.22 (9.66 – 20.96); P 
< 0.0001) when compared to non-coagulopathic patients. 
On average, each coagulopathic patient was transfused 9 (6 – 16) PRBC units and 8 (4 – 
12) FFP units in the first 24 hours, compared to an average of 0 (0-0) units of either in 
patients with normal coagulation (P < 0.0001). 
Coagulopathic patients were also more likely to require immediate DCS than non-
coagulopathic patients (70.0 percent vs. 2.6 percent; RR: 20.6  (12.2 – 34.6); P < 0.0001). 
Additionally, coagulopathic patients that survived had significantly longer critical care 
(14 (3 – 25) days versus 0 (0-1) days; p < 0.0001)) and hospital (30 (15 – 51) days versus 
8 (2 – 20) days; p < 0.0001) length of stay, compared to survivors with normal 
coagulation. 
 
Table 5.2: Comparison of outcomes and resuscitation requirements in 491 injured 
patients stratified by coagulation status. 
Outcome 
Missing 
Data 
(%) 
Coagulopathy 
(N=53) 
Normal 
Coagulation 
(N=438) 
Risk Ratio  
(95% CI) P -Value 
Mortality:      
24-hour 0 13 (24.5) 1 (0.2) 11.1  (8.0 – 15.4) < 0.0001 
Hospital 0 26 (49.1) 23 (5.2) 8.7  (5.5 – 13.6) < 0.0001 
Emergency intervention in first 24 hours:    
Transfusion 0 51 (96.2) 70 (16.0) 78.0  (19.3 – 315.6) < 0.0001 
Massive transfusion 0 25 (47.2) 4 (0.9) 14.2  (9.7 – 21.0) < 0.0001 
DCS 10 35 (70.0) 10 (2.6) 20.6  (12.2 – 34.6) < 0.0001 
Data presented as number (%). Risk Ratios are for the coagulopathic group, as compared with the normal 
coagulation group. DCS, Damage Control Surgery 
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Figure 5.1: Kaplan-Meier estimates of the probability of survival for 491 injured patients 
with either normal coagulation or a coagulopathy. The P-value was calculated using the 
log-rank (Mantel-Cox) test. 
 
5.4.3 Validation 
The model maintained excellent predictive performance in the validation population 
(Figure 5.2). In the temporal validation cohort, the AUROC was 0.964 (0.941 – 0.987) 
and at a sensitivity set at 90 percent the specificity was 92 percent. The performance in 
the temporal cohort was significantly better than in the development cohort (0.964 (0.941 
– 0.987) versus 0.927 (0.902 – 0.953); P = 0.03). In the external validation cohort, the 
AUROC was 0.927 (0.852 – 1.0) and at a sensitivity set at 90 percent the specificity was 
84.5 percent. The model had similar performance in the external validation and 
development cohorts (AUROC 0.927 (0.852 – 1.0) versus 0.927 (0.902 – 0.953); P = 
0.71). The model remained accurate and well calibrated in both validation cohorts (Table 
5.3). 
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Figure 5.2: Accuracy of the trauma-induced coagulopathy predictive model in the 
development and validation cohorts. Accuracy was assessed using the Receiver Operating 
Characteristic (ROC) curve for coagulopathy predictions. This plots the true positive rate 
(sensitivity) against the false positive rate (1 – specificity). The red dotted line represents 
a true positive rate of 90 percent. At a true positive rate of 90 percent the false positive 
rate was 18, 8, and 15 percent for the development, temporal validation, and external 
validation cohorts respectively. 
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Table 5.3: Predictive performance measures for the trauma-induced coagulopathy model 
in the development, temporal validation, and external validation cohorts. 
Performance	Measure	
Development	
Cohort	
Validation	Cohort	
Temporal	 External	
AUROC	 0.927	 0.964a	 0.927	
At	90%	Sensitivity:	 	 	 	
Specificity	 82	%	 92	%	 85	%	
Positive	Predictive	Value	 40	%	 56	%	 47	%	
Negative	Predictive	Value	 98	%	 99	%	 99	%	
At	80%	Sensitivity:	 	 	 	
Specificity	 87	%	 95	%	 90	%	
Positive	Predictive	Value	 45	%	 65	%	 60	%	
Negative	Predictive	Value	 97	%	 98	%	 97	%	
Hosmer-Lemeshow	Statistic	 9.3	(P	=	0.32)	 11.0	(P	=	0.20)	 8.7	(P	=	0.37)	
Brier	Score	 0.06	 0.03	 0.06	
Brier	Skill	Score	 0.39	 0.53	 0.38	
a	The	performance	differs	significantly	(p	<	0.05)	compared	with	the	development	cohort.	
AUROC,	Area	Under	the	Receiver	Operating	Characteristic	Curve.	
	 	 	
 
5.4.4 Sensitivity Analyses 
 
Individual predictors 
The strength of the relationship between individual predictors included in the model and 
traumatic coagulopathy are shown in Figures 5.3 and 5.4. Blood gas variables were the 
strongest individual predictors of traumatic coagulopathy. The overall model, however, 
was a better predictor of traumatic coagulopathy than any individual variable in the 
model.  
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Missing information 
The model’s performance was not dependant on any individual predictors’ information 
being available, and missing predictor information had minimal effect on the models 
overall performance. Sensitivity analyses, where each predictor variable in turn was 
omitted from the models inputs, did not demonstrate any significant effect on the models 
ability to predict traumatic coagulopathy (Fig 5.5). Indeed, the omission of all blood gas 
variable inputs, the three strongest individual predictors, had minimal effect on the 
model’s predictive performance (overall performance: AUROC 0.952 (0.925 - 0.979) 
versus performance without blood gas information: AUROC 0.943 (0.911 – 0.976); P = 
0.286). 
 
 
Figure 5.3: Area under the Receiver Operating Characteristic (ROC) curve with 95 
percent Confidence Intervals for trauma-induced coagulopathy predictions in 491 injured 
patients using individual predictors and the full predictive model. The area under the 
ROC curve was calculated for each continuous and ordinal predictor in the model. 
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Figure 5.4: Odds Ratios with 95 percent Confidence Intervals (CI) for trauma-induced 
coagulopathy in 491 injured patients, according to individual predictors and the full 
predictive model. An Odds Ratio was calculated for each binary predictor in the model. 
The full model was operated at the threshold that achieved 90 percent sensitivity for 
traumatic coagulopathy in the development cohort. FAST, Focused Assessment with 
Sonography for Trauma; MOI, Mechanism Of Injury. 
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Figure 5.5: Performance of a Bayesian Network model at predicting trauma-induced 
coagulopathy in 491 injured patients when each of the models predictors, and all the 
blood gas variables, in turn, were omitted as inputs. Performance was measured by 
calculating the Area Under the Receiver Operating Characteristic (ROC) curve with 95 
percent Confidence Intervals.  
 
5.4.5 Comparison to diagnostic tests 
The Bayesian Network model was able to calculate the probability of traumatic 
coagulopathy in all 491 injured patients in the validation population. At the designated 
operating threshold, the model identified 48 of 53 patients with traumatic coagulopathy. 
The accuracy of the models predictions was excellent, with an AUROC of 0.952 (0.925 - 
0.979), sensitivity of 90.6 percent and specificity of 89.5 percent. 
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By comparison, a laboratory PTr result was available for 432 injured patients (88.0 
percent). In three patients, clinicians were unable to obtain an admission blood sample, 
and in the remainder the sample haemolysed. A PTr > 1.2 identified 28 of 53 patients 
with traumatic coagulopathy. The diagnostic performance of the PTr test was an AUROC 
of 0.919 (95 percent CI: 0.873 – 0.965), sensitivity of 52.8 percent and specificity of 97.7 
percent. 
Rotational thromboelastometry (EXTEM CA5) provided a result for 420 patients (85.6 
percent) and clot amplitude at 5 minutes ≤ 35mm identified 28 of the 53 patients with 
traumatic coagulopathy. The diagnostic performance of the EXTEM CA5 test was an 
AUROC of 0.853 (95 percent CI: 0.787 – 0.919), sensitivity of 52.8 percent and a 
specificity of 92.5 percent. 
In the validation population, the Bayesian Network model had similar performance to PTr 
(p= 0.175) and significantly better performance than EXTEM CA5 (p= 0.001), at 
identifying injured patients with a clinically relevant trauma-induced coagulopathy. 
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5.5 Discussion 
 
Key findings 
Injured patients that present to hospital with an established coagulopathy have a 
formidable requirement for immediate resuscitative interventions and are responsible for 
almost all early trauma deaths. This study validates the clinical relevance of trauma-
induced coagulopathy, and the excellent performance of a predictive model for this 
condition in new patients. 
In addition, this study validates the ability of a Bayesian network to handle missing 
predictor information. The trauma-induced coagulopathy model’s performance does not 
depend on any individual predictor, and accuracy is maintained with up to a fifth of 
predictor information missing. Furthermore, this study demonstrates that a Bayesian 
network predictive model can identify injured patients at risk of a clinically relevant 
coagulopathy with comparable accuracy to validated diagnostic tests, while overcoming 
many of the major limitations of these tests. 
 
Implications of findings 
The findings of this study have some important implications for trauma care and 
prognostic modelling. Perhaps the most important clinical implication is that the model 
can provide accurate and objective evidence of an individual patient’s risk of 
coagulopathy. This is fundamental information for rational decisions on whether to 
activate, and use, damage control treatment strategies (Roberts et al., 2015, Holcomb et 
al., 2007a). Furthermore, the model provides rapid predictions using immediately 
available clinical information, thereby facilitating decisions at a time when treatment is 
most effective.  
Immediate and aggressive damage control strategies improve survival in coagulopathic 
trauma patients (Stone et al., 1983, Rotondo et al., 1993, Holcomb et al., 2007a). 
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However, these strategies can cause considerable waste and harm if not indicated (Miller 
et al., 2005, Malone et al., 2003). Deciding on the appropriate use of damage control 
techniques, where the expected benefits outweigh the potential harms, can be difficult 
(Roberts et al., 2015). This is because decisions rely on the identification of patients at 
risk of coagulopathy, which is often uncertain at the time decisions need to be made. 
Diagnostic coagulation tests may reduce this uncertainty but are unhelpful in early 
decision-making as results are not available. Decisions are therefore based on clinical 
intuition. Although intuitive reasoning allows rapid decision-making, it is prone to error 
and has been shown to be unreliable in trauma patients, particularly at initial evaluation 
(Pommerening et al., 2015, Goettler et al., 2010). This validated model has the potential 
to provide meaningful support for early damage control decisions and reduce avoidable 
human errors associated with intuitive reasoning. 
 
The model’s ability to accurately predict coagulopathy, using clinical information only, 
and without the need for blood analysis, has particular relevance for trauma care in poorly 
resourced settings. Low- and middle-income countries bear the greatest burden of trauma 
morbidity and mortality, and a means to accurately identify high-risk patients enables 
triage and prioritising the utilization of scarce resources (WHO, 2014). In these settings, 
access to point-of care and laboratory diagnostic capabilities may be limited, but access to 
information technology is becoming widespread (Lewis et al., 2012). Clinical decision-
support applications that use the Trauma-Induced Coagulopathy Bayesian Network may 
enable health care workers in these settings to provide timely and targeted haemostatic 
interventions, and improve the quality and consistency of trauma care. 
 
In addition, the model can be used within trauma systems as a quality assurance tool to 
audit major haemorrhage protocol activations and damage control intervention decisions. 
The model may also be valuable for trauma research. It is an ideal tool for clinically 
	 163	
relevant risk categorisation and may also be used to select appropriate populations for 
efficient experimental studies on interventions for trauma-induced coagulopathy. 
 
The findings of this study also have important implications for the methods used to 
develop prognostic models for use in emergency settings. This study supports the use of 
domain knowledge to reduce over-fitting and develop evidence-based models with better 
generalisability. An advantage of Bayesian networks is that they provide a platform that 
facilitates the incorporation of a broad range of evidence in model development (Yet et 
al., 2014a, Fenton and Neil, 2012b). Furthermore, this study demonstrates that Bayesian 
networks can produce robust models that are able to use a variable selection of predictor 
information, and capable of handling missing or uncertain information. This is likely to 
be a meaningful advantage in emergency settings, and overcomes a major limitation of 
traditional prognostic models, which require accurate and complete predictor information 
to function	(Fenton and Neil, 2012b). 
 
 
5.6 Strengths and limitations 
 
Strengths 
The Bayesian Networks predictive performance was validated in new patients presenting 
to three trauma centres in two countries. Each of the validation populations had 
significant differences to the development population, strengthening the validity of 
findings. Data was prospectively collected according to a standardised protocol, 
minimising the risk of information bias and missing information. Furthermore, the 
coagulation status of all patients was classified using a standardised method that 
overcomes the limitations of imperfect diagnostic tests and reduces the risk of 
measurement bias. 
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 Limitations 
This study has some limitations. First, the model’s performance was validated in a 
civilian trauma population, where all patients were treated in well-resourced specialist 
trauma centres. The performance in military trauma populations and in less well-
resourced settings is not known. The model, however, is designed to predict a 
pathophysiological response to trauma, prior to therapeutic intervention. While injury 
characteristics and the incidence of coagulopathy may differ in different settings, the 
mechanisms of Trauma Induced Coagulopathy remain constant, and the model is 
designed to take all known mechanisms into consideration. Furthermore, although 
different trauma systems may have a significant impact on the progression and outcome 
of coagulopathic patients, the trauma system itself will have minimal influence on an 
individual patients initial risk of developing coagulation derangements (Hess et al., 2008). 
Nonetheless, the model’s performance in military and poorly resourced settings should be 
validated before use in these populations. 
Second, the model is designed to enable early identification of coagulopathy risk to 
support rapid activation of targeted haemostatic interventions. The model was not 
designed to measure the response of the coagulation system to these interventions, and 
has not been validated for this purpose. Near-patient tests, such as thromboelastography, 
are able to describe specific coagulation function defects, and may be better suited to 
assess the response to therapy and tailor damage control interventions accordingly 
(Johansson et al., 2013).  
Last, although the Bayesian network provides fundamental information to support 
rational damage control decisions, the impact of this information on decision-making, and 
ultimately patient outcomes, has not been assessed. Further research is warranted to 
examine the effect of using the model on clinical decisions, patient outcome, and cost-
effectiveness of care, compared to standard trauma care. 
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6.1 Introduction 
 
6.1.1 Predicting limb viability 
Once resuscitation is underway, the next step in the management of a patient with a 
severe lower limb injury is to decide whether limb salvage is possible. In some situations 
it may be clear that salvage is not an option. Examples of these situations include injuries 
where insufficient limb tissue remains for reconstruction, or injuries where the remaining 
tissue is clearly no longer viable. In the majority of cases, however, the decision may not 
be as obvious. In these cases, a comprehensive assessment of the wound should be 
performed in the operating theatre as soon as is possible after injury (NICE, 2016, 
Nanchahal J, 2009). Once the limb is reperfused and all contaminated and clinically non-
viable tissue has been debrided, an assessment of the predicted viability and functional 
capacity of the remaining tissue is made. This information should be used by surgeons, 
and their patients, to make decisions on whether to pursue limb salvage or amputation. 
The next two chapters describe the development of a prognostic model to help surgeons 
accurately predict limb viability. Chapter Six describes how potential prognostic factors 
were identified, and Chapter Seven describes the development and validation of the 
model. 
 
6.1.2 Prognostic factors in Severe Lower Limb Trauma 
A severe lower limb injury that involves Lower Extremity Vascular Trauma (LEVT) is a 
potentially devastating injury that may result in death, profound disability or limb loss 
(Kauvar et al., 2011, Tan et al., 2011, Mullenix et al., 2006). Management priorities are 
clear, foremost to save the patient’s life and secondly to salvage the most functional limb 
possible (Feliciano et al., 2011, Scalea et al., 2012). Severe LEVT however, presents 
some of the most challenging decision-making in trauma surgery (Scalea et al., 2012, de 
Mestral et al., 2013). 
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Deciding between limb salvage and amputation is particularly complex with delayed or 
incorrect decisions leading to worse outcomes (Chapter One). Modern emergency 
surgery strategies aim to preserve all potentially viable tissue, thus allowing a window of 
opportunity for systematic wound assessment, patient counselling and early, informed 
decision-making (Glass et al., 2009, Nanchahal J, 2009). Good decisions rely on the 
ability to objectively estimate each treatments predicted outcome, ideally supplemented 
with both the patient’s and surgical team’s informed preference. Careful consideration of 
individual patient and injury prognostic factors is a central component of this decision-
making process (de Mestral et al., 2013, Scalea et al., 2012, MacKenzie et al., 2002). 
 
A number of prognostic factors for amputation have been described, including a 
traditional set comprising age, mechanism of injury (MOI), injury characteristics, 
duration of ischaemia, and presence of shock or compartment syndrome (MacKenzie et 
al., 2002, Scalea et al., 2012). These have been incorporated into numerous decision-
support guidelines (ACS, 2005, Scalea et al., 2012) and scores (Gregory et al., 1985, 
Johansen et al., 1990, Russell et al., 1991, McNamara et al., 1994, Howe et al., 1987, 
Krettek et al., 2001, Rajasekaran et al., 2006). However, the supporting evidence for the 
majority of factors is weak and often conflicting, with prospective evaluation of existing 
scores failing to validate any clinically useful prognostic ability (Bonanni et al., 1993, 
Bosse et al., 2001, Durham et al., 1996). To improve decision-making and optimise 
outcome for these devastating injuries, an accurate understanding of prognosis and 
prognostic factors is required. 
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6.2 Study Aims 
 
The overall aim of this systematic review is to develop a contemporary and more precise 
understanding of prognostic factors for amputation following surgical repair of LEVT. 
Our first objective is to estimate the overall risk of amputation following LEVT repair. 
Second, to identify potential patient, injury and treatment prognostic factors for 
amputation.  
Last, to measure the strength of association between the identified prognostic factors and 
amputation. 
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6.3 Methods 
 
This systematic review and meta-analysis is reported according to the Preferred 
Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement (Moher 
et al., 2009). The review protocol was prospectively registered with PROSPERO 
(CRD42012002720) and is available at http://www.crd.york.ac.uk/PROSPERO/ 
(Appendix I). 
 
6.3.1 Search Strategy 
Relevant publications were identified by an electronic search of the MEDLINE, 
EMBASE and Cumulative Index of Nursing and Allied Health Literature (CINAHL) 
databases using combinations of the following keywords and Medical Subject Headings 
(MeSH) terms: “wounds and injuries”, “amputation, traumatic”, “leg injuries”, “vascular 
system injuries”, “iliac artery”, “femoral artery”, “popliteal artery” and “tibial arteries”. 
The full MEDLINE search strategy is shown in Table 6.1. Search strategies were 
appropriately modified for EMBASE and CINAHL. Searches were limited to English 
language and human studies.  Advances in trauma care and surgical techniques have 
improved limb salvage outcomes, therefore, to minimise historical outcome bias, searches 
were limited to publications after 01 January 2000. The last search was performed on 01 
July 2012. Two authors independently screened the search output for potentially relevant 
citations, and then assessed the full-text of all identified citations for inclusion eligibility. 
Divergence was resolved by consensus through a third independent reviewer. The 
reference lists of included articles were manually searched for additional relevant 
publications. 
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Table 6.1: Full Medline search strategy. 
Step Search term 
1. exp “WOUNDS AND INJURIES”/ 
2. exp AMPUTATION, TRAUMATIC/ 
3. exp LEG INJURIES/ 
4. OR/1-3 
5. exp ILIAC ARTEY/ 
6. exp FEMORAL ARTERY/ 
7. exp POPLITEAL ARTERY/ 
8. exp TIBIAL ARTERIES/ 
9. OR/5-8 
10. 4 AND 9 
11. exp VASCULAR SYSTEM INJURIES/ 
12. 3 AND 11 
13. 10 OR 12 
Limits: Publication Year (2000 – 2012), Human and English Language. 
exp, explode. 
 
 
6.3.2 Eligibility Criteria 
Observational studies reporting amputation rates for patients undergoing surgical repair 
of LEVT were included. Studies were excluded if they: (1) did not clearly report the 
population (surgical repair of LEVT) or outcome (secondary amputation) of interest, (2) 
only considered iatrogenic vascular injuries or chronic complications of vascular trauma, 
(3) only considered paediatric injuries, (4) contained less than five patients with LEVT or 
(5) only described non-standard surgical treatment or non-surgical treatment of vascular 
injuries.  
 
6.3.3 Outcome Data 
The primary outcome was amputation. This was defined as a major limb amputation, 
above the ankle, performed as a second procedure following an attempt at surgical 
reperfusion. Potential prognostic factors were identified from the included studies. All 
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patient, injury and treatment factors investigated in two or more studies were analysed, 
regardless of the reported strength of association. 
 
6.3.4 Data Extraction 
Two reviewers independently extracted methodological, population characteristic, 
prognostic factor and outcome data, using a piloted data extraction form (Appendix II). 
The following was extracted from each study: study design, number of patients, setting, 
level of trauma care, country of origin, publication year, duration of follow-up, number of 
limbs with surgically repaired LEVT, number of secondary amputations and the 
amputation rate in limbs with and without each identified prognostic factor. Study authors 
were contacted to obtain additional or missing prognostic information. 
 
6.3.5 Definitions 
Surgical repair was defined as any attempt to surgically restore blood flow to the distal 
lower extremity and included thrombectomy, primary repairs, interposition grafts and 
temporary shunt placement. Arterial injuries were catagorised into four zones according 
to anatomical level of injury: (1) Iliac, including common and external iliac arteries; (2) 
Femoral, including common, superficial and Profunda femoral arteries; (3) Popliteal; and 
(4) Tibial, including the tibio-peroneal trunk, anterior tibial artery, posterior tibial artery 
and peroneal artery. Multiple arterial injuries were catagorised by the most proximal level 
of injury requiring surgical repair. Mechanism of injury (MOI) was catagorised as blunt, 
blast, and penetrating, with penetrating injuries subdivided into those caused by gun shot 
wounds and those by stabbings. Primary studies dichotomised shock and soft tissue injury 
using differing thresholds. These prognostic factors were analysed according to the 
primary study categorisation. Primary study thresholds for shock included: Systolic 
Blood Pressure (SBP) < 90mmHg; SBP < 100mmHg; SBP < 90mmHg or Base Deficit > 
6 mEq/ml or ≥ 4 units of Packed Red Blood Cells transfused in 24 hours (PRBC/24hr); 
and ≥ 10 units PRBC/24hrs. Primary study thresholds for soft tissue injury included: 
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Mangled Extremity Severity Score (MESS) (Johansen et al., 1990) soft tissue component 
≥ 3; cases requiring reconstructive surgery techniques to achieve soft tissue cover and 
adjectives such as severe, extensive and major with clinical descriptors. Ischaemic time 
was dichotomised into less than or greater than six hours as this was the most common 
primary study threshold, calculable for all studies reporting this variable. Arterial repair 
was catagorised as primary repair (including thrombectomy, lateral repair, patch 
angioplasty and end-to-end anastomosis) and interposition graft, which was subdivided 
into those performed with autologous vein and those with prosthetic material. Venous 
injury treatment was dichotomised as ligation or repair. 
 
6.3.6 Risk of bias  
Risk of bias was assessed by individual sensitivity analysis of the following 
methodological factors: selection bias was assessed by analysing study design and sample 
size; performance bias was assessed by analysing the setting, level of trauma care, 
median year of study recruitment (< 2000 or ≥ 2000) and the economic development of 
the country according to the United Nations classification (2012); and attrition bias was 
assessed by analysing duration of follow-up (< 6 months or ≥ 6 months). Studies that did 
not report follow-up duration were catagorised as < 6 months for analysis. Primary 
outcome measurement bias was minimised by excluding studies that did not clearly 
define and report secondary amputation. To minimise prognostic factor measurement 
bias, only studies with objective categorisation and clear reporting were included in the 
analysis of individual prognostic factors. The quality of included studies was assessed 
using a framework proposed by Altman (2001). One point was available for each of 
eleven study features relating to the patient sample, intervention, follow-up, outcome, 
prognostic variables and analysis (Table 6.2). Risk of bias was assessed by a sensitivity 
analysis of the composite quality score (≥ median score or < median score). Publication 
bias was visually assessed with a funnel plot of effect size against sample size and 
statistically assessed with the Eggers test (1997). 
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Table 6.2: Criteria proposed by Altman (2001) used to score the methodological quality 
of included studies. 
Criteria 
 Patient Sample 
1. Inclusion criteria defined? 
2. Sample selection explained? 
3. Baseline characteristics of sample described? 
4. Were participants a representative sample from a relevant population? 
5. Were all eligible patients included? 
 Intervention 
6. Surgical intervention described? 
7. Staff, place and facilities appropriate for performing the intervention? 
 Follow-up 
8. Sufficiently long (≥ 6 months for majority of sample)? 
 Outcome 
9. Secondary amputation appropriately defined/described? 
 Prognostic Variables 
10. Were important prognostic variables identified? 
 Analysis 
11. Adjustment for confounding? 
For each criteria, a ‘yes’ answer scores one point and an ‘unsure’ or ‘no’ answer scores zero.  
Maximum score is eleven and minimum zero. 
 
 
6.3.7 Statistical Analysis 
Meta-analysis was performed using Bayesian Networks (Fenton and Neil, 2012b). A 
Bayesian approach to meta-analysis offers a number of advantages over the traditional 
frequentist approach (Sutton and Abrams, 2001). These advantages are particularly 
valuable in a meta-analysis of observational studies where heterogeneity, non-normal 
data distribution and zero event rates are expected. A Bayesian approach directly 
addresses these difficulties (Sutton and Abrams, 2001, Warn et al., 2002). The Bayesian 
Networks used in this study explicitly model between-study heterogeneity and within-
study variability; do not assume normal data distribution; and do not require the addition 
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of a continuity factor for analyses when the event rate is zero. Moreover, a Bayesian 
approach allows the calculation of a 95 percent Credible Interval (CrI) and the ability to 
perform hypothesis tests using the entire posterior distribution of the parameter estimate. 
Such hypothesis tests with posterior probabilities addresses the clinical question more 
directly than conventional hypothesis tests with p-values (Burton et al., 1998). 
A proportion and 95 percent CrI was calculated as the primary outcome in individual 
studies. These were pooled using a Bayesian random-effects model (Table 6.3). Using the 
same model, sensitivity analyses were performed to assess the risk of bias. Sub-group 
analyses were performed for each prognostic factor and both an absolute (proportion) and 
relative (Odds Ratio) measure of effect calculated. Odds Ratios could only be calculated 
in studies that reported outcomes for both the presence and absence of the potential 
prognostic factor. These were pooled using a similar Bayesian random-effects model 
(Table 6.3). Non–informative prior distributions for the pooled effects (mean: 0, variance: 
1000) were used and uniform distributions (range: 0–2) for τ, the between-study standard 
deviation. For meta-analysis of odds ratios, the posterior probability (P) that the pooled 
estimate is greater than 1 was calculated. A P less than 10 percent is considered strong 
evidence of protective effect and P greater than 90 percent, strong evidence of harmful 
effect (Aitkin et al., 2009). Heterogeneity was reported as the I2 statistic. Inter-reviewer 
agreement for inclusion eligibility was evaluated with the kappa statistic. Statistical 
analyses were performed using AgenaRisk software (Agena, London, UK). 
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Table 6.3: Bayesian Network models for A) Proportions and B) Odds Ratio meta-
analysis. 
A) Proportions !!~!"# !! ,!! 	!"#$%(!!) = !! 	!!~!(!, !!)	!~!(0,1000)	!~!"#$(0,2)	
B) Odds Ratio !!!~!"#(!!! ,!!!)	!!!~!"#(!!! ,!!!)	!"#$% !!! = !! 	!"#$% !!! = !! + !! 	!!~!(!, !!)	!~!(0,1000)	!~!"#$(0,2)	
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6.4 Results 
 
6.4.1 Search results and characteristics of included studies 
Overall, 45 studies were included (Figure 6.1). There was near perfect agreement 
between reviewers on study eligibility (κ = 0.96 [95 percent CI: 0.92 – 1.0]). Two 
hundred and seven studies were excluded because of an ineligible study type: narrative 
review (91), case report (66), case series ≤ 5 (46) and systematic review (4). Forty-eight 
studies were excluded because of an ineligible study population: no acute lower limb 
vascular trauma (19), vascular injuries not described (21) and surgery either not 
performed, described or standard practice (9). Thirteen studies were excluded because 
amputation outcome was not reported (4) or secondary amputation was not defined (9). 
The authors of 27 included studies were contacted for additional or missing prognostic 
information, eleven replied and six provided unpublished original data (Davidovic et al., 
2005, Fox et al., 2010, Perkins et al., 2012, Burkhardt et al., 2010, Woodward et al., 
2008, Dar et al., 2003). Characteristics of the included studies are presented in Table 6.4.  
 
Figure 6.1: PRISMA flow chart of study selection process. 
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6.4.2 Secondary amputation rate 
The 45 included studies described a total of 3168 patients who underwent surgical LEVT 
repair in 3187 discrete lower limbs. Three hundred sixty nine limbs underwent secondary 
amputation. The pooled secondary amputation rate was 10.0  (95 percent CrI: 7.4 to 13.1) 
percent (Figure 6.2).  
 
Figure 6.2: Forest plot of secondary amputation proportions for included studies. Overall 
pooled proportion and heterogeneity, calculated using a Bayesian random-effects 
hierarchical model, is presented. 
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6.4.3 Heterogeneity 
Heterogeneity between included studies was responsible for a large proportion of the total 
variability in study outcomes (Figure 6.2). The majority of heterogeneity was clinical, 
arising from differences in study populations and consequential distribution of prognostic 
factors (Figure 6.6). Differences in study methodology had minimal effect on study 
outcome variability (Figure 6.3). 
 
6.4.4 Risk of bias 
Sensitivity analyses did not identify any significant risk of selection, performance or 
attrition bias (Figure 6.3). Secondary amputation was appropriately defined and measured 
in all included studies, limiting the risk of measurement bias. The median quality score of 
included studies was 8 (range: 4 to 10) out of a maximum 11. Sensitivity analysis of 
studies with a ‘low’ and ‘high’ score did not identify any significant risk of bias. There 
was no evidence of publication bias. Visual inspection of a funnel plot (Figure 6.4) and 
Eggers test (p = 0.204) showed no significant asymmetry. 
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Figure 6.3: Sensitivity analyses of methodological differences between included studies. 
 
Figure 6.4: Funnel plot of effect size against sample size for 45 included studies. 
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6.4.5 Prognostic factors for secondary amputation 
The included studies described 15 potential prognostic factors for secondary amputation 
(Figure 6.5). Two thirds (10/15) of these prognostic factors had conflicting evidence 
supporting their association with amputation. Four prognostic factors (age, gender, 
associated nerve injury, method of arterial repair) had no evidence to support a significant 
association with amputation, while compartment syndrome was the only factor where all 
studies reporting its effect showed a significant association with amputation. 
 
 
Figure 6.5: Potential prognostic factors identified from the included studies and the 
evidence supporting an association with secondary amputation (2000 to 2012). 
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6.4.5.1 Patient factors 
 
Age was poorly reported and could only be analysed in 12 studies describing 577 patients 
(Table 6.5). Four studies (Davidovic et al., 2005, Gupta et al., 2001, Mills et al., 2004, 
Perkins et al., 2012) described patients older than 55 years and a higher amputation rate 
was observed in this population (Figures 6.6 and 6.7). Gender was adequately reported in 
18 studies describing 1809 patients (Table 6.5). Females had a small but significantly 
higher risk of secondary amputation than males (Figures 6.6 and 6.7). 
 
6.4.5.2 Injury factors  
 
Mechanism of Injury 
 
MOI was reported in 41 studies describing 2813 injured limbs (Table 6.5). The risk of 
secondary amputation increased with a higher energy MOI: penetrating (5 percent), blunt 
(16 percent), blast (19 percent) (Figures 6.6 and 6.7). In 31 studies, penetrating MOI was 
further divided into those resulting from gun shot wound’s (1176 limbs, 96 secondary 
amputations) and stab wounds (207 limbs, 4 secondary amputations). Vascular injury 
resulting from GSW’s had a higher risk of secondary amputation than those resulting 
from stab wounds (0.06 [95 percent CrI: 0.02 – 0.10] versus 0.01 [95 percent CrI: 0.0 – 
0.04]); OR 1.3 [95 percent CrI: 0.27 – 3.2]; P = 0.59).  
 
Anatomical site of Injury 
The anatomical site of the arterial injury was clearly reported in 41 studies describing 
2859 injured limbs (Table 6.5). Vascular repair of femoral artery injuries had the lowest 
risk of secondary amputation (4 percent), while repairs of popliteal (14 percent) and iliac 
arteries (18 percent) were associated with substantially higher risk (Figures 6.6 and 6.7).  
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The presence of additional arterial injuries at multiple anatomical levels was specifically 
reported in 17 studies describing 1205 limbs (Table 6.5).  Patients injured at multiple 
arterial levels had 5-times the risk of secondary amputation when compared to those with 
single level injuries (Figures 6.6 and 6.7). 
 
Associated Injuries 
The presence or absence of associated limb injuries was clearly reported in 32 studies 
describing 2416 injured limbs for fractures and knee dislocations; 24 studies describing 
2303 limbs for venous injuries; and 12 studies describing 1384 limbs for nerve injuries 
(Table 6.5). The degree of soft tissue injury was reported in 18 studies describing 1015 
patients (Table 6.5). Primary studies classified a significant soft tissue injury using: 
clinical descriptors (Fox et al., 2010, Gupta et al., 2001, Kuralay et al., 2002, Pourzand et 
al., 2010, Topal et al., 2010, Fox et al., 2008b, Dar et al., 2003); the MESS score (Callcut 
et al., 2009, Guerrero et al., 2002, McHenry et al., 2002, Yahya et al., 2005); as injuries 
necessitating reconstructive techniques to achieve soft tissue cover (Subasi et al., 2001, 
Soni et al., 2012, Parmaksizoglu et al., 2010) and confirmation of no soft tissue defect 
(Mills et al., 2004, Miranda et al., 2002, Nicandri et al., 2010, Patterson et al., 2007). A 
significant soft tissue injury was associated with a six-fold increase in amputation while 
the presence of a fracture was associated with a four-fold increase. An additional venous 
or nerve injury was not associated with a substantial increase in amputation risk (Figures 
6.6 and 6.7). 
 
Injury complications 
Shock, prolonged ischemia (> 6 hours), and compartment syndrome were clearly reported 
in nine studies describing 792 patients, 16 studies describing 1052 limbs and ten studies 
describing 1341 limbs respectively (Table 6.5). Prolonged ischaemia and the 
development of compartment syndrome were associated with a four- and five-fold 
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increase in the risk of secondary amputation. Admission shock was not associated with a 
significant increase in secondary amputation (Figures 6.6 and 6.7). 
 
6.4.5.3  Treatment factors 
 
Arterial repair 
The surgical method of arterial injury repair was clearly reported in 28 studies describing 
2025 vascular injuries (Table 6.5). Injuries that required an interposition graft had twice 
the risk of secondary amputation when compared to injuries that underwent primary 
repair (Figures 6.6 and 6.7). The method of interposition graft was further sub-divided in 
26 studies describing 1184 injuries. Injuries repaired with a prosthetic interposition graft 
had a higher risk of secondary amputation than those repaired with reversed autologous 
vein (0.17 [95 percent CI: 0.05 – 0.38] versus 0.10 [95 percent CI: 0.06 – 0.15]; OR 1.88 
[95 percent CI: 0.55 – 5.825); P = 0.88). 
 
Venous repair 
The management of 904 associated venous injuries was reported in 21 studies (Table 
6.5). The risk of secondary amputation was six times lower following venous repair than 
venous ligation (Figures 6.6 and 6.7). 
 
Prophylactic fasciotomy 
The use of prophylactic faciotomies was reported in 12 studies describing 971 injured 
limbs (Table 6.5). The proportion of patients undergoing secondary amputation was 
similar in cohorts that did and did not have prophylactic faciotomies (Figures 6.6). 
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Figure 6.6: Absolute risk (pooled proportion) of secondary amputation according to 
identified demographic, injury, and treatment prognostic factors. 
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Figure 6.7: Relative risk (pooled Odds Ratio) of secondary amputation for identified 
demographic, injury, and treatment prognostic factors. 
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Table 6.5: Matrix showing the primary studies that provided information for analysis of 
each prognostic factor. 
Reference A
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Pourzand et al. (2010) - - X X - X X - X X X - - X - 
Fox et al. (2010) - X X X - X X - X X X - X X - 
Barros D'Sa et al. (2006) - - X - - - - - - - - - - - - 
Subasi et al. (2001) - X X X - X X X X - X X X X - 
Nikoli et al. (2002) - - X X X - X - - - - - - - - 
Jie et al. (2007) - - - - - - X - - - - - - - - 
Patterson et al. (2007) - - X X - X X X - - X - - - - 
Rozycki et al. (2003) - - X X - - X - X - - - - X - 
Sagraves et al. (2003) - - X X X - - - - - - - X - - 
Gupta et al. (2001) X X X X X X X - X X X X X X X 
Burkhardt et al. (2010) X - X X - - - - - - - - X - - 
Subramanian et al. (2008) - X X X - - - - X - - - - - - 
Yahya et al. (2005) - - X X X X - - - - - - X - X 
Simmons et al. (2012) - - - X - - - - - - - - - - - 
Nair et al. (2000) - - X X X - X X X X X X X X - 
Nicandri et al. (2010) - - X X X X X - - - X - X - - 
Scott and Hirshberg (2004) - - X X X - - - - - - - X - - 
Klineberg et al. (2004) - - X X X - X - - - - - X - X 
Hafez et al. (2001) - X X X X - X X X - - X X X X 
Callcut et al. (2009) - X X X - X - X X - - - - - - 
Mills et al. (2004) X - X X X X X - - - X - X - - 
Moini et al. (2007) - - X X - - - - - - X - X - X 
Guerrero et al. (2002) - - X X - X X - - - - X X - - 
Davidovic et al. (2005) X X X X - - X - X - X - X X - 
Kuralay et al. (2002) X - - X - X X - X - - - - X - 
Soni et al. (2012) X X X X X X X - - - X - X - X 
Topal et al. (2010) - X X X X X X X X - - X X X X 
Perkins et al. (2012) X X X X - - - - X X - - X X - 
Ekim et al. (2004) X - X X - - X X X - - X X X X 
Kohli and Singh (2008) - - - - - - - - - - - - - X - 
Degiannis et al. (2007) - - X X - - - - - - - - - - - 
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Table 6.5: Matrix showing the primary studies that provided information for analysis of 
each prognostic factor (continued). 
Reference A
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Fox et al. (2008b) X X X X - X X - X X X X X X - 
Sriussadaporn and Pak-art 
(2002) 
X X X X X - X X X - X - X X X 
Miranda et al. (2002) - - X X X X X - - - - - X - - 
Ekim and Odabasi (2010) - - X X - - X - X - - - - X - 
Burg et al. (2009) - - X X - - X X - - - - - - - 
Woodward et al. (2008) - - X X - - - - X - X - - - X 
Zhu et al. (2010) X X X X - - X - X - - - X X X 
Kurtoglu et al. (2007) - X X X - - X - X - - X X X X 
Dar et al. (2003) - X X X X X X X X X X X X X - 
Parmaksizoglu et al. (2010) X X X X - X X X X - - - X X - 
McHenry et al. (2002) - - X - X X X - - - X - - - - 
Makitie et al. (2006) - X X X X - X - X X - - - - - 
Liu et al. (2010) - - X X - - X - - - - - X - - 
Asensio et al. (2006) - X X X - - X X X X - - X X - 
Total number of articles: 12 18 41 41 17 18 32 12 24 9 16 10 28 21 12 
X: study information was used in prognostic factor analysis.  
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6.5 Discussion 
 
Key findings 
This study provides the first comprehensive analysis of the most widely appreciated 
prognostic factors for amputation following LEVT. Approximately one in ten limbs that 
undergo vascular repair will require amputation, the rate of which varies depending on 
specific patient and injury characteristics. Factors associated with a substantial increase in 
amputation include MOI, site of arterial injury, multiple level arterial injuries, associated 
fracture or major soft tissue injury, ischaemic time, development of compartment 
syndrome, and the surgical method of vascular repair. By comparison, demographic 
factors, such as older age and female gender, and admission shock are associated with a 
smaller increase in risk, while additional venous or nerve injuries are not associated with 
an important increase in secondary amputation. This improved understanding of LEVT 
prognosis will facilitate informed decision-making and allow more accurate 
communication of risk with colleagues, patients and family. 
 
Comparison to existing literature 
Current understanding of prognostic factors for amputation is weak, despite being an 
integral component of surgical decision-making in limb-threatening injuries. This is 
reflected in the conflicting conclusions of published literature and the poor performance 
of prognostic models comprising these factors (Bonanni et al., 1993, Bosse et al., 2001, 
Durham et al., 1996). There may be a number of reasons for this poor performance. 
Firstly, the weak evidence on which many traditional prognostic factors are based - the 
majority were derived from small, retrospective, single-centre observational studies or 
expert opinion (Gregory et al., 1985, Howe et al., 1987, Johansen et al., 1990, Russell et 
al., 1991, McNamara et al., 1994). Secondly, it is assumed that the same prognostic 
factors apply to both primary and secondary amputation	(ACS, 2005). This assumption is 
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not supported by evidence (de Mestral et al., 2013, MacKenzie and Bosse, 2006). For 
example, admission shock is a strong prognostic factor for primary amputation but is only 
weakly associated with secondary amputation (de Mestral et al., 2013, MacKenzie and 
Bosse, 2006). Finally, the relative strength of the relationship between each factor and 
amputation may be inadequately understood. As a result, many of the available 
amputation scores and guidelines imply an equal weighting of constituent factors (Russell 
et al., 1991, Howe et al., 1987, McNamara et al., 1994, Johansen et al., 1990, ACS, 
2005). This generalisation overstates the importance of some factors while 
underestimating the impact of others (MacKenzie et al., 2002). 
 
Explanation of findings 
Damage to limb tissues may be a direct consequence of energy transfer during injury or 
through the effects of ischaemic necrosis. The level and extent of this tissue damage is 
directly related to outcome (MacKenzie et al., 2000, MacKenzie et al., 2002, Kauvar et 
al., 2011, de Mestral et al., 2013, Mullenix et al., 2006, Tan et al., 2011). A number of 
injury characteristics are markers of these processes and have been used as prognostic 
factors (ACS, 2005, Scalea et al., 2012). The results of this meta-analysis demonstrate the 
wide variation in prognostic significance of these characteristics, ranging from a greater 
than five-fold increase in secondary amputation for LEVT associated with severe soft 
tissue injury or complicated by compartment syndrome, to a relatively weak relationship 
between additional venous or nerve injuries and amputation. 
 
The method of vascular repair is determined by the degree of vascular injury and 
therefore should also bear prognostic significance. Surprisingly, none of the individual 
studies in our review identified a significant relationship between the method of arterial 
repair and secondary amputation. However, meta-analysis of their results shows a 50 
percent higher risk of amputation for arterial injuries that require an interposition graft 
compared to those that can be primarily repaired. Similarly, the management of a venous 
		 193	
injury is strongly associated with outcome. Venous ligation is frequently used as a 
damage control procedure in patients with complex venous injuries, especially those that 
are physiologically compromised (Aucar and Hirshberg, 1997). This procedure seems to 
be a more effective marker of the extent of injury, and therefore prognosis, than simply 
the presence or absence of a venous injury. 
 
Demographic characteristics, such as age and gender, are recognised prognostic factors 
for functional and psychological outcomes after major injuries, including severe lower 
extremity trauma (MacKenzie and Bosse, 2006, Holbrook et al., 2001). Although age was 
traditionally believed to be an important prognostic factor (ACS, 2005, Gregory et al., 
1985, Johansen et al., 1990, McNamara et al., 1994), neither age nor gender has been 
shown to be prognostic of amputation in large observational studies (de Mestral et al., 
2013, MacKenzie et al., 2000, Mullenix et al., 2006). Furthermore, none of the studies 
included in this review identified an association between demographic factors and 
secondary amputation. Shackford et al. (2013), however, observed a significant 
relationship between demographic factors and secondary amputation in extremity 
vascular injuries requiring interposition grafts. This meta-analysis shows a higher 
amputation in those older than 55 years but should be interpreted with caution, as the 
pooled sample of older patients is small (29 patients) with only four undergoing 
secondary amputation. Surprisingly, meta-analysis also shows a small but significant 
increase in secondary amputation in females. A possible explanation may be the 
confounding effect of injury characteristics and we are investigating this relationship 
further. Overall, demographic factors are comparatively weak predictors of secondary 
amputation and should not be relied upon in amputation decisions. 
 
Implications of findings 
Few of the identified prognostic factors have the potential to be modified. However, those 
that can be modified provide substantial opportunities for improved outcome. The 
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duration of limb ischaemia, development of compartment syndrome, and presence of 
haemorrhagic shock are key modifiable determinants of outcome, and trauma systems 
should have strategies in place to promptly recognise and manage these emergencies 
(Percival and Rasmussen, 2012, Brohi et al., 2011). Effective interventions include the 
appropriate use of tourniquets (Beekley et al., 2008, Kragh et al., 2009), temporary 
vascular shunts (Rasmussen et al., 2006b, Gifford et al., 2009, Glass et al., 2009), 
fasciotomies (Percival and Rasmussen, 2012, Nanchahal J, 2009), and damage control 
resuscitation (Fox et al., 2008a) ; and the efficient triage of patients with limb-threatening 
injuries to specialist centres with the requisite expertise, equipment and resources 
(Nanchahal J, 2009, Mackenzie et al., 2008). In addition, the surgical management of 
concomitant venous injuries may have an important impact on limb outcome. Repair of 
deep venous injuries proximal to the trifurcation is recommended (Nanchahal J, 2009, 
Kuralay et al., 2002). 
 
6.6 Strengths and limitations 
 
Strengths 
This analysis is based on a large sample of patients with limb-threatening vascular 
injuries from a wide spectrum of geographical and economic locations. The findings 
advance the understanding of prognostic factors for secondary amputation and will be 
applicable in a wide variety of settings. This knowledge may also provide the opportunity 
to develop improved decision-support tools for severe lower limb injuries. Furthermore, 
the Bayesian approach provides robust conclusions and overcomes many of the 
limitations of conventional meta-analysis methods for observational studies.  
Analyses of methodological differences between studies did not show any significant risk 
of bias. A small difference in effect is observed when comparing the method of data 
collection (retrospective versus prospective). The majority of prospective studies only 
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included patients with vascular injuries resulting from knee dislocations. The relatively 
low burden of tissue damage in these injuries provides an explanation for the lower 
amputation rate observed. Additionally, studies with a short duration of follow-up may 
under-report the true secondary amputation rate, as a small proportion of secondary 
amputations are performed as a delayed procedure months to years after injury (Bosse et 
al., 2002, Krueger et al., 2012). Similarly, studies with lower methodological quality may 
also under-report secondary amputation rates. These two factors may have influenced 
results in this study, albeit not significantly. 
 
Limitations 
This study has a number of limitations. As is the case with all meta-analyses, our results 
are dependant on the content and quality of reporting in the included studies. 
Categorisation of continuous prognostic factors in the primary studies, and in our 
analyses, may have reduced prognostic information and power (Altman and Royston, 
2006). Furthermore, observational studies are prone to confounding and variation 
between studies may not be random. Indeed, we found large heterogeneity between 
included studies. Both clinical and methodological reasons for this heterogeneity were 
explored and analyses were performed using models that account for heterogeneity. The 
majority of heterogeneity was clinical, related to study population differences. This 
should be considered when interpreting the overall secondary amputation risk of patients 
with LEVT. We analysed the unadjusted association between each prognostic factor and 
secondary amputation. Clearly, many of the identified prognostic factors are related and 
future studies are needed to investigate their confounding influences. Finally, it is 
possible that other important prognostic factors for secondary amputation exist that were 
not identified by the search.  
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CHAPTER SEVEN 
 
Development and Validation of a Prognostic 
Model for Limb Viability 
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7.1 Introduction 
 
Assessing the risks associated with surgical intervention, or no intervention, is a 
cornerstone of informed decision-making (Dickson and Chong, 2009). Severe lower limb 
injuries, especially those that involve vascular trauma, pose a number of risks to the 
patient, including a risk to their life and to their limbs viability and future function. The 
degree of each risk is variable and influenced by a number of factors, the most important 
being the characteristics of the injury, the treatment provided, and the time taken to 
intervene. Deciding the treatment strategy most likely to achieve the best outcome is 
complex. Good judgement requires the ability to estimate the risks associated with an 
individual injury, and estimate the impact different treatment strategies may have on 
these risks. In Chapter Four, a diagnostic model for Trauma Induced Coagulopathy (TIC) 
was developed. TIC is a key determinant of the need for life-saving intervention, and an 
accurate estimate of the risk of TIC is critical during initial therapeutic decision-making. 
TIC, however, is not the only risk that needs to be considered when managing a patient 
with a severe lower limb injury. The risk to limb viability also requires careful 
consideration. In this chapter, a model that can quantify the risk to limb viability is 
developed. 
 
Damage to limb tissues may be a direct consequence of energy transfer during injury or 
secondary to ischaemic necrosis due to prolonged disruption of the tissues blood supply. 
The level and extent of this tissue damage determines the limb’s viability and directly 
influences therapeutic decisions (MacKenzie et al., 2002, de Mestral et al., 2013, 
Nanchahal J, 2009). Ideally, surgical management would include rapid reperfusion of the 
limb to limit ischaemic damage, followed by reconstruction of the injured tissues to 
salvage the limb’s function. However, in some situations, attempts at limb reperfusion or 
reconstruction may be harmful, and early amputation may achieve the best overall 
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outcome (Bondurant et al., 1988, Percival and Rasmussen, 2012). Limb viability is one of 
the most important factors that influence these surgical decisions (Percival and 
Rasmussen, 2012, Glass et al., 2009). Indeed, a non-viable limb was the principal reason 
for half of all amputations following lower extremity vascular trauma during the recent 
wars in Iraq and Afghanistan (Chapter Three).  
Estimating the risk to limb viability can be challenging. With improved trauma systems, 
only a small proportion of casualties with limb-threatening injuries have delayed access 
to care, and present with clearly non-viable limbs (Rasmussen et al., 2006a, White et al., 
2011a). In these cases, decision-making is straightforward, as there are no alternatives to 
amputation. However, in the majority of cases, the risk to limb viability is unclear at the 
time of initial wound assessment. This uncertainty makes decision-making difficult. A 
means to accurately estimate the predicted outcome of limb reperfusion and projected 
limb viability	would improve individual risk assessment and support informed therapeutic 
decisions. 
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7.2 Aims and objectives 
The aim of this study was to develop a prognostic model for limb viability, and validate 
the model’s performance in a cohort of patients with severe lower limb trauma. 
The first objective was to develop an evidence-based Bayesian Network for limb viability 
that can be used to predict the risk of a non-viable limb. 
The second was to assess the predictive performance of the model in a cohort of severe 
lower limb injuries. 
Third, was to compare the performance of the prognostic model against the performance 
of the Mangled Extremity Severity Score (MESS), at predicting amputations because of a 
non-viable limb. 
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7.3 Methods 
 
7.3.1 Study design and Participants 
This study describes the development and validation of a prognostic model for limb 
viability following severe lower limb trauma that includes a vascular injury. The 
prognostic model was developed using Bayesian networks. The methodology combined 
knowledge and data (Yet et al., 2014c) from a systematic review and meta-analysis 
(Chapter Six) and a large cohort study, the Global War On Terror Vascular Injury 
Initiative (GWOT-VII). GWOT-VII was reviewed and approved by the US Army 
Medical Research and Materiel Command Institutional Review Board and informed 
consent was obtained for all participants. This study represents a collaboration between 
the Centre for Trauma Sciences, and the School of Electronic Engineering and Computer 
Science, at Queen Mary, University of London; the United Kingdom’s Academic 
Department of Military Surgery & Trauma (ADMST); and the United States Army 
Institute of Surgical Research (USAISR).  
 
 
7.3.2 Sources of information: 
 
Systematic Review and Meta-Analysis 
Information from a systematic review of the contemporary literature on prognostic factors 
for amputation following lower limb vascular trauma (Chapter Six) was used to inform 
model development. The review was performed according to PRISMA guidelines and the 
study protocol was prospectively published on the PROSPERO register 
(CRD42012002720). Relevant publications were identified by an electronic search of the 
MEDLINE, EMBASE, and Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) databases between January 2000 and July 2012. Additional publications were 
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identified from the reference lists of included studies. Studies that described the outcome 
of adults undergoing surgical repair of lower extremity vascular trauma were eligible for 
inclusion. Patient, injury, and treatment factors associated with limb amputation were 
identified from the included studies. Bayesian meta-analysis was used to calculate an 
absolute (pooled proportion) and relative (pooled Odds Ratio) measure of the amputation 
risk associated with each of the identified prognostic factors. 
 
Cohort study 
GWOT-VII is a cohort study that maintains prospective follow-up of US military 
servicemen who sustained extremity vascular trauma while serving in the wars in Iraq 
and Afghanistan (Stannard et al., 2012). Cases are identified from the Joint Theatre 
Trauma Registry (JTTR), which is a comprehensive database of all injured casualties 
treated at US Military treatment facilities. Both registries are held and maintained by the 
United States Army Institute of Surgical Research (USAISR) at Fort Sam Houston, 
Texas.  
Potential participants for this study were identified from the GWOT-VII database. US 
servicemen who sustained a major lower extremity injury involving at least one named 
lower extremity artery, distal to the aortic bifurcation, between 01 March 2003 and 01 
February 2012, were eligible for inclusion. Exclusion criteria were: complete traumatic 
limb amputation; primary resuscitative (Damage Control) limb amputation; injuries that 
underwent amputation because insufficient tissue remained for reconstruction; isolated 
Profunda Femoris injuries; and iatrogenic vascular injuries. Cases where the reason for 
limb amputation was not clearly documented were also excluded. The model is developed 
to predicting the risk of a non-viable limb. Primary resuscitative amputations were 
excluded as the viability of the limb, had salvage been pursued, is unknown. Similarly, 
amputations performed because insufficient tissue remained for reconstruction were also 
excluded, as the reason for amputation is poor predicted function, and limb viability if 
salvage was pursued is unknown. Isolated Profunda Femoris artery trauma was excluded, 
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as these injuries have minimal affect on limb viability when the femoral-popliteal-tibial 
axis is patent. Furthermore, Profunda Femoris trauma was not identified as a risk factor 
for amputation in the systematic review. Finally, iatrogenic vascular injuries were 
excluded as they fall outside of the intended scope of the model. 
 
7.3.3 Data collection 
Data on selected patient, injury, and acute management variables were extracted from the 
GWOT-VII database and the JTTR. This is supplemented and corroborated with 
additional information from the Armed Forces electronic medical records, patient 
questionnaires and direct patient contact. Data accuracy and quality is assured and 
maintained by specially trained research nurses. Injury severity was classified by trained 
personnel according to the Injury Severity Score (ISS) (Baker et al., 1974) and Mangled 
Extremity Severity Score (MESS) (Johansen et al., 1990). Outcome data, in terms of limb 
viability and indications for amputation, were obtained from operative records, multi-
discipline meeting records, clinic letters, patient questionnaires, and patient interviews. 
All patients were followed-up until 01 February 2013, one year after the end of the study 
period. 
 
7.3.4 Outcome 
The primary outcome was limb viability. Viability was defined as limb tissue with the 
capacity to survive and live successfully (OED, 2015). Each injured limb included in the 
study was classified as either viable or non-viable. Limbs were classified as viable if they 
did not undergo amputation during the study period; underwent an elected secondary 
amputation for functional limitations, chronic pain, or chronic osteomyelitis; or were 
successfully reconstructed and then suffered a second traumatic injury or iatrogenic insult 
that resulted in amputation. Limbs were classified as non-viable if they underwent 
amputation and the documented reason for amputation was non-viable limb tissue.  
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7.3.5 Model development 
The prognostic model was developed using Bayesian Networks (BNs), a powerful 
technology that permits multiple sources of information to be combined and used to 
calculate predictions (Fenton and Neil, 2012b). BNs consist of two parts: a network 
structure that graphically describes the models’ variables and their relations, and a set of 
parameters that captures the strength of the relationships between variables. The BN was 
developed using a methodology that allows the combination of existing knowledge and 
data. The method follows a step-wise approach that is described below. A detailed 
explanation of the methodology has been published (Yet et al., 2014c). 
 
Step 1) Predictor Selection 
Variables included in the model were selected using clinical knowledge. By definition, all 
non-viable limbs will ultimately require amputation, however not all amputations are 
performed because of a non-viable limb. Prognostic factors for amputation following 
lower extremity vascular trauma were identified by a systematic literature review 
(Chapter Six). The mechanistic relationship between each of the identified prognostic 
factors and limb viability was assessed, and variables that were mechanistically related to 
limb viability were included in the BN model. To avoid over-fitting, data from the cohort 
study was not used to select predictors. 
 
Step 2) Predictor states 
The possible states that each predictor can take were also defined using clinical 
knowledge.  The systematic review identified fifteen categorical variables. However, four 
of these variables are continuous variables (age, degree of soft tissue injury, degree of 
shock, and duration of ischaemia) that had been dichotomised by the constituent studies 
included in the review. Dichotomising continuous variables may be convenient for 
descriptive purposes but significantly reduces the predictive power of the variable 
(Altman and Royston, 2006). To overcome this limitation, dichotomised predictors 
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included in the BN were modelled as ordinal variables with more than two clinically 
relevant categories. The thresholds for these categories were informed by clinical 
knowledge. The remaining predictors were modelled using the states identified by the 
systematic review. To avoid over-fitting, data from the cohort study was not used to 
define the predictor states. 
 
Step 3) Network Structure 
The network structure is a graphical representation of the clinical problem. It takes the 
form of a directed acyclical graph that consists of nodes and edges. Each node represents 
a variable and the directed edges represent the relationships between the variables. 
Developing a network structure that represents the causal mechanisms and clinical 
understanding of a problem is important (Fenton and Neil, 2012a). Such models have 
improved face validity, clinical credibility, avoid over-fitting, and enable generality to 
populations other than the population the model was developed from. These are essential 
properties of clinically useful prognostic models (Wyatt and Altman, 1995). Data-driven 
approaches, that ignore clinical knowledge, may produce models that contradict common 
sense and clinical understanding, and fail to satisfy many of the properties of a clinically 
useful tool. 
The model was built in fragments corresponding to the level of arterial injury. Clinical 
knowledge was used to define the mechanistic relations between predictor variables and 
limb viability. Where required, latent variables were introduced to model important 
intermediate mechanistic steps. In this way, a structure that reflects the current clinical 
understanding of factors that influence limb viability was developed. Identical fragments 
were then combined to produce a mathematically efficient model. To avoid over-fitting, 
data-driven approaches were not used to inform the models structure.  
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Step 4) Parameter learning 
A set of parameters, that quantifies the relationship between a variable and those 
variables related to it, was defined for each node. These parameters are probability values 
assigned to each of the possible states of the variable that the node represents. The 
parameters of a given node are conditioned on the possible states of its parent nodes. For 
nodes without parents, the parameter is estimated from the prior probability of the 
respective state occurring in the population of interest. For each node, a Node Probability 
Table (NPT) was constructed that contains a set of all possible probability values the 
node can take given its relations.  
Parameters were learned from clinical knowledge and data. The meta-analysis in Chapter 
Six provides a pooled estimate of probabilities and odds ratios for univariate 
relationships. These were used to model the respective nodes in the Bayesian network 
with a single parent. The meta-analysis results, however, cannot be directly used for 
nodes with multiple parents or for relationships with intermediate nodes. Parameters for 
the remaining nodes were learned by combining the results of the meta-analysis with data 
from the cohort study using the method described by Yet et al. (2014c). 
 
Step 5) Cross Validation 
The predictive performance of the model was tested using ten-fold cross validation 
(Kohavi, 1995). In this approach, the development cohort is randomly divided into ten 
equal size samples. Nine samples are used to train the model and the performance is then 
tested on the remaining sample. The process is repeated ten-fold, with each sample used 
once as test data. The results are then combined to calculate a performance estimate. 
Using this method, the model is trained and internally validated on two statistically 
independent cohorts containing all of the development data. Ten-fold cross validation is 
the recommended method of estimating the predictive performance of a model in a new 
population (Kohavi, 1995). It has a number of advantages over other methods such as 
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holdout and bootstrapping, including less bias, less variance, and a low risk of over-
fitting. 
 
 
7.3.6 Performance 
The model’s predictive performance was assessed using multiple measures of 
discrimination, calibration and accuracy. Discrimination was measured using the Area 
Under the Receiver Operating Characteristic curve (AUROC) (Swets, 1988), sensitivity, 
specificity, and the Diagnostic Odds Ratio (DOR) (Glas et al., 2003). The AUROC has a 
value between 0.5 (no discriminatory ability) and 1.0 (perfect model). Models with an 
AUROC greater than 0.9 may be regarded as having excellent performance, whereas 0.7 
to 0.9 indicates moderate performance, and 0.5 to 0.7 poor performance. The DOR is the 
ratio of the odds of a positive prediction among those with the condition relative to the 
odds of a positive prediction among those without the condition. The value of DOR 
ranges from 0 to infinity, with higher values indicating better discriminatory 
performance. As a general rule, a potentially useful tool will have a DOR above 25, while 
a DOR of less than 25 indicates an unhelpful tool (Jaeschke et al., 1994, Deeks, 2001). 
Calibration measures whether the predicted probability agrees with that observed. 
Calibration was evaluated using the Hosmer-Lemeshow (HL) test statistic (Hosmer and 
Lemesbow, 1980) and by visual assessment of the predicted and observed frequency of 
coagulopathy in 10 equal groups stratified by risk. A low HL p-value indicates poor 
calibration. Accuracy combines features of discrimination and calibration to measure how 
close, on average, predicted outcomes are to actual outcomes. Accuracy was evaluated 
with the Brier Score (BS) (Brier, 1950) and the Brier Skill Score (BSS) (Weigel et al., 
2007). The BS has a value between 0 (perfect model) and 1 (worst possible model) and 
the BSS has a range from - ∞ to 1, where a negative value indicates a worse prediction 
than the average probability and 1 indicates a perfect model.  
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7.3.7 Sensitivity analyses 
The impact that each predictor variable has on the models probability calculations was 
assessed using one-way sensitivity analyses. The results were plotted on a tornado graph. 
This enables a visual comparison of the relative impact each predictor variable has in the 
final model.  
The study population includes patients that underwent both primary and secondary 
amputations. Primary amputations were performed for clearly non-viable injuries. 
Including primary amputations in the validation population may exaggerate the 
performance of the model, as these cases are likely to have high predictions that correlate 
with their amputation outcome. Furthermore, the performance of the model in patients 
where limb viability is unclear has greater clinical value, as the results have the potential 
to support early decisions that avoid potentially harmful salvage attempts. The 
performance of the model on the whole study population was therefore compared to its 
performance on the study population with all primary amputations excluded. 
 
7.3.8 Comparison to the Mangled Extremity Severity Score (MESS) 
Finally, the predictive performance of the Bayesian Network model was compared to that 
of the MESS. MESS is a well-established score designed to predict the risk of 
amputation, defined as a non-viable limb rather than a dysfunctional limb, in patients 
with lower extremity vascular trauma (Johansen et al., 1990). Trained personnel, 
independent of this study and blind to the structure and results of the Bayesian Network, 
calculated all MESS scores at the time of initial wound evaluation. 
 
7.3.9 Statistical analyses 
Statistical analyses were performed using GraphPad PRISM v6 (GraphPad, La Jolla, CA, 
USA) or SPSS v20 (SPSS, Chicago, Il, USA). The Bayesian Network model was 
developed with, and is powered by, AgenaRisk software (Agena, London, UK). Normal-
quartile plots were used to test for normality. Unless otherwise specified, categorical data 
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are reported as frequency with percent and numerical data as median with Inter Quartile 
Range (IQR). Where appropriate, the chi- square (χ2) or Fisher’s exact test were used to 
compare categorical data and the Mann-Whitney U-test was used to compare numerical 
data. The area under ROC curves was calculated and compared using the method 
described by Hanley and McNeil (Hanley and McNeil, 1982). The area under correlated 
ROC curves was compared using a non-parametric method that accounts for the paired 
test design (DeLong et al., 1988). Area under ROC curves and DOR are reported with 
their corresponding 95 percent confidence intervals (CI). Statistical significance was set 
as a two-tailed P-value of <0.05. 
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7.4 Results 
 
7.4.1 Study population 
Between 01 March 2003 and 01 February 2012, 576 US soldiers sustained lower 
extremity vascular injuries in 601 limbs, and were included in the GWOT-VII registry. 
Ninety-one injured limbs met the clinical exclusion criteria for this study: traumatic 
amputation (19), primary resuscitative amputation (19), amputation because insufficient 
tissue remained for reconstruction (23), isolated Profunda Femoris Artery injury (27), and 
iatrogenic vascular injury (3). Two cases were excluded because the reasons for 
amputation were unclear. Data from the remaining 508 injured limbs, in 487 soldiers, 
were used to develop and validate the model. The median age of included soldiers was 23 
(range: 18 – 54) years, and 339 limbs (66.7 percent) sustained a blast mechanism of 
injury. The median Injury Severity Score was 14 (10 – 21) and the median Mangled 
Extremity Severity Score for injured limbs was 6 (5 – 7). Baseline characteristics of the 
study population are shown in Table 7. 1. 
 
7.4.2 Outcome 
All 508 included limbs sustained injuries that threatened limb viability. Fourteen limbs 
(2.8 percent) were assessed as clearly non-viable at initial presentation and were treated 
with primary amputation. The remaining 494 limbs underwent surgery to reperfuse the 
limb. Of these, 444 limbs (89.9 percent) remained viable and 50 limbs (10.1 percent) 
became non-viable.  All 50 non-viable limbs underwent secondary amputation. These 
procedures were performed between one day and 59 days after injury.  
In addition, 31 viable limbs (7.0 percent) also underwent amputation. The reasons for, 
and timing of, viable limb amputations were: 29 elected amputations for functional 
limitations, chronic pain, or chronic osteomyelitis (performed between 49 and 922 days 
after injury); one iatrogenic injury (11 days after injury); and one case resulting from 
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complications of a second traumatic injury (1848 days after the original injury). Baseline 
characteristics of viable and non-viable limbs are shown in table 7.1. 
 
Table 7.1: Baseline characteristics of 508 injured limbs according to outcome. 
Characteristic 
Missing 
Data (%) 
Viable 
(N=444) 
Non-viable 
(N=64) P-value 
Age – years (range)a <1 23 (18 - 54) 23 (19 - 46) 0.599 
Mechanism of Injury - Blast 0 288 (64.9) 51 (79.7) 0.023 
Injury Severity:     
Injury Severity Scorea 5.3 14 (10 – 18) 21 (16 – 29) < 0.0001 
Mangled Extremity Severity Score 5.7 6 (5 – 6) 7 (6 – 7) < 0.0001 
Arterial injury:     
Iliac Artery 0 13 (2.9) 3 (4.7) 0.439 
Femoral Artery 0 142 (32.0) 25 (39.1) 0.259 
Popliteal Artery 0 89 (20.0) 21 (32.8) 0.034 
Tibial Arteries 0 200 (45.1) 15 (23.4) 0.001 
Multiple Arterial Injuries 0 16 (3.6) 13 (20.3) <0.0001 
Associated Injuries:     
Soft tissue injury - Severe 23.4 48 (14.6) 48 (78.7) < 0.0001 
Fracture 3.5 214 (50.2) 56 (87.5) < 0.0001 
Venous injury 0 179 (40.3) 34 (43.1) 0.058 
Nerve injury 13.2 130 (34.0) 24 (40.7) 0.379 
Complications:     
Shock - uncompensated 2.0 78 (17.8) 41 (67.2) < 0.0001 
Duration of ischaemia > 6 hours 48.2 1 (0.4) 17 (47.2) < 0.0001 
Compartment Syndrome 0 29 (6.5) 4 (6.3) 1.000 
Treatment factors:     
Primary repair 3.1 77 (17.9) 7 (11.1) 0.212 
Interposition graft 3.1 219 (51.0) 40 (63.5) 0.079 
Ligation 3.1 133 (31.3) 14 (22.2) 0.185 
Categorical data presented as number (percent) and numerical data presented as median (IQR) 
a Refers to 487 soldiers with limb injuries. 
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7.4.3 Model development 
 
Predictors 
The systematic review (Chapter Six) identified 45 relevant studies that described the 
outcome of 3187 lower extremity vascular injuries. From these studies, 15 potential 
prognostic factors for amputation were identified. Nine of these predictors were 
considered mechanistically related to limb viability and included in the model (Table 
7.2). The six factors not included in the model were age, gender, associated nerve injury, 
associated venous injury and method of repair, and prophylactic fasciotomy.  
The majority of predictors were modelled using the states identified in the systematic 
review. Four variables (degree of soft tissue injury, degree of shock, duration of 
ischaemia, and Tibial artery injury) were modelled in more detail than the dichotomised 
states identified in the systematic review. Definitions of the possible states of each 
predictor included in the model are presented in table 7.2. 
 
Network Structure 
The network structure of the model captures the relations between predictor variables, 
latent variables, and outcome (Figure 7.1 A and B). The final model’s structure is 
composed of two fragments. One fragment relates to injuries that involve arteries above 
the popliteal trifurcation, and the other relates to injuries involving arteries below the 
trifurcation. Each fragment has four components. These components correspond to key 
mechanistic determinants of limb viability: 1) degree of ischaemic damage, 2) degree of 
tissue damage, 3) adequacy of tissue perfusion, and 4) characteristics of the vascular 
injury. 
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Table 7.2: Definitions of predictor variables in the Bayesian Network model. 
Predictor Variable 
Type of 
Node Definition 
Mechanism of Injury Labelled Blast / Blunt / Penetrating 
Arterial Injury:   
Anatomical Level Labelled Level of arterial injury divided into four anatomical 
zones: Iliac (includes common and external iliac 
arteries), Femoral (includes common and superficial 
femoral arteries), Popliteal, and Tibial (includes 
peroneal, anterior tibial and posterior tibial). 
Number of Tibial 
Arteries Injured 
Numeric Number of Tibial arteries injured, discrete whole 
number between 0 and 3. 
Multiple Level Arterial 
Injury 
Boolean Arterial injuries at more than one anatomical level: yes / 
no. 
Associated Injuries:   
Soft Tissue Injury Ranked Degree of soft tissue injury at the same level as arterial 
injury.a None, Mild (no tissue loss), Moderate (< 25 
percent tissue loss), Severe (25 – 75 percent tissue loss), 
Profound (> 75 percent tissue loss, mangled extremity) 
Fracture Boolean Fracture or dislocation at same level as arterial injury: 
yes / no. 
Complications:   
Shock Ranked Degree of haemorrhagic shock: None (SBP always > 
90mmHg, ≤ 2 units blood/24 hours), Compensated (SBP 
transiently below 90mmHg, > 2 units blood/24 hours), 
or Uncompensated (SBP consistently below 90mmHg, 
massive blood transfusion, coagulopathy). 
Duration of Ischaemia Ordinal 1) Less than one hour, 2) between one and three hours, 
3) between three and six hours, and 4) greater than six 
hours. 
Compartment Syndrome Boolean Present / Absent 
Method of Arterial Repair Labelled Primary repair (including thrombectomy, lateral repair, 
patch angioplasty and end-to-end anastomosis), 
Interposition Graft (including those performed with 
autologous vein and those with prosthetic material), 
Ligation, and Temporary Vascular Shunt. 
a Degree of soft tissue injury is measured in the anatomical zone of the limb corresponding to the 
arterial injury: Thigh (Femoral), Knee (Popliteal), and Leg (Tibial). SBP, Systolic Blood Pressure 
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A) Above-Trifurcation Fragment 
 
B) Below-Trifurcation Fragment 
 
Figure 7.1: Structure of the Bayesian Network prognostic model. Predictor variables 
(white), latent variables (grey), and the outcome variable (black) are presented together 
with the directions of the relationships between variables. The model is divided into two 
fragments: Above-Trifurcation (A) and below-Trifurcation (B). Each fragment has four 
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causal components. The dashed lines represent a variable that is only present in the 
Below-Trifurcation fragment. 
 
7.4.4 Performance 
The model had excellent overall performance at predicting limb viability. The AUROC 
was 0.932 (95 percent CI: 0.898 – 0.967) (Figure 7.2). When operated at a threshold 
probability of 0.21, the sensitivity was 90.6 percent, specificity 85.5 percent, and DOR 
56.8 (95 percent CI: 43.1 – 74.9). On visual inspection, the predicted risk of a non-viable 
limb calibrated well with the observed outcome (Figure 7.3); and the Hosmer-Lemeshow 
goodness-of-fit test result was not significant (HL statistic: 14.1; p = 0.079). Overall, the 
models predictions were accurate, with a Brier Score of 0.06 (95 percent CI: 0.05 – 0.07) 
and a Brier Skill Score of 0.39 (95 percent CI: 0.25 – 0.48). The predictive performance 
of the ‘Above-Trifurcation’ and ‘Below-Trifurcation’ fragments of the model were 
similar and are shown in Table 7.3.   
 
7.4.5 Sensitivity analyses 
All predictor variables contributed to the model’s result, with the degree of soft tissue 
injury, degree of ischaemic tissue damage, and degree of shock having the greatest 
impact on predictions (Figure 7.4). 
Fourteen limbs underwent primary amputation. In these cases, the median predicted 
probability of a non-viable limb was 0.50 (range: 0.30 – 0.74). At a threshold of 0.21, the 
model predicted all primary amputations. Excluding primary amputations from the 
validation population did not have any significant affect on the models performance. The 
AUROC was 0.923 (0.880 – 0.965) and at a threshold of 0.21 the sensitivity was 90.0 
percent, specificity 85.5 percent, and DOR 53.1 (95 percent CI: 40.5 – 69.6). 
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Figure 7.2: Overall accuracy of the limb viability prognostic model. Overall accuracy 
was assessed using Area Under the Receiver Operating Characteristic (AUROC) curve 
for viability predictions in a cohort of 508 severe lower limb injuries. This plots the true 
positive rate (sensitivity) against the false positive rate (1 – specificity). The AUROC was 
0.932. At a sensitivity of 90 percent the false positive rate was 15 percent. 
 
 
Figure 7.3: Model calibration in cohort of 508 severe lower limb injuries. The Hosmer 
and Lemeshow test statistic was 14.1 and there was no significant difference between the 
predicted and observed frequency of a non-viable limb in each risk group (p = 0.079). 
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A) Above-Trifurcation Fragment 
 
B) Below-Trifurcation Fragment 
 
Figure 7.4: One-way sensitivity analyses of the impact individual predictor variables 
have on the models result. A) Impact of predictors in the Above-Trifurcation fragment, 
B) Impact of predictors in the Below-Trifurcation fragment. The dotted line represents 
the prior probability of amputation in each population. 
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Table 7.3: Predictive performance of the Above- and Below-Trifurcation fragments of 
the limb viability model. 
Performance Measure 
Above-Trifurcation 
Fragment (n=293) 
Below-Trifurcation    
Fragment (n=215) 
Discrimination:   
AUROC 0.945 (0.907 – 0.984) 0.895 (0.821 – 0.968) 
Specificity (%) a 86.0 (80.9 – 90.1) 80.0 (73.8 – 85.3) 
DOR 54.1 (41.2 – 71.0) 55.7 (41.6 – 74.6) 
Calibration:   
Hosmer-Lemeshow statistic 5.1 (p = 0.745) 11.4 (p = 0.180) 
Accuracy:   
Brier Score 0.06 (0.05 – 0.08) 0.05 (0.03 – 0.07) 
Brier Skill Score 0.46 (0.35 – 0.57) 0.15 (-0.15 – 0.45) 
Data are presented with 95 percent Confidence Intervals unless otherwise specified. 
a Specificity calculated at 90 percent sensitivity. 
AUROC, Area Under the Receiver Operator Characteristic Curve; DOR, Diagnostic Odds Ratio. 
 
 
7.4.6 Comparison to the Mangled Extremity Severity Score (MESS) 
Four hundred seventy nine injured limbs (94.3 percent) had a MESS score available for 
comparison. The median MESS was 6 (Range: 1 – 10). One hundred thirty six injured 
limbs (28.4 percent) had a MESS greater or equal to seven, the recommended threshold to 
predict the need for amputation, while 343 limbs (71.6 percent) had a MESS less than 
seven. Of the limbs predicted to need amputation by the MESS, 48 (35.3 percent) 
underwent amputation, 35 (25.7 percent) because of a non-viable limb and 13 (9.6 
percent) for other indications. Of the limbs predicted as salvageable by MESS, 41 (12.0 
percent) underwent amputation, 23 (6.7 percent) because of a non-viable limb and 18 (5.2 
percent) for other indications. 
The MESS had only a moderate ability to predict limb viability. The AUROC was 0.723 
(95 percent CI: 0.656 – 0.790) and at a threshold of seven the sensitivity was 60.3 
percent, specificity 76.0 percent, and DOR 4.8.  
		 218	
The MESS had significantly worse ability to predict the need for amputation for any 
indication. The AUROC was 0.540 (95 percent CI: 0.444 – 0.635) and at a threshold of 
seven the sensitivity was 53.9 percent, specificity 77.4 percent, and DOR 3.9. 
The BN prognostic model had significantly better performance than MESS at predicting 
limb viability (AUROC 0.932 (0.898 – 0.967) versus 0.723 (0.656 – 0.790); P < 
0.0001)(Figure 7.5). A comparison of performance measures of the BN prognostic model 
and the MESS are shown in Table 7.4. 
 
 
Figure 7.5: Comparison of the Area Under the Receiver Operator Characteristic  
(AUROC) curve for predicting amputations performed because of a non-viable limb 
using a Bayesian Network prognostic model and the Mangled Extremity Severity Score 
(MESS). There was a significant difference between the AUROC of each model (P < 
0.0001, DeLong). 
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Table 7.4: Comparison of the performance of the Bayesian Network prognostic model 
and the Mangled Extremity Severity Score (MESS) at predicting amputations performed 
because of a non-viable limb in a cohort of 479 severe lower limb injuries. 
Performance Measure Bayesian Network MESS 
AUROC 0.932 (0.898 – 0.967) 0.723 (0.656 – 0.790) 
Sensitivity (%) 90.6 (80.7 – 96.5) 60.3 (46.6 – 72.9) 
Specificity (%) 85.5 (81.9 – 88.7) 76.0 (71.6 – 80.0) 
DOR 56.8 (43.1 – 74.9) 4.8 (4.0 – 5.8) 
Data are presented with 95 percent Confidence Intervals. The operating threshold for the 
Bayesian Network is a probability > 0.21, and for the MESS, a score ≥ 7. AUROC, Area Under 
the Receiver Operator Characteristic Curve; DOR, Diagnostic Odds Ratio. 
 
 
7.4.7 Model presentation and application 
A preview version of the complete model is available at 
http://valinor.agena.co.uk:8080/vbn/vbn.html. Entering predictor values allows the 
calculation of an individual patients probability of developing a non-viable limb. The tool 
is specifically designed to provide an individualised risk assessment that allows 
clinicians, and the patient, to exercise their own informed judgement and choice. The tool 
is not designed to predict decisions or prescribe treatments at a prespecified threshold.  
This version of the model should not be used to inform clinical decisions until its 
performance in new patients has been validated and the impact of predictions on 
decision-making and patient outcomes has been assessed. 
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7.5 Discussion 
 
Key findings 
Limb viability is a key outcome following severe lower limb trauma and is central to 
decisions between attempting salvage and amputation. In a large proportion of cases the 
risk to limb viability is unclear at the time decisions need to be made, greatly increasing 
the difficulty of these decisions and potentially jeopardising sound judgement. We have 
developed a Bayesian Network that can accurately predict limb viability from 
information that is available at the optimal time for surgical decision-making. This model 
combines the best available evidence on limb viability prognostic factors with high 
quality individual patient data from a large cohort study. At the time of initial wound 
evaluation, this prognostic model can accurately predict the outcome of limb reperfusion 
and objectively estimate the projected risk to limb viability for an individual injury. 
Furthermore, the model has significantly superior performance to an existing and well-
established decision-support tool, the Mangled Extremity Severity Score (MESS). 
 
Potential applications of findings 
The ability to accurately quantify the risk to limb viability for individual injuries has 
important implications for clinical practice, quality assessment, and future severe lower 
limb trauma research. Clinically, the Bayesian Network can be used to enhance 
situational awareness and reduce uncertainty by providing clinicians with a clear estimate 
of the risk to limb viability at the time treatment decisions need to be made. This 
information may be weighed-up against other key risks, including the risk to life and 
estimates of functional outcome, to complement clinical judgement and support rational 
treatment decisions. Where possible, the model may also be used to provide patients with 
understandable information regarding the risks associated with their injuries, facilitating 
shared decision-making and establishing sensible treatment expectations.  
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Errors or delays in decision-making, and unrealistic treatment expectations, are important 
causes of poor outcome following severe lower limb trauma (Bondurant et al., 1988, 
Hansen Jr, 1989). By providing the means to perform an accurate risk assessment, the 
Bayesian Network can support informed and rational decision-making, which has the 
potential to improve patient outcomes from these devastating injuries. 
 
For trauma systems, the model may provide a quality assurance tool that supports internal 
and external benchmarking of performance. By comparing observed and predicted 
outcomes, an overall assessment of the quality of trauma care can be made. In addition, 
unexpected outcomes for individual cases can be identified and referred for more detailed 
interrogation. 
 
The prognostic model may also have a role in trauma research. Risk estimation may help 
understand differences in case-mix, when comparing different studies. Within studies, 
cohorts may be catagorised according to risk, to allow more informative analysis. 
Furthermore, the model could be used to select patients with an appropriate degree of risk 
to allow more efficient clinical trials.  
 
Model Structure 
All non-viable limbs will require amputation. Potential predictors for the Bayesian 
Network were identified by systematically reviewing the contemporary literature for 
prognostic factors related to amputation (Chapter Six). The identified factors that were 
mechanistically related to tissue viability were included in the model. A number of 
identified factors were not included in the model, either because there was insufficient 
evidence to support a relationship with amputation, or because there was no evidence to 
support a mechanistic relationship with tissue viability. For example, age was historically 
believed to be an important prognostic factor for amputation and is included in a number 
of the lower limb predictive scores and guidelines (ACS, 2005, Gregory et al., 1985, 
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Johansen et al., 1990, McNamara et al., 1994). However, age was not included in the 
Bayesian Network. The LEAP study and multiple analyses of the US National Trauma 
Data Bank have shown that the association between age and primary or secondary 
amputation is weak (de Mestral et al., 2013, Konstantinidis et al., 2011, MacKenzie et al., 
2000, Mullenix et al., 2006). Our meta-analysis is consistent with these findings (Chapter 
Six). Furthermore, there is no direct mechanistic link between age and the risk to tissue 
viability following injury. Although age may act as a surrogate marker for co-morbidities 
that influence tissue viability and healing, such as peripheral vascular disease or diabetes, 
older age and the presence of chronic co-morbidities does not appear to be related to 
treatment decisions or outcome following severe lower limb trauma (MacKenzie et al., 
2000, de Mestral et al., 2013). Similarly, gender and sensory function of the foot where 
also excluded as model predictors because current evidence shows a weak association 
with amputation decisions and there is no evidence to suggest a mechanistic relationship 
with tissue viability (MacKenzie et al., 2000, de Mestral et al., 2013, Bosse et al., 2005, 
Perkins et al., 2015). 
Several factors that were relevant to tissue viability and amputation/salvage decisions 
were identified, and included in the Bayesian Network. These factors were all related to 
one of four mechanistic determinants of limb viability, namely: the degree of tissue 
damage, the degree of ischaemic damage, the adequacy of tissue perfusion, and 
characteristics of the vascular injury. These four mechanisms formed the core structure of 
the Bayesian Network. 
The network structure was developed in four fragments that relate to the level of the 
arterial injury (Iliac, Femoral, Popliteal, and Tibial). The Iliac, Femoral, and Popliteal 
fragments were identical and combined to form a single ‘Above-Trifurcation’ fragment. 
Three tibial vessels provide the blood supply to the leg. At this level, limb viability is also 
related to the number of tibial vessels injured (Burkhardt et al., 2010, Padberg et al., 
1992). The network structure at the Tibial level was therefore modified to include an 
additional variable for the number of tibial arteries injured. This formed the ‘Below-
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Trifurcation’ fragment. The final model consisted of two fragments, ‘Above-trifurcation’ 
and ‘Below-trifurcation’. 
 
Comparison to existing literature 
Several predictive scores have been developed to help surgeons decide which limbs can 
be salvaged, and which would benefit from early amputation (Gregory et al., 1985, 
Johansen et al., 1990, Krettek et al., 2001, McNamara et al., 1994, Rajasekaran et al., 
2006, Russell et al., 1991, Howe et al., 1987). These scores define successful salvage as a 
viable limb rather than a functional limb (Dagum et al., 1999, Durham et al., 1996) and 
apart from the Ganga Hospital Score (Rajasekaran et al., 2006), all are designed for use in 
patients with lower extremity vascular trauma. None of these scores, however, are 
accurate enough to reliably support individual treatment decisions (Bonanni et al., 1993, 
Bosse et al., 2001). In a retrospective validation study, Bonanni et al. (1993) showed low 
sensitivity of the Mangled Extremity Syndrome Index (six percent), Mangled Extremity 
Severity Score (22 percent), Predictive Salvage Index (33 percent), and Limb Salvage 
Index (61 percent) in 58 civilians with severe lower limb injuries. In a prospective and 
much larger study, the Lower Extremity Assessment Project (LEAP) assessed the clinical 
utility of the MESS; Predictive Salvage Index (PSI); Limb Salvage Index (LSI); Nerve 
Injury, Ischemia, Soft-Tissue Injury, Skeletal Injury, Shock, and Age of Patient Score 
(NISSSA); and Hanover Fracture Scale (HFS) in 556 civilian high-energy lower-
extremity injuries. Their analysis demonstrated a relatively high specificity, but again a 
low sensitivity and only moderate predictive performance for all the scores, confirming 
the limited clinical usefulness of the current lower-extremity predictive scores in 
supporting treatment decisions (Bosse et al., 2001). 
 
Despite their moderate performance, the lower limb predictive scores have shown that 
limb outcome, in terms of amputation or salvage, is predictable and relies on a complex 
interaction between multiple prognostic factors. A large number of potential prognostic 
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factors have been described (MacKenzie et al., 2002, Scalea et al., 2012). The strongest 
seem to be the degree of soft tissue injury and the duration of tissue ischaemia 
(MacKenzie et al., 2002, Glass et al., 2009, Perkins et al., 2015). These two factors are 
incorporated in the majority of lower extremity trauma management guidelines and 
predictive scores (ACS, 2005, Scalea et al., 2012, Nanchahal J, 2009, Gregory et al., 
1985, Howe et al., 1987, Johansen et al., 1990, Krettek et al., 2001, McNamara et al., 
1994, Russell et al., 1991). The presence of shock has also been shown to be a strong 
predictor of primary amputation following both military (Brown et al., 2009) and civilian 
injuries (de Mestral et al., 2013, MacKenzie et al., 2002), and is a key component in 
many scores (Gregory et al., 1985, Johansen et al., 1990, Krettek et al., 2001, McNamara 
et al., 1994, Rajasekaran et al., 2006). In addition, a devascularised limb is a fundamental 
determinant of viability, and is considered in all the lower limb management guidelines 
and predictive scores (except the Ganga Hospital Score, which is specifically designed 
for patients without vascular injury) (Nanchahal J, 2009, Scalea et al., 2012, Feliciano et 
al., 2011).  
A number of characteristics of vascular injuries have particular prognostic value. The 
anatomical level of arterial injury is a well-recognised determinant of the risk to limb 
viability, with popliteal injuries associated with the highest amputation rates (Kauvar et 
al., 2011, Mullenix et al., 2006). The number of tibial vessels injured also correlates with 
the risk to limb viability (Burkhardt et al., 2010, Padberg et al., 1992). Additionally, 
multiple level arterial injuries have recently been identified as an especially strong 
predictor of limb viability (Kauvar et al., 2011, Perkins et al., 2015).  
 
An important consideration in the development of the existing lower limb predictive 
scores was not only the accuracy, but also the simplicity of the tools. Simplicity was 
required to enhance clinical utility (Johansen et al., 1990). As a result, many of the scores 
only include factors thought to be the strongest predictors. Simplicity, however, may 
come at the expense of accuracy, and this may in part explain the moderate performance 
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of these scores (Bohanec and Bratko, 1994). Due to the widespread availability of 
computers and improvements in computing power, the simplicity of prognostic scores 
may be less important in present-day health care than in the 1990’s. Indeed, the uptake of 
computer technology that is now capable of handling powerful mathematical algorithms 
has the potential to fundamentally change risk assessment and decision-making in health 
care (Kawamoto et al., 2005, Garg et al., 2005, Bates et al., 2001, Bates et al., 2003).  
 
Mangled Extremity Severity Score 
Johansen et al. proposed the MESS in 1990 and it has become the most widely used 
lower limb predictive score (Johansen et al., 1990). Their aim was to develop a simple 
scoring system, which could be used following an initial wound examination, to 
accurately discriminate between salvageable and non-salvageable limbs. MESS consists 
of four prognostic criteria. However, two of the criteria combine a number of prognostic 
factors. The skeletal and soft tissue criterion takes into consideration the mechanism of 
injury, presence of a fracture, degree of soft tissue injury, and degree of wound 
contamination. Likewise, the limb ischaemia criterion takes into consideration the degree 
and duration of ischaemia, as well as the perfusion and sensory function of the limb. The 
remaining criteria consider a single prognostic factor each, namely the degree of shock 
and the age of the patient. In total, the MESS score considers ten unique prognostic 
factors grouped into four criteria.  
By comparison, our Bayesian Network has many structural similarities to the MESS 
score. The Bayesian Network also considers ten unique prognostic factors grouped into 
four broad mechanistic criteria. The strongest predictors in both models are the degree of 
soft tissue injury, degree of ischaemic damage, and presence of shock. Seven prognostic 
factors are common to both models. The only MESS predictors not included in the 
Bayesian Network are patient age, limb sensory function, and the degree of wound 
contamination. These factors were excluded, as current evidence does not support a 
prognostic relationship with limb viability.  
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The models, however, differ in the way in which each tool uses the predictor information 
to calculate prognosis. The four MESS criteria are categorised, and a point score, 
increasing with increasing risk, is attached to each category. MESS is a simple 
summation of these four scores, with a MESS ≥ 7 suggested as predictive of the need for 
amputation. The Bayesian Network, on the other hand, considers the mechanistic 
relations between all known prognostic factors to estimate the risk to limb viability. 
 
The predictive performance of the MESS has been extensively evaluated in both civilian 
(Bonanni et al., 1993, Bosse et al., 2001, Dagum et al., 1999) and military populations 
(Brown et al., 2009, Sheean et al., 2014). In both of these populations, the MESS had 
only a moderate ability to predict the need for amputation. This study represents the 
largest external validation of the MESS score in a Military severe lower limb trauma 
population, and the findings are consistent with previous validation studies. Overall, the 
MESS has a sensitivity and positive predictive value of approximately 50 percent and is 
clearly not accurate enough to be relied upon for treatment decisions (Table 7.5). 
 
 
 
 
 
 
 
 
 
 
 
 
		 227	
Table 7.5: Studies evaluating the performance of the Mangled Extremity Severity Score 
(MESS) at predicting the need for amputation in civilian and military trauma populations. 
Pooled predictive performance is calculated for each population. A MESS ≥ 7 is used as 
the threshold in all studies. 
Author Sample Size Sensitivity Specificity PPV NPV 
Civilian studies      
Bonanni et al. (1993) 58a 0.22 0.53 0.17 0.60 
Dagum et al. (1999) 40a 0.40 0.89 0.33 0.91 
Bosse et al. (2001) 556 0.46 0.91 0.65 0.82 
Pooled Performance 654 0.43 0.88 0.56 0.81 
Military studies      
Brown et al. (2009) 85 0.86 0.84 0.64 0.95 
Sheean et al. (2014) 155 0.35 0.88 0.50 0.80 
Perkins 479 0.54 0.77 0.35 0.88 
Pooled Performance 719 0.53 0.80 0.42 0.87 
PPV, Positive Predictive Value; NPV, Negative Predictive Value 
a Primary amputations excluded 
 
 
Limitations of the existing scores 
Despite the structural similarities, the Bayesian Network has significantly better 
predictive performance than MESS and the other lower limb predictive scores. Two 
potentially important reasons for this are worth discussing. 
 
Firstly, the moderate performance of the existing scores in new patients may, in part, be 
because these scores are over-fitted to their development data. All the scores were 
developed using relatively small retrospective datasets, and score predictors were selected 
from these datasets using significance testing or based on expert opinion. These methods 
have a high risk of selection bias and of producing a score that approximates the 
characteristics of the development data rather than true relationships (Royston et al., 
2009, Steyerberg et al., 2001, Austin and Tu, 2004). This results in a model with 
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excellent performance in the development data, but is unable to reproduce this 
performance in new populations. This finding reflects the current evidence-base and 
strongly suggests that existing scores are over-fitted to their development populations.  
 
Second, simple scores may not be adequate in complex problems. The existing lower 
limb prediction tools are all simple scoring systems. The ability to weight factors in these 
scores is limited, and in many cases different factors are given equal weight or the 
weighting is arbitrary. Furthermore, these scores are unable to account for any 
interactions between variables. Severe lower limb injuries, however, represent a complex 
problem. Outcomes and treatment decisions are based on the interactions of multiple 
risks, each of which is predicted from the interactions of multiple prognostic factors. 
Some of these factors have a much larger influence than others, and the influence of 
many factors are correlated. Furthermore, the degree of a factors influence may vary 
depending on the characteristics of the patient and wound. Simple scores are not able to 
handle this degree of complexity, and this limitation may manifest in the accuracy of 
predictions. 
 
Relevance of predicted outcome to Decision-Support 
For a prognostic model to be useful in supporting decisions, it should predict an objective 
and relevant patient outcome that informs the decision-making process. The lower limb 
scores predict historical amputation decisions, and although amputation is an objective 
and relevant patient outcome, there are important limitations to predicting a clinicians 
treatment decisions. First, predicting the decision, rather than presenting the information 
needed to make a rational decision, does not provide much support to the decision-
making process. Second, historical amputation decisions may contain errors that will be 
learned and propagated by the scores developed from them. It is possible that unnecessary 
amputations, by today’s standards, may have been performed in the populations used to 
develop the existing lower limb scores (Type 1 errors). For instance, at the time the lower 
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limb scores were developed an insensate foot was considered one of the most important 
indications for early amputation, and was strongly associated with amputation decisions 
(MacKenzie et al., 2002). This was criticised in a seminal study from the Lower 
Extremity Assessment Project, which demonstrated that initial plantar sensation was not 
prognostic of long-term sensory status or functional outcome if limb salvage was 
undertaken (Bosse et al., 2005). It is now accepted that initial plantar sensation is not an 
indication for lower limb amputation, however, many of the existing scores have been 
developed to predict these cases (Bosse et al., 2005). 
Limbs may also have been classified as successfully salvaged that later required an 
amputation (Type II errors). The development studies of many predictive scores do not 
report the duration of follow-up (Gregory et al., 1985, Howe et al., 1987, Russell et al., 
1991, McNamara et al., 1994). As demonstrated in Chapter Three, a significant 
proportion of amputations occur months to years after injury. Delayed amputations, if not 
accounted for, may affect the accuracy of the predictive scores.  
Although developing a model to predict historic amputation decisions is convenient, it is 
quite different from predicting the risks that influence decisions. Limb viability is an 
objective patient outcome that is central to a large proportion of amputation/salvage 
decisions. To overcome the limitations of predicting a treatment, and provide more 
informative decision support, the Bayesian Network was developed to predict a true 
patient outcome (limb viability) rather than a surrogate marker (the decision to amputate).  
 
7.6 Strengths and Limitations 
 
Strengths 
This study has a number of strengths. Most important is that the model is developed to 
predict an outcome that is central to amputation/salvage decisions, and is often uncertain 
at the time these decisions need to be made. Second, the structure of the model is derived 
		 230	
from existing knowledge and represents an evidence-based understanding of the factors 
that affect limb viability following limb-threatening trauma. Knowledge-based methods 
of developing prognostic models are labour intensive, and therefore rarely used, however, 
they offer significant benefits over traditional methods including improved face validity, 
clinical credibility, low risk of over-fitting, and better predictive performance in new 
patients (generalisability). Third, the models parameters were learned using a method that 
combines a meta-analysis of contemporary literature and individual patient data from a 
large cohort study (Yet et al., 2014c). This significantly increases the amount of 
information available to learn the strength of parameters and the likelihood that parameter 
estimates will approximate reality. Finally, the prognostic model is developed using 
Bayesian Networks, a powerful technology that is better suited to handle the multiple 
interactions and natural variability of complex clinical problems than traditional 
prognostic modelling methods (Fenton and Neil, 2012b, Van Gerven et al., 2008).  
 
Limitations 
This study has a number of limitations that should be acknowledged. Most important, the 
model’s performance has not been validated in new patients. Performance was estimated 
using the development dataset, and there is a risk this estimate may not be an accurate 
representation of the models performance in new patients. This risk may be minimal, 
however, as for the most part the model was developed using existing knowledge. Key 
steps in model development, which can result in over-fitting (and a biased performance 
estimate) if based on data, were purposefully performed completely independent of the 
development dataset. These steps included defining the structure of the model, selecting 
predictors, and predictor categorisation. The development dataset was only used to 
estimate parameters where published evidence was lacking. Furthermore, 10-fold cross 
validation represents the most accurate and least biased method of estimating model 
performance (Kohavi, 1995). Nonetheless, the model’s performance in new patients must 
be assessed to determine its external validity.  
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Second, the model’s performance was assessed in a US military cohort of severe lower 
limb injuries, and its performance in civilian or less-resourced settings is unknown. A 
military cohort may differ in important ways from severe lower limb trauma populations 
in other settings, and these differences may impact the models accuracy. The model, 
however, was not designed specifically for military trauma populations, and a wide range 
of knowledge from diverse populations and settings was used in development. 
Ultimately, the model’s performance will need to be assessed in a variety of settings to 
determine the generalisability of the tool. 
Finally, a degree of measurement error is possible. Classification of limb viability relied 
on the clinical assessment, and documentation accuracy, of the treating surgeon. A 
precise and objective measure, such as tissue histology, was not used. Although a single 
clinical assessment is not perfect, and documentation of findings may be incomplete, the 
military standard is for all limb amputation decisions to be confirmed by a second 
surgeon and the indications clearly documented prior to amputation (Clasper, 2007). 
These steps would enhance measurement accuracy. Indeed, only two cases out of the 
original cohort of 601 injured limbs (0.003 percent) had unclear documentation of the 
reason for amputation, and both of these cases were excluded from this study.
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CHAPTER EIGHT 
 
Conclusions 
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8.1 Summary of findings 
This thesis presents an improved understanding of decision-making following severe 
lower limb trauma, and describes the development and validation of novel and accurate 
prognostic models that can help identify those patients whose limb can be safely and 
effectively salvaged, and also identify those for whom attempts at limb salvage would be 
dangerous or potentially fail.  
 
Chapter One describes the relevance of severe lower limb trauma to health and reviews 
the contemporary management of these injuries. The related management guidelines are 
summarised, emphasising the treatment goals and key steps in decision-making. It is clear 
from this review that key decisions are often based on uncertain information, and good 
judgement relies heavily on clinical experience and intuition. The chapter ends with a 
description of the tools available to support surgeons with these difficult decisions. A 
critical appraisal of these tools highlights their methodological weaknesses and their 
limited ability to support decision-making. 
 
Chapter Two examines fundamental elements of surgical decision-making. Sound 
judgement in complex problems requires strong situational awareness and an analytical 
approach to decision-making. Uncertainty is common and can impede situational 
awareness and make rational decisions difficult. The ability to understand, communicate, 
and reason with uncertainty is therefore essential, and probability provides a language to 
accomplish this. Bayes theorem and Bayesian networks provide powerful tools that 
enable accurate estimates of the probabilities of uncertain states using available 
information and knowledge. As such, they may provide the ideal tools to improve 
situational awareness and support rational and evidence-based decisions in complex 
problems. 
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Chapter Three establishes the rationale for amputation decisions following severe lower 
limb trauma.  It also demonstrates important characteristics of these decisions including 
key determinants, and the time frames that decisions are made in. The principal reason for 
nearly 90 percent of amputations were life-saving haemorrhage control, insufficient tissue 
for reconstruction, non-viable limb tissue, or functional limitations. Three of these risks 
(the need for life-saving intervention, predicted limb viability, and predicted limb 
function) are often uncertain at the optimal time for decision-making, making amputation 
decisions difficult. 
 
Chapter Four explains the role of Trauma Induced Coagulopathy (TIC) in determining 
the need for life-saving intervention and validates the clinical relevance of TIC in damage 
control decision-making and patient outcomes. Evidence supporting the causal 
mechanisms of TIC was identified and used to develop a Bayesian network prognostic 
model for the condition. The model is able to provide an early and accurate estimate of an 
individual patients risk of TIC using routine baseline clinical information. 
 
Chapter Five validates the accuracy and generality of the TIC prognostic model in new 
patients. The Bayesian network can estimate the risk of a clinically relevant coagulopathy 
more accurately than any individual clinical predictor, and with comparable accuracy to 
validated diagnostic tests. The advantage of the model over these diagnostic tests is that it 
can reliably identify patients at risk of TIC at the right time for decision-making. In 
addition, the chapter demonstrates the ability of the Bayesian network to handle missing 
predictor information, a common problem in emergency situations that limits the function 
of traditional prognostic models. 
 
Chapter Six provides a comprehensive analysis of prognostic factors for amputation 
following lower limb vascular trauma. In addition, the study determined the absolute and 
relative amputation risk associated with each prognostic factor. 
		 235	
 
Chapter Seven uses the evidence established in Chapter Six to develop a Bayesian 
network prognostic model for limb viability. The model is able to accurately predict the 
outcome of limb reperfusion and objectively estimate the projected risk to limb viability 
for an individual injury, at the time of initial wound evaluation. Furthermore, the model 
has significantly better performance than an established and widely used decision-support 
tool, the Mangled Extremity Severity Score (MESS). 
 
 
8.2 Strengths and limitations 
The main strengths and limitations of each section of this thesis have been acknowledged 
in the corresponding chapters. There are, however, some important over-arching strengths 
and limitations that have not been discussed, and are presented here.  
 
Strengths 
This thesis demonstrates how Bayesian networks can be used to develop decision-support 
tools that both support Evidence Based Medicine (EBM) and help overcome some of the 
difficulties in achieving EBM. The principal aim of EBM is to integrate relevant 
epidemiological evidence, clinical judgement, and the patients’ perspective into clinical 
decision-making (Sackett et al., 1996). Real EBM makes the care of the individual 
patients its top priority (Greenhalgh et al., 2014). While EBM has unquestionably 
advanced health care, it does have some considerable limitations (Tonelli, 1998). 
Probably the most important criticism of EBM, ironically, is its lack of individualisation. 
An overemphasis on using one element, the best available evidence, to determine 
decisions, has shifted the focus of clinical care from what is important to the individual 
patient towards the average effect in a study population (Tonelli, 1998). As a result, the 
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contribution from sound clinical judgement and the patients’ needs and values has been 
devalued.  
Another notable weakness is that despite the widespread acceptance of EBM principles, 
the practicalities of how to integrate the different sources of information remain unclear 
(Engebretsen et al., 2015, Greenhalgh, 1999). No systematic approach to meaningfully 
draw on, and combine, all elements (epidemiological evidence, clinical expertise and 
judgement, and patient perspective) have been offered, even though this is fundamental to 
interpretation and ultimate decision-making. Furthermore, accessing and interpreting the 
sheer volume of evidence that may be applicable to an individual decision is impractical 
in daily clinical care (Greenhalgh et al., 2014), and may be impossible in emergency 
situations.  
The Bayesian networks developed in this thesis contribute to EBM in three important 
ways. Firstly, they allow different types of evidence (including published literature, high-
quality data, clinical expertise, and individual patient characteristics) to be integrated and 
combined in a natural way. Second, they enable individualised, meaningful, and evidence 
based interpretations of this information. For example, they can be used to quantify the 
degree of uncertainty and calculate clinically relevant risks for an individual patient. This 
information supports clinicians, and their patients’, in making rational judgements and 
informed decisions. Third, the network acts as an evidence repository, organising the 
knowledge related to a particular domain, and allowing efficient access when decision-
support is needed.  
 
Many prognostic models that are designed to support clinical decision-making are not 
adopted into routine practice because of a lack of clinical credibility (Wyatt and Altman, 
1995). For good reason, doctors are reluctant to use decision-support tools to inform their 
clinical decisions unless they can believe the model and trust its predictions.  
The Bayesian networks developed in this thesis have a number of features that enhance 
their clinical credibility. First, the models are designed to predict clinically relevant 
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outcomes using information that is normally available. Second, they are able to generate 
these predictions at an appropriate time for decision-making. Third, the structure of both 
models reflects current knowledge and was informed by systematically reviewing the 
contemporary literature. 
In addition, the graphical nature of Bayesian networks is ideally suited to represent this 
knowledge as well as the models reasoning mechanisms. This allows users to understand 
and interpret the models structure and logic, something that is not possible with 
traditional ‘black-box’ prognostic models. To enhance this capacity, a framework has 
been developed to organise and present the relevant knowledge and clinical evidence on 
which the models are based (Yet, 2013, Yet et al., 2014b). This provides users with the 
ability to browse clear yet detailed information pertaining to the models, including 
variable definitions, sources of information, and how each piece of evidence relates to the 
models (Figures 8.1 A and B). Furthermore, the evidence framework will enable 
upgrading and local modification of the Bayesian networks as new knowledge becomes 
available and old evidence becomes obsolete. 
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A) Evidence Browser: Example Variable 
 
B) Evidence Browser: Example Relation 
 
Figure 8.1: Screenshots from the online evidence browser developed by Yet (2013) 
which is available at http://atcbn.traumamodels.com:8080 showing: A) an example of 
information on a variable (lactate) in the TIC model, and B) an example of information 
on a relation (hypoperfusion and lactate) in the TIC model. 
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Limitations 
The aim of this thesis was to develop decision-support tools that are capable of providing 
the information needed to make informed decisions following severe lower limb trauma. 
The tools have been specifically designed not to predict decisions or prescribe treatments, 
but rather to provide relevant individualised risk assessments that allow clinicians, and 
their patients’, to exercise their own judgement and choice. It is assumed that the 
provision of accurate information will lead to better decisions and improved patient 
outcomes. However, these assumptions have not been tested in this thesis, and it is not yet 
known what effect these tools will have on severe lower limb trauma decision-making 
and outcome. 
 
A number of potential risks and benefits were identified that are key considerations when 
deliberating the best treatment options. Some are clear at the time of decision-making, 
while others are uncertain. This thesis has focused on developing models to predict key 
risks that influence immediate and early decisions, and have a high degree of uncertainty 
at the time of optimal decision-making. These, however, are not the only risks that are 
important to consider when making decisions. For example, estimates of the future 
function of the injured limb, if salvaged or amputated, are important considerations in 
many situations. Although these models provide accurate information on two important 
risks (trauma induced coagulopathy and limb viability), decisions should be based on a 
balance of all the relevant risks in each individual case, and not on the models predictions 
in isolation. 
 
 
8.3 Future work 
This thesis has developed our overall understanding of surgical decision-making 
following severe lower limb trauma and why these decisions are often difficult. Rational 
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treatment decisions depend on an accurate assessment of the risk to life, limb viability, 
and future limb function; and these risks are frequently uncertain at the time decisions 
need to be made. This thesis describes the development and validation of two evidence-
based prognostic models that enable an accurate and timely assessment of the risk of 
coagulopathy (the key indication for damage control intervention) and limb viability. 
Future work should focus on developing a prognostic model for functional outcome. 
Good quality evidence on functional outcomes following severe lower limb trauma exists 
(Bosse et al., 2002, MacKenzie et al., 2005, Doukas et al., 2013) and this evidence 
suggests that functional outcome depends on the combined effect of multiple factors 
(MacKenzie and Bosse, 2006). It is therefore conceivable that the methods described by 
Yet et al. (2014a, 2014c) for combining knowledge and data, could be used to develop an 
accurate Bayesian network prognostic model for functional outcome. Figure 8.1 
represents a possible starting point for development of the network structure of such a 
model.  
 
Figure 8.2: Factors influencing the long-term functional outcome of trauma survivors 
with severe lower limb injuries. 
 
Ideally, a prospective cohort study would be required to collect relevant data for model 
development; however, it may be possible to identify an existing dataset that includes 
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high quality information on all relevant factors. Potential datasets include those from the 
Lower Extremity Assessment Project (LEAP), a multicentre, prospective, observational 
study (Bosse et al., 2002), and/or the Military Extremity Trauma Amputation/Limb 
Salvage (METALS) Study, a retrospective cohort study (Doukas et al., 2013). 
 
Future research should also explore methods to optimise the user interface and clinical 
utility of these tools. An important limitation of many potentially valuable prognostic 
models is the time it takes to collect and input the required predictor information. 
Clinicians face increasing time pressures and may be reluctant to use a tool that adds to 
their workload (Bates et al., 2003). A system that automatically captures predictor 
information in real-time, from original sources, with automated display of calculations at 
an appropriate time for decisions, would be ideal. These features are strongly associated 
with improved clinical practice (Kawamoto et al., 2005). However, this requires clinical 
information to be routinely recorded in an electronic format. While some predictors, such 
as vital signs and blood analyses, are already captured electronically, others, such as 
history and examination findings, are still frequently recorded in hand-written notes. 
There is, however, a worldwide shift from paper-based to electronic patient records, with 
the National Health Service in England aiming to be paperless by 2018 (DOH, 2013). The 
development of suitable electronic patient records that can integrate computerised 
decision-support tools, such as the Bayesian networks developed in this thesis, have the 
potential to significantly improve health care (Bates et al., 2003, Bates and Gawande, 
2003, Kawamoto et al., 2005). 
 
Clinically useful methods of presenting the models probability estimates also requires 
further exploration. Although both models provide accurate predictions of clinically 
relevant patient risks, the significance of an absolute value may not be immediately 
apparent to the user. 
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Future research should define clinically relevant risk categories that support clinicians, 
and their patients’, in making informed decisions. In addition, relevant thresholds to 
guide critical interventions, such as activation of a Major Haemorrhage protocol or 
initiation of a damage control approach to surgery, should be investigated from a patient 
outcome, resource use, and cost perspective. 
 
Finally, the ultimate aim of the decision-support tools developed in this thesis is to 
improve the quality of trauma care and patient outcomes. A well-conducted clinical trial, 
designed to measure the impact that providing predictions has on decision-making, 
quality of care, and patient outcomes, compared to usual care, is warranted. The ideal 
methodology would be a randomised control trial and, as severe lower limb injuries are 
relatively rare, a multicentre trial would be necessary to recruit sufficient participants in 
an efficient timeframe. Such a trial would also help determine the role of knowledge-
based Bayesian networks as tools to support individualised and evidence based decisions 
in complex clinical problems. 
 
 
8.4 Conclusions 
This thesis has advanced the understanding of surgical decision-making following severe 
lower limb trauma, and presents two novel prognostic models to support these difficult 
decisions. These tools allow an accurate assessment of critical risks in individual cases. 
This information may help clinicians and patients understand their situation, and supports 
rational judgement on the most beneficial therapy. Prospective evaluation of the impact 
of these tools on decision-making and patient outcomes is needed. In the future, 
prognostic models like these Bayesian networks may be key to enabling clinicians to 
make individualised and evidence-based treatment decisions. 
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Data Extraction: Prognostic Factors for Secondary Amputation 
 
Author: Year: Journal: 
Title: 
 
Study design: Single centre / Multiple centres 
Setting:  Civilian / Military / Mixed Recruitment period: 
Country of origin: UN Classification: Developed / Developing 
 
Sample Size: Specialist Centre:  Y / N Duration of Follow-up: 
Population: 
 
Surgical intervention described? Yes / No / Unclear 
Non-standard or non-surgical intervention? Yes / No / Unclear 
Secondary amputation appropriately defined / described? Yes / No / Unclear 
 
 
Number of limbs with surgical repair of LEVT  
Number of secondary amputations  
 
 
Notes: 
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